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It’s the little things: An exploration of small RNAs and selfish genetic elements of the 
human bacterial pathogens Coxiella burnetii and Bartonella bacilliformis 
 
Chairperson: Dr. Michael Minnick 
 
Coxiella burnetii is a Gram-negative gammaproteobacterium and zoonotic agent of Q 
fever in humans. Previous work in our lab has demonstrated that C. burnetii codes for 
several small RNAs (sRNAs) that are differentially expressed between in vivo and in 
vitro growth conditions. sRNAs serve as post-transcriptional regulatory effectors 
involved in the control of nearly all biological processes. We demonstrated that several of 
the identified sRNAs, namely Coxiella burnetii small RNA 3 (CbsR3), Cbsr13, and 
CbsR16, represent members of two novel families of miniature inverted-repeat 
transposable elements (MITEs), termed QMITE1 and QMITE2. Furthermore, we have 
characterized a highly expressed, infection-specific sRNA, CbsR12, and have determined 
that it is necessary for expansion of the C. burnetii intracellular niche in a human 
monocyte-derived alveolar macrophage cell line. We have determined that CbsR12 may 
participate in broad gene regulation by acting as an “RNA sponge” for the global 
regulatory RNA-binding protein CsrA. Additionally, CbsR12 is a trans-acting sRNA that 
targets transcripts of the carA, metK, and cvpD genes in vitro and in vivo. 
          Bartonella bacilliformis is a Gram-negative alphaproteobacterium and the 
etiological agent of Carrión’s disease in humans. B. bacilliformis is spread between 
humans through the bite of female phlebotomine sand flies. As a result, the pathogen 
encounters significant environmental shifts during its life cycle, including changes in pH 
and temperature. Bacterial sRNAs can serve as a means of rapid regulation under shifting 
environmental conditions. We therefore performed total RNA-sequencing analyses on B. 
bacilliformis grown in vitro then shifted to one of ten distinct conditions that simulate 
various environments encountered by the pathogen during its life cycle. From this, we 
identified 160 sRNAs significantly expressed under at least one of the conditions tested. 
Northern blot analysis was used to confirm the expression of eight novel sRNAs. We also 
characterized a Bartonella bacilliformis group I intron (BbgpI) that disrupts an un-
annotated tRNACCU
Arg
 gene and determined that the intron splices in vivo and self-splices 
in vitro. Furthermore, we verified the predicted molecular targeting of a sand fly-specific 
sRNA, Bartonella bacilliformis small RNA 9 (BbsR9), to transcripts of the ftsH, nuoF, 
and gcvT genes, in vitro.
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Bacterial small RNAs as a means of rapid gene regulation 
Overview of small RNA functions 
Bacterial small RNAs (sRNAs) are small (<500 nts) transcripts that usually do not code 
for functional proteins. Instead, they serve as cis- and/or trans-acting regulators through a 
variety of mechanisms (reviewed in [1]). For example, cis-acting sRNAs are often coded 
antisense to a functional gene target. Upon transcription, the sRNA binds to the mRNA 
with perfect complementarity, usually culminating in ribonuclease degradation of the 
target. This effectively limits the free mRNA molecules available for translation 
(reviewed in [2]). Alternatively, trans-acting sRNAs are often coded in distant intergenic 
regions (IGRs) and bind to a variety of mRNAs through a more limited base-pairing 
mechanism involving a seed region of around ~7 - 12 nts (Figure 1.1). Many trans-acting 
sRNAs have been discovered in bacteria since Escherichia coli MicF was first described 
in 1984 [3]. These regulatory RNAs have been implicated in a variety of processes, 
including virulence [4], global regulation of transcription [5], iron homeostasis [6], 
protein degradation [7], and stress response [8, 9]. 
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Figure 1.1: Generalized mechanism of sRNA regulation. sRNAs can positively or 
negatively regulate translation of the mRNAs to which they bind by freeing or creating a 
ribosome-binding site occlusion, respectively. Adapted from: Vanderpool et al. 2011. 
 
          Some sRNAs are widely conserved in bacteria. These sRNAs often serve an 
essential function, the loss of which may result in cell death. For example, 6S RNA is 
widely found in all bacterial phyla except for Deinococcus, Thermus, Thermotogae, 
Tenericutes, Elusimicrobia, and Fibrobacteres, although even in these phyla, highly 
diverged copies of 6S RNA may be found [10]. 6S RNA functions by binding and 
sequestering RNA polymerase complexed with sigma 70, leading to global inhibition of 
transcription under certain conditions [11]. 6S RNA was first discovered in E. coli in 
1967 [12], but it wasn’t until more than 30 years later that it was found to regulate RNA 
polymerase activity during stationary phase [5]. Indeed, an E. coli strain lacking 6S RNA 
was found to be at a survival disadvantage during stationary phase [13]. 
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          Another example of a highly conserved sRNA is the tmRNA, a bifunctional sRNA 
that acts as both a tRNA and mRNA. tmRNA primarily functions by binding to and 
rescuing stalled ribosomes. Unlike an actual tRNA, though, tmRNA lacks an anticodon 
so instead functions as an mRNA by coding for a short peptide that is added to the C-
terminal end of the nascent polypeptide chain [14]. This peptide targets the incomplete 
nascent protein for degradation. Like 6S RNA, tmRNA was first discovered and 
described in E. coli [15], although unlike 6S RNA, a mutant strain of E. coli unable to 
express tmRNA does not have a significant growth phenotype [7]. The in vivo stability of 
tmRNA is much like that of a tRNA, leading to a generally high abundance of the sRNA 
in bacterial cells [14]. High expression or conservation of a sRNA, then, is not 
necessarily linked to necessity. This stresses the need for functional characterization of 
sRNAs based on factors other than expression and conservation. Indeed, an important 
additional characteristic of a sRNA may be its reliance on RNA chaperones for function. 
 
The Hfq chaperone 
Typically, trans-acting sRNAs require assistance in “finding” their respective mRNA 
targets. In most bacteria, this is accomplished by the RNA chaperone Hfq, which binds to 
both sRNAs and mRNAs and plays the role of a molecular matchmaker (reviewed in 
[16]). Hfq is essential for the function of many trans-acting sRNAs that rely on limited 
base pairing to regulate their target mRNAs [17]. Hfq was first identified more than 50 
years ago as a host factor required for replication of the Qβ bacteriophage in E. coli 
(reviewed in [18]). Since then, hfq homologs have been discovered in many bacteria, and 
mutants of these hfq genes expectedly cause pleiotropic phenotypes specific to the 
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repertoire of sRNAs they are associated with (reviewed in [19]). Hfq binds to its target 
sRNAs and mRNAs via its proximal face, distal face, rim, and C-terminal regions, which 
are solvent-exposed motifs with unique architectures able to bind RNA molecules [19]. 
For example, the proximal face of Hfq binds to poly-U stretches immediately following a 
hairpin loop structure, such as those found in Rho-independent terminators [20]. All 
known Hfq-binding sRNAs have been found to bind Hfq via this structure [20]. 
Meanwhile, the distal face of Hfq binds to both sRNAs and mRNAs via a sequence of 
ribonucleotides that varies between bacteria. For example, the E. coli Hfq distal face 
binds to (A-A-N)n repeat motifs, while Staphylococcus aureus Hfq binds to (A-L)n repeat 
motifs, where L is a linker ribonucleotide [21]. The rim region of E. coli Hfq is a 
secondary binding site for UA-rich regions in sRNAs and mRNAs [22], while the C-
terminal disordered region of Hfq seems to function as a stabilizing force in the binding 
of some sRNAs [23]. Generally speaking, Hfq-binding sRNAs can be divided into two 
classes: Class I sRNAs bind to the proximal and rim domains of Hfq and target mRNAs 
that bind the distal face, and Class II sRNAs bind the proximal and distal domains of Hfq 
and target mRNAs with rim domain binding sites (Figure 1.2) [16]. 
 5 
 
Figure 1.2: Mechanisms of Hfq binding and gene regulation. Negative and positive 
regulation via sRNA-Hfq complexes is shown in (a) and (b), respectively. Hfq-binding 
sRNAs can lead to stabilization (c) or degradation (d) of the sRNA. Hfq-sRNA 
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complexes targeting mRNAs can also lead to mRNA degradation (e). Adapted from: 
Vogel J et al. 2011. 
 
          Hfq is not obligatory, however. For example, S. aureus has several sRNAs but does 
not require Hfq protein for their activities [24]. Similarly, Coxiella burnetii does not have 
a readily apparent hfq gene. However, this doesn't rule out the possibility of an atypical 
Hfq or some other novel RNA chaperone in these bacteria. Bartonella bacilliformis strain 
KC583 encodes a single hfq gene, although its function in the bacterium has yet to be 
elucidated. 
 
CsrA and RsmY/Z 
Some sRNAs act by binding to and titrating RNA-binding proteins, effectively 
sequestering them away from regulatory activities. For instance, C. burnetii codes for two 
homologs (CsrA-1, CsrA-2) of the RNA-binding protein CsrA (also referred to as 
repressor of stationary phase metabolites, RsmA), which has been shown to regulate 
metabolism, biofilm formation, and Type IV secretion in other bacteria [25-27]. CsrA 
functions as a homo-dimer where each monomer binds to a Shine-Dalgarno (SD)-like 
motif (AGGA or ANGGA), leading to inhibition and, in some cases, upregulation, of 
translation (Figure 1.3) [28]. CsrA is regulated by CsrA-binding sRNAs, termed CsrB/C 
(also called RsmY/Z). Classical CsrB/C sRNAs consist of a series of stem-loops 
containing exposed AGGA or ANGGA motifs that bind and sequester CsrA, effectively 
limiting its mRNA regulatory capabilities [29]. Some RsmY/Z sRNAs, however, differ in 
the number of stem-loop regions containing CsrA-binding sites, and can harbor far fewer 
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motifs than the classical CsrB/C E. coli counterparts [30, 31]. The CsrA regulatory 
cascade has not been studied in C. burnetii, in large part due to the absence of readily-
discernible RsmY/Z sRNAs, although the CsrA regulon in Legionella pneumophila, a 
close relative of C. burnetii, has been extensively studied [32, 33].  
 
Figure 1.3: Generic mechanism of CsrA-mediated negative regulation. CsrA targets 
SD-like motifs of stem-loop structures. CsrA first binds to a high affinity target upstream 
of a transcript’s ribosome-binding site (a). Then, the proximity of CsrA to the ribosome-
binding site (b) leads to SD sequestration (c), preventing ribosome binding and inhibiting 
translation. Adapted from: Mercante J et al. 2009. 
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          The regulatory cascade leading to CsrA production varies between bacteria. This is 
due in some part to CsrA being involved in adaptation to host infection conditions, which 
differs between pathogenic bacteria depending on the niche they inhabit. For example, L. 
pneumophila occupies an intracellular niche in which it is essential for the bacterium to 
avoid lysosomal degradation. CsrA is a repressor of L. pneumophila transmission 
phenotypes and an activator of intracellular replication [32]. Thus, a successful infection 
relies on production of CsrA within the intracellular niche, although tight regulation is 
required for the activation of transmission phenotypes during the later stages of infection. 
In L. pneumophila and many other bacteria, CsrA is regulated by a two-component 
system (TCS) referred to as LetA/S, where LetS represents a sensor histidine kinase that 
senses some environmental stimuli that marks the necessity for transmission phenotypes. 
Concurrently, the RpoS sigma factor is also produced during L. pneumophila stationary 
phase. RpoS, along with the aid of the LetA response regulator, transcribes the RsmY/Z 
sRNAs, which bind to and sequester CsrA, allowing for the activation of transmission 
phenotypes and the production of effectors necessary for survival within the “next” 
intracellular niche (Figure 1.4) [27]. Like Hfq, though, CsrA is not ubiquitious among 
pathogens. B. bacilliformis, for example, does not code for any known CsrA homologs.  
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Figure 1.4: The L. pneumophila CsrA regulatory cascade. LetA/S and the RpoS sigma 
factor are indirect regulators of CsrA via the RsmY/Z sRNAs. Adapted from: Rasis M et 
al. 2009. 
 
sRNA-dependent regulation of virulence 
sRNAs have been implicated in the regulation of most bacterial processes, from 
transcription (6S RNA) and housekeeping (tmRNA), to the translation of specific gene 
subsets (RsmY/Z). Importantly, these sRNAs (6S RNA, tmRNA, and RsmY/Z) all 
perform their regulatory functions indirectly via protein binding. Most sRNAs function 
by directly binding mRNAs in cis or in trans, with or without the assistance of Hfq 
(Figure 1.5) [34]. For example, one of the most extensively studied trans-acting sRNAs 
is RNAIII of S. aureus. Firstly, while it is very uncommon for trans-acting sRNAs to 
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contain an open reading frame (ORF), RNAIII encodes the δ-hemolysin at its 5' end that 
aids in virulence [35]. Furthermore, RNAIII targets multiple mRNAs in trans, leading to 
their up- or down-regulation. Among the down-regulated virulence factors are coagulase 
(coa gene) [36] and peptidoglycan hydrolase (lytM gene) [37], while the α-hemolysin 
(hla gene) is up-regulated [38]. This regulatory scheme facilitates S. aureus 
dissemination. Another example is the PapR sRNA of uropathogenic E. coli strains, 
which binds to the coding sequence of papI mRNA, thereby causing translational 
repression [39]. The product of papI is itself involved in the activation of P-fimbriae 
biosynthesis. P-fimbriae is an essential virulence factor involved in the attachment of 
uropathogenic E. coli to renal tissue [40]. Regulation by the PapR sRNA, then, prevents 
activation of P-fimbriae synthesis, when required, during infection. 
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Figure 1.5: Mechanisms and examples of sRNAs affecting virulence. Numerous 
examples are given of cis-encoded (A) and trans-encoded (B) sRNAs that affect the 
virulence of pathogenic bacteria. Adapted from: Chakravarty and Massé. 2019. 
 
Means of identifying sRNA targets 
Perhaps the most challenging step in determining the roles of sRNAs in virulence is 
identifying the mRNA targets to which a particular sRNA binds. As an initial step, it is 
common to employ algorithms that can scan a given genome for mRNAs that may 
contain seed regions able to be bound by a particular sRNA. Although several of these 
algorithms exist, each prioritizes a certain metric, and thus, some tend to perform better 
than others when comparing the predictions to known in vivo sRNA targets [41]. For 
example, the TargetRNA2 algorithm prioritizes conservation of the sRNA, followed by 
the accessibility of the sRNA seed region, the accessibility of the mRNA target region, 
and the energy of hybridization [42]. As a result, the algorithm is best suited for sRNAs 
with known homology to other sRNAs. Meanwhile, the IntaRNA 2.0 algorithm 
prioritizes the energy of hybridization, followed by accessibility of the sRNA and mRNA 
as determined by RNA secondary structure prediction. Conservation of the 
sRNA/mRNA, though, is not taken into consideration [43]. Meanwhile, the CopraRNA 
algorithm rigorously prioritizes conservation of the sRNA and mRNA, while its methods 
for computing free energy and sRNA/mRNA accessibility are more outdated [44]. It is 
helpful, then, to have some a priori knowledge of the sRNA of interest when considering 
the results of these algorithms. For example, the expression pattern of the sRNA in 
various stages of growth, in axenic culture vs. in vivo conditions, etc., are all valuable in 
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determining which in vitro targets “make sense”. That said, these in silico predictions 
need to be confirmed through other methods such as in vitro binding assays and/or in vivo 
cross-linking experiments. 
          RNA-RNA electrophoretic mobility shift assays (EMSAs) are valuable for the 
determination of specific sRNA-mRNA interactions. When combined with in vitro 
mutagenesis of predicted seed regions, one can even identify the specific RNA bases 
mediating these interactions [45, 46]. There are also several methods for the in vivo cross-
linking of sRNAs to their targets. These sRNA-mRNA complexes are usually captured 
and sequenced in order to determine the biologically relevant repertoire of mRNA targets 
for any given sRNA. For example, cross-linking, ligation, and sequencing of hybrids 
(CLASH) is predicated on the affinity purification of UV cross-linked RNA-protein 
complexes [47]. Some of these RNA-protein complexes will contain multiple RNAs that 
are then ligated to each other before RNA-sequencing [47]. For example, CLASH has 
been used to determine the repertoire of E. coli sRNA-mRNA interactions mediated by 
Hfq during nutrient-limiting conditions [48]. 
 
Bacterial selfish genetic elements 
Overview of selfish genetic elements 
A selfish genetic element is a DNA segment that enhances its own transmission and 
maintenance at the expense of other genes in a given genome. This is regardless of 
whether such an element would enhance the fitness of an organism or not [49]. The 
concept of a selfish genetic element was first noted in 1928, when it was found that the 
female X chromosome in the fruit fly, Drosophila obscura, seemed to be over-abundant 
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in fruit fly populations, indicating an uneven female:male sex ratio that could lead to 
extinction of the species [50]. In 1950, Barbara McClintock discovered the existence of 
transposable elements (TEs) in maize [51]. This represented the first characterization of a 
selfish genetic element. Despite this, it wasn’t until 1980 that Leslie Orgel and Francis 
Crick popularized the concept of selfish DNA, showing that these elements spread in a 
population regardless of their effect on fitness [52].  
          In the context of bacteria, selfish genetic elements constitute anywhere from 0-21% 
of a genome and seems to vary with ecology rather than phylogeny [53]. Notably, 
bacteria undergoing reductive evolution harbor larger amounts of selfish genetic elements 
when compared to other bacteria [54]. The impetus for reductive evolution seems to be 
the transition of an organism from free-living to obligate parasite [54]. As this transition 
occurs and some genes become unnecessary due to the nutrient replete environment of 
the host, large quantities of DNA may be lost. This leads to an increase in the number of 
pseudogenes (pseudogenization) and the multiplication and spread of selfish genetic 
elements, in part due to successive bottleneck events [55].  As an obligate intracellular 
pathogen, C. burnetii represents a bacterium undergoing reductive evolution. As such, it 
contains a high number of pseudogenes (10.1% of all ORFs) and a variety of different 
selfish genetic elements [56]. 
Transposons, insertion sequences, MITEs, and Group I introns 
Bacterial TEs include transposons (Tns), insertion sequences (IS), miniature inverted-
repeat transposable elements (MITEs), and group I introns, among others [57]. TEs are 
considered intracellular mobile genetic elements in that they rely on other mobile genetic 
elements for inter-cellular spread [57]. While Tns, IS, MITEs, and group I introns all 
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have similarities in function, there are some differences that distinguish one from another. 
Tns represent a broad term for TEs and can be divided into two major categories: Class I 
(retrotransposons) and Class II (DNA transposons). Retrotransposons are most often 
found in eukaryotes and so won’t be discussed. Class II Tns can be found in both 
eukaryotes and prokaryotes [57]. Furthermore, each class can be divided into autonomous 
Tns, which are able to catalyze their own transfer, and non-autonomous Tns, which 
require some other element for transposition [57]. Broadly, Tns represent large DNA 
segments that contain a gene coding for a transposase enzyme. That gene is flanked by 
terminal inverted-repeat (TIR) sequences that aid in targeting the Tn to specific DNA 
sequences in a cut-and-paste mechanism that is facilitated by the transposase enzyme 
[57].  
          Bacterial Tns usually encode other genes that may provide some adaptive benefit 
for an organism, such as an antibiotic resistance gene [58]. When no gene other than the 
transposase gene is present, a Tn is referred to as an IS. As a result, IS elements are 
smaller than Tns. IS elements are widely distributed in bacteria and may have large 
effects on genome evolution [57]. For example, the phenomenon of IS expansion is seen 
in bacteria that have recently adopted a host-restricted lifestyle [59]. IS expansion is 
thought to be an early consequence of host adaptation brought on by the sudden 
enhancement of genetic drift due to successive population bottlenecks in a host nutrient 
replete environment [60]. Ultimately, as a bacterium becomes adapted to the host, 
deletion of IS elements and adjacent DNA leads to genome reduction. As IS elements 
become non-autonomous due to loss of transposase function, these elements are 
eventually lost as the bacterial genome becomes more streamlined [57]. 
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          MITEs are non-autonomous class II TEs with defective or missing transposase 
genes. As such, they can only be mobilized in trans by transposases expressed from 
related Tns [61]. Most bacterial MITEs consist of 4-30 bp TIRs with a TA dinucleotide at 
their termini. MITEs are typically small (100-400 bp) and do not encode proteins; rather, 
their transcripts generate highly stable stem-loop structures [62]. MITE insertions have 
been implicated in virulence by fostering a plastic genome that enhances acquisition of 
virulence traits [63] and through physical insertions that alter ORFs and directly lead to 
virulence phenotypes [64]. Promoter regions and ORFs are common features of bacterial 
MITEs [65-68]. Moreover, integration host factor (IHF)-binding sites and 
methyltransferse binding domains have been reported [66, 69]. While most MITEs 
integrate into IGRs, some have been reported: a) in structural RNA genes [70], b) in 
protein-encoding genes to create in-frame protein fusions [71], and c) proximal to genes 
whose transcripts are regulated by the corresponding MITE RNA [72, 73]. Thus, MITEs 
can potentially interact at DNA, RNA or protein levels in a host bacterium, depending 
upon their structure and genomic sites of integration. 
          Group I introns are considered to be autonomous class II TEs that insert into 
tRNAs, rRNAs, and protein-coding genes. Generally speaking, group I introns are 
ribozymes that, upon transcription, catalyze their own splicing. Although this RNA 
splicing is auto-catalytic, they sometimes require protein co-factors for self-splicing in 
vitro, and it is presumed that all group I introns require protein co-factors to some extent 
for splicing in vivo [74]. Furthermore, some group I introns harbor a gene coding for a 
homing endonuclease, which is thought to further facilitate their transposition [75]. 
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Coxiella burnetii is a zoonotic, obligate intracellular human pathogen 
Overview of pathogenicity 
C. burnetii is a Gram-negative, obligate intracellular bacterium and etiological agent of Q 
(query) fever in humans. Q fever most often manifests as an acute, flu-like illness, which 
in rare cases progresses to potentially life-threatening endocarditis [76]. C. burnetii 
undergoes a biphasic life cycle in which it alternates between a metabolically-active, 
replicative large-cell variant (LCV) and a non-replicative, spore-like small-cell variant 
(SCV) [77]. Upon aerosol transmission of SCVs to a mammalian host, C. burnetii is 
primarily endocytosed by alveolar macrophages, after which it survives acidification of 
the host phagolysosome and metamorphoses to LCVs. C. burnetii then utilizes the fusion 
of its Coxiella-containing vacuole (CCV) with lysosomes and autophagosomes in order 
to expand the intracellular niche (Figure 1.6) [78, 79]. CCV expansion is dependent on 
C. burnetii protein synthesis, but independent of replication, so expansion of the CCV is 
facilitated by a repertoire of Dot/Icm effector proteins secreted by a Type IV-B secretion 
system (T4BSS) [80, 81]. Many Dot/Icm substrates have been identified in recent years 
[82] and shown to modulate the host inflammasome [83], influence 
autophagosomal/lysosomal fusion with the CCV by various mechanisms [84-88], and 
regulate the host transcriptome after localizing to the nucleus [89, 90]. Little is known 
about regulation of C. burnetii’s T4BSS, although the PmrA response regulator has been 
shown to enhance synthesis of the T4BSS apparatus as well as certain Dot/Icm substrates 
[91]. 
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Figure 1.6: Developmental cycle of C. burnetii. The developmental cycle of C. burnetii 
in alveolar macrophages is shown. The LCV (light blue) and SCV (dark blue) 
morphotypes are indicated as the infection proceeds. Adapted from: Minnick and 
Raghavan, 2011. 
 
          The only confirmed virulence factor in C. burnetii is lipopolysaccharide (LPS). C. 
burnetii LPS undergoes a process called phase variation where its length and molecular 
properties may change, leading to altered virulence [92]. For example, expression of 
phase I LPS (full-length LPS) leads to virulence in mammal hosts, while expression of 
phase II LPS (deep rough LPS) renders the LPS immunogenic, leading to clearance [93]. 
It has also been shown that repeated passages of C. burnetii in embryonated hen’s eggs 
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with phase I LPS (~10 passages) leads to a phase II LPS phenotype [94]. The noted 
difference in immunogenicity is due to the steric hindrance of antibody binding to phase I 
LPS compared to phase II LPS [95]. Recently, a series of C. burnetii genes was 
implicated in successful synthesis of phase I LPS, and it was shown that an accumulation 
of mutations in several genes leads to truncation and formation of phase II LPS in vivo 
[96]. 
C. burnetii small RNAs 
A previous study revealed 15 novel C. burnetii sRNAs that were differentially transcribed 
either in LCVs vs. SCVs, or in host cell infections vs. growth in ACCM-2 medium [97, 
98]. Of special interest were Coxiella burnetii small RNA 1 (CbsR1) and CbsR12, which, 
along with being upregulated during infection compared to growth in axenic medium, 
also have predicted Rho-independent terminators and strong predicted promoter elements 
[97]. We hypothesize that these highly expressed, “infection-specific” sRNAs play 
important roles in C. burnetii infection of mammalian cell lines. 
C. burnetii selfish genetic elements 
C. burnetii’s genome suggests that it is a relatively recent obligate intracellular pathogen, 
based upon the high number of pseudogenes and selfish genetic elements [99]. Among 
these elements are an intein [100], two group I introns [101], an intervening sequence 
(IVS) [102], and TEs, including multiple copies of IS1111 [103]. The IS1111 transposon 
has been studied extensively and found to preferentially insert into a palindromic DNA 
sequence that is widely distributed throughout the C. burnetii genome [104]. This 
palindromic DNA sequence has been described as a GTAG repetitive extragenic 
palindrome (REP), although the nature and distribution of the REP has not been 
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described [105]. There is little information on other families of TEs in the C. burnetii 
genome. We hypothesize that non-autonomous IS elements such as MITEs also exist 
within the C. burnetii genome. 
 
Bartonella bacilliformis is a vector-borne, facultative intracellular human pathogen 
Overview of pathogenicity and disease 
B. bacilliformis is a Gram-negative, facultative intracellular bacterium and the etiological 
agent of Carrión’s disease in humans. Carrión’s disease often manifests as a biphasic 
illness characterized by acute hemolytic anemia followed by eruptions of blood-filled 
hemangiomas of the skin [106]. Timely antibiotic administration restricts the fatality rate 
of Carrión’s disease to ~10%, although if left untreated, the rate has been reported to be 
as high as 88% [107, 108]. B. bacilliformis is transmitted between humans through the 
bite of female phlebotomine sand flies, specifically Lutzomyia spp. [109, 110]. The 
endemic region of Carrión’s disease has historically been limited to arid, high-altitude 
valleys (600 – 3200m) in the Andes Mountains of Peru, Colombia, and Ecuador, 
reflecting the habitat of the sand fly vector [111, 112].  
          The initial, acute stage of Carrión’s disease is referred to as Oroya fever (OF), and 
it is characterized by colonization of the entire circulatory system, leading to infection of 
~61% of all circulating erythrocytes [112, 113]. This bacterial burden typically leads to 
severe anemia, fever, jaundice, and hepatomegaly, among other symptoms [114]. Weeks 
or months following OF, B. bacilliformis seemingly invades endothelial cells, where it 
triggers cell proliferation and angiogenesis. This event leads to formation of 
hemangiomas of the skin, referred to as verruga peruana (VP) (Figure 1.7). The VP stage 
 20 
is chronic and lasts about one month to a year [106, 111]. Although Carrión’s disease can 
present as a severe illness, there are many documented cases with relatively milder 
symptoms and/or the onset of VP without having presented with OF symptoms [115]. In 
consideration of reports involving less virulent B. bacilliformis strains and the possibility 
that other Bartonella spp. can cause mild symptoms resembling Carrión’s disease, the 
incidence of the disease is likely underreported [116-118]. 
 
Figure 1.7: Model of an acute B. bacilliformis infection. Upon transmission by a 
phlebotomine sand fly (not depicted), B. bacilliformis may first invade endothelial cells, 
followed by dissemination to the blood stream and infection of erythrocytes, leading to 
cell death and hemolytic anemia. Subsequently, endothelial cells may provide a 
secondary niche during the chronic VP stage of infection. Adapted from: Gomes and 
Ruiz, 2017.  
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Infection cycle and virulence factors 
The B. bacilliformis infection cycle is strikingly under-studied compared to other vector-
borne pathogens. It is clear that the bacterium is transmitted by female L. verrucarum 
sand flies, although artificial feeding experiments showed that L. longipalpis can also 
“vector” the pathogen in the laboratory [110]. These studies also revealed that B. 
bacilliformis colonized and persisted in the lumen of the abdominal midgut of L. 
verrucarum but were digested along with the blood meal in L. longipalpis [110]. Despite 
this, viable bacteria were retrieved from both insects following a 7-d colonization period 
[110]. Other Lutzomyia spp. have been found to contain B. bacilliformis DNA, but 
colonization experiments have not been performed [119]. It has also been suggested that 
other mammals may serve as reservoir hosts for B. bacilliformis. However, serosurveys 
of animals that came into contact with infected humans were negative for B. bacilliformis 
DNA [120]. Interestingly, in various attempts to establish an animal model of B. 
bacilliformis infection, the bacterium was only able to infect rhesus macaques [121] and 
owl monkeys [122]. These results suggest that other primates could conceivably serve as 
natural reservoir hosts for B. bacilliformis, although there is a paucity of non-human 
primate species in L. verrucarum’s geographic range. Regardless, the lack of a small 
animal model severely limits the prospects of laboratory studies examining B. 
bacilliformis infections in vivo. 
          A number of virulence attributes are involved in B. bacilliformis pathogenesis, 
including erythrocyte attachment [123], invasion [124-126] and hemolysis [127]. 
Similarly, several factors have been implicated in endothelial cell invasion [128] and 
proliferation [129-131]. However, regulatory mechanisms that facilitate the pathogen’s 
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virulence, colonization, and persistence in the sand fly have not been explored, to date. 
The disparate environments encountered by B. bacilliformis during transmission from 
sand fly vector to human host, and back again, suggest that genetic regulatory 
mechanisms are used to rapidly adapt to prevailing conditions. For example, the 
temperature of the sand fly vector would be comparable to ambient temperatures in the 
geographical range of the insect. The competent vector, L. verrucarum, is endemic to 
high-elevation ranges of the Occidental and Inter-Andean valleys of Peru, Colombia, and 
Ecuador [132], where temperatures range from 17⁰ C - 22⁰ C; fairly consistent with 
laboratory “room temperature” [133]. Upon transmission to the human host, the 
bacterium would need to adjust to a human body temperature of ~37⁰ C. Similarly, 
human blood has a pH of ~7.4, while the pH of the sand fly (L. longipalpis) abdominal 
midgut after a blood meal is ~8.2, lowers to ~7.7 as the blood meal is digested, and 
decreases to ~6.0 after digestion [134, 135]. In contrast, the thoracic midgut is maintained 
at pH ~6.0, regardless of digestion status [134]. A rapid means of regulating virulence 
and stress-related factors to counteract sudden shifts in temperature and pH would be 
clearly adaptive for B. bacilliformis. We hypothesize that sRNAs play a role in the 
rapid gene regulation necessary for B. bacilliformis adaptation to different aspects of 
its infection cycle. 
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Chapter 2 
Identification of novel MITEs (miniature inverted-repeat transposable 
elements) in Coxiella burnetii: implications for protein and small RNA 
evolution 
As published in: BMC Genomics. 2018 Apr 11;19(1):247. doi: 10.1186/s12864-018-
4608-y 
 
Abstract 
Coxiella burnetii is a Gram-negative gammaproteobacterium and zoonotic agent of Q 
fever. C. burnetii's genome contains an abundance of pseudogenes and numerous selfish 
genetic elements. MITEs are non-autonomous Tns that occur in all domains of life and 
are thought to be ISs that have lost their transposase function. Like most TEs, MITEs are 
thought to play an active role in evolution by altering gene function and expression 
through insertion and deletion activities. However, information regarding bacterial 
MITEs is limited. Here, we describe two MITE families discovered during research on 
small non-coding RNAs (sRNAs) of C. burnetii. Two sRNAs, Cbsr3 and Cbsr13, were 
found to originate from a novel MITE family, termed QMITE1. Another sRNA, CbsR16, 
was found to originate from a separate and novel MITE family, termed QMITE2. 
Members of each family occur ~50 times within the strains evaluated. QMITE1 is a 
typical MITE of 300-400 bp with short (2-3nt) direct repeats (DRs) of variable sequence 
and is often found overlapping annotated ORFs. Additionally, QMITE1 elements possess 
sigma-70 promoters and are transcriptionally active at several loci, potentially 
influencing expression of nearby genes. QMITE2 is smaller (150-190 bps), but has longer 
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(7-11nt) DRs of variable sequences and is mainly found in the 3' untranslated region 
(UTR) of annotated ORFs and IGRs. QMITE2 contains a GTAG REP that serves as a 
target for IS1111 TE insertion. Both QMITE1 and QMITE2 display inter-strain linkage 
and sequence conservation, suggesting that they are adaptive and existed before 
divergence of C. burnetii strains. 
 
Introduction 
C. burnetii is a Gram-negative, obligate intracellular gammaproteobacterium and the 
etiologic agent of Q fever in humans. Q fever is an acute, flu-like illness that can present 
with pneumonitis, hepatitis and malaise. In less than 5% of cases, chronic infection can 
develop with potentially life-threatening endocarditis as the most common manifestation 
[76]. C. burnetii undergoes a biphasic life cycle in which it alternates between a 
metabolically-active, replicative large-cell variant (LCV) and a dormant, spore-like 
small-cell variant (SCV) [136]. Upon inhalation of SCV’s by a mammalian host, alveolar 
macrophages internalize the bacteria and trap them within a highly acidic (pH ~4.5) 
parasitophorous vacuole that has features of a mature phagolysosome [78]. C. burnetii 
has adapted to survive in this acidic environment, where it forms a replicative niche. 
Dot/Icm effectors are translocated to the host cell in a T4BSS-dependent manner in order 
to establish and maintain the vacuole [81]. LPS is another critical virulence determinant 
in C. burnetii [137], although it has been found to be truncated (rough) in some strains, 
including the Nine Mile phase II laboratory strain, RSA 439 [138]. Interestingly, the 
Dugway 5J108-111 strain has a full-length LPS, but is avirulent [139]. Dugway is 
considered to be the most primitive of the sequenced C. burnetii strains based on a larger 
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genome with apparently less reductive evolution than virulent strains, such as RSA 493 
[56]. It is hypothesized that Dugway either contains a gene(s) that impedes infection in 
humans, or that the virulent RSA 493 strain has some altered virulence gene(s) rendering 
it infective [140]. 
          C. burnetii was recently shown to produce at least 15 sRNAs [97]. In this report, 
we show that Coxiella burnetii sRNA 3 (Cbsr3), CbsR13, and a newly defined sRNA, 
CbsR16, arose from two novel MITE families of the pathogen. Furthermore, we 
demonstrate how these novel MITE families can serve as a timeline for IS1111 
transposition based upon their linkage and sequence conservation between strains. 
Finally, we show that although MITE copies show linkage and sequence conservation, an 
indel in a potential virulence-associated gene (enhC) affected by QMITE2 has created a 
truncated version of the gene in the virulent RSA 493 strain as compared to the avirulent 
Dugway strain. 
 
Materials and Methods 
Discontiguous MegaBLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi) was used as a local 
alignment program using default parameters to identify regions of homology to CbsR13 
and CbsR16 in the C. burnetii genome (strains RSA 493; GenBank accession number 
AE016828.3 and Dugway 5J108-111; GenBank accession number CP000733.1). In order 
to compare the various QMITE loci in the RSA 493 genome, multiple sequence 
alignments of QMITE copies were performed using MUSCLE alignments via Geneious 
version 11.0.2 software with the default settings [141] 
(https://www.geneious.com/download/). Phylogenetic analyses of various groups of 
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QMITE insertions were carried out by first trimming the MUSCLE alignments utilizing 
Gblocks version 0.91b software [142] 
(http://molevol.cmima.csic.es/castresana/Gblocks.html). This served to eliminate poorly 
aligned and highly divergent regions in the various alignments. The default parameters 
are exceptionally stringent and are catered towards longer input sequences. Thus, the 
minimum block length was reduced to four, and gap positions were allowed for half of 
the input sequences at each aligned position in order to accommodate the relatively 
shorter input sequences. Phylogenetic trees of these trimmed alignments were then 
constructed using FastTree version 2.1 [143] 
(http://www.microbesonline.org/fasttree/#FAQ). The generalized time-reversible model 
of nucleotide evolution was used and phylogeny was inferred using maximum likelihood. 
The resulting Newick tree file was visualized using FigTree version 1.4.3 
(http://tree.bio.ed.ac.uk/software/figtree/). To support our designations of QMITEs as 
MITEs, supplemental MITE predictions of the C. burnetii RSA 493 genome were 
performed using MUSTv2 software [144] 
(http://www.healthinformaticslab.org/supp/resources.php). Predicted RNA secondary 
structures used to confirm the presence of TIRs were generated using mfold [145] 
(http://unafold.rna.albany.edu/?q=mfold). In order to demonstrate the potential for 
transcription of QMITE inserts, prediction of sigma-70 consensus promoter elements and 
Rho factor-independent terminators in QMITE inserts was performed using BPROM 
(http://www.softberry.com/berry.phtml?topic=bprom&group 
=programs&subgroup=gfindb) and ARNold (http://rna.igmors.u-psud.fr/toolbox/arnold/), 
respectively. CIRCOS software [146] (http://circos.ca/software/ download/ circos/) was 
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used to visualize and depict positions of QMITEs on the C. burnetii chromosome. RNA-
Seq data [Sequence Read Archive (SRA) database under accession number SRP041556] 
were analyzed using a custom pipeline, although various nesoni version 0.128 
applications for processing high-throughput sequence data were also used 
(http://www.vicbioinformatics.com/software.nesoni.shtml). Transcripts per million 
(TPM) were calculated using custom perl and python scripts that can be accessed through 
GitHub (https://github.com/shawachter/TPM_Scripts). The Artemis genome browser was 
used to visualize alignment files generated from ambiguous and unambiguous read data 
(http://www.sanger.ac.uk/science/tools/artemis) [147]. Other figures were created using 
Powerpoint 2010 software (Microsoft, Redmond, WA). 
 
Results 
CbsR3 and CbsR13 loci are members of a novel MITE family 
CbsR13 was originally identified as a C. burnetii sRNA by RNA-Seq analysis of the 
transcriptome [97]. It is often helpful to analyze both ambiguous and unambiguous reads 
associated with any RNA-Seq data. Ambiguous reads refer to those reads that can’t be 
aligned to one specific area of the genome because multiple copies of that sequence exist 
in the genome. Unambiguous reads refer to those that could only be mapped to one 
region of the genome. Upon visualization of ambiguous and unambiguous reads that map 
to the CbsR13 locus, we discovered that there were many ambiguous reads associated 
with it (Figure 2.1A). We also found that CbsR13 RNA produced a stable predicted 
secondary structure resembling a very long palindromic sequence (Figure 2.1B). 
Although a megaBLAST search produced several hits of high homology, the divergent 
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nature of the CbsR13 sequences necessitated use of a discontiguous megaBLAST search, 
which identified dozens of sequences with significant homology to CbsR13 in the 
genome. Specifically, the search identified 44 ranges, with E values of 8e-11 to 3e-123. 
Of these hits, 21 were at least 75% of the length of CbsR13 (>232 bp). It was noted upon 
alignment of the regions flanking these sequences that some of the ranges contained 
truncated 5′ ends and elongated 3′ ends. An artificial sequence combining the native 
CbsR13 sequence and the 3′ extension (see Figure S2.1) was thus used as an input for 
another discontiguous megaBLAST search. This search revealed 45 ranges, with E values 
from 9e-10 to 5e-123. Twenty-three of these hits were at least 75% of the input sequence 
length (>350 bp). A multiple alignment and phylogenetic analysis of these 23 sequences 
is shown in Figure 2.2A and Figure S2.2, respectively. The remaining 22 elements 
ranged in size from 39-321 bp (not shown), possibly representing degenerate forms of the 
original nucleotide sequences. One megaBLAST hit for the extended-CbsR13 
corresponded to a large portion of the CbsR3 gene sequence (i.e., nt 481609-481806) (see 
Figure 2.2A, range 2) [97]. This result suggests that the two sRNAs share a common 
ancestor, although unambiguous TPM values from RNA-Seq show that CbsR13 is 
expressed at a markedly higher level relative to CbsR3 (Figure S2.3). Confirming what is 
seen in Figure 2.1A, the ambiguous TPMs associated with CbsR3 and CbsR13 are much 
higher than the unambiguous TPMs, indicating that additional CbsR13 loci are 
transcriptionally active (Figure S2.3). Indeed, a sigma-70 promoter search using 
BPROM predicts a promoter in the forward strand and two promoters in the reverse 
strand of the input sequence (Figure S2.1). 
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Figure 2.1: Ambiguous and unambiguous reads map to the CbsR13 locus. (A) 
Artemis view of reads mapping to the CbsR13 locus (RSA 439 genome). The x-axis 
indicates the location (bp) on the chromosome and the y-axis indicates coverage of reads 
mapping to that location. Reads above the y-axis indicate antisense reads, whereas reads 
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below the y-axis indicate sense reads mapping to that genomic location. Blue lines 
signify ambiguous reads mapping to this locus, while the red lines denote unambiguous 
reads. (B) mfold secondary structure prediction of the CbsR13 sRNA. Red, blue, and 
green lines forming stem structures indicate G-C, A-U, and G-U base-pairing, 
respectively (predicted ∆G = -128.5 kcal/mol). 
 
 
Figure 2.2: CbsR13 loci contain a canonical IHF-binding site. (A) MUSCLE sequence 
alignment of discontiguous megaBLAST hits (>75% of input sequence) associated with 
the extended-CbsR13 input sequence. Conserved bases appear as gray blocks, while 
unaligned bases appear as green, yellow, blue, and red bands, corresponding to T, G, C, 
and A bases, respectively. An identity indicator is shown above the sequence alignment, 
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where height signifies conservation of bases at that position, with a color indicator for 
overall identity between aligned ranges (green: 100%, yellow: 20-99%, red: 0-19%). The 
consensus sequence is shown above the identity indicator as colored bands indicating 
bases as described above. (B) The same alignment as shown in (A), focusing on the 
potential IHF-binding site. The sequence above the red line indicates the consensus IHF-
binding site utilizing nucleotide notation, and above the alignment is a sequence logo 
where the height of the displayed bases indicates the relative identity of the aligned base 
at that position.  
 
          A common motif associated with bacterial TEs is an IHF-binding site [67]. IHF is a 
bacterial DNA-binding protein that binds to a specific DNA motif and facilitates bending 
of the DNA. It is thought that this bending aids in transposition of the locus [148]. The 
consensus IHF-binding nucleotide sequence is WATCAANNNNTTR [149]. Although 
IHF-binding sites are common in bacterial TEs, they are not always present in MITEs 
[67]. A manual search through the aligned ranges in Figure 2.2A, though, led to the 
discovery of a well-conserved IHF-binding site (Figure 2.2B). We chose Range 5 
(Figure 2.2A) as a representative for this repeated sequence due to its completeness, and 
utilized mfold to visualize where this IHF-binding site was located and to see if the 
sequence had a TIR that could aid in the element’s categorization as a MITE. As shown 
in Figure 2.3A, it is clear that the element has a TIR of 21 bp in length. Based on the 
length of the element (~400 bp), the TIR, and the multiple loci scattered throughout the 
C. burnetii RSA 493 genome, we conclude that this element is a bona fide MITE. 
Moreover, no similar MITEs have been previously described, and BLASTn searches 
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found no orthologues in other genomes. Thus, we can conclude that this is a novel MITE 
that we designate as QMITE1. Other ranges in Figure 2.2A generated similar predicted 
secondary structures, with corresponding TIRs ranging from 21-28 nts (not shown). 
MUSTv2 software was also employed to confirm QMITE1 as a MITE (Figure S2.4) 
[144]. Using stringent parameters, MUSTv2 identified eight of the top ten most 
homologous ranges to the extended-CbsR13 input sequence and also identified 2-4 bp 
DRs of nucleotide compositions WW, SS, or GAAG. From this information, a model of 
QMITE1 was generated and is shown in Figure 2.3B. 
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Figure 2.3: CbsR13 loci represent a novel MITE, called QMITE1. (A) mfold 
secondary structure prediction of a selected QMITE1 (range 5; predicted ∆G = -192.72 
kcal/mol). Red bars bracket the TIRs and the blue line indicates the location of the 
potential IHF-binding site. (B) Model of QMITE1 depicting DRs as red arrow heads and 
the TIRs as hatched arrow heads. Length ranges for these features are also shown. 
 
QMITE1 copies encode basic peptides and overlap with annotated genes 
Along with being transcriptionally active, 19 QMITE1 copies fully contain short, 
annotated ORFs that encode predicted peptides with an average isoelectric point (pI) of 
12.4. These basic peptides can be divided into three major groups based on sequence 
similarity (Figure S2.5), and they constitute the entire DUF1658 family of small, 
uncharacterized C. burnetii proteins in the Pfam database [150].  
          Other annotated genes that are affected by QMITE1 insertions mainly encode 
hypothetical proteins of unknown function. However, QMITE1 copies also overlap with 
several functional genes, including: ubiB C-terminal 2-bp overlap, pntAA C-terminal 42-
bp overlap, mutT C-terminal 26-bp overlap, CBU_2058 proline/betaine transporter C-
terminal 49-bp overlap, nagZ C-terminal 50-bp overlap, and CBU_2020 glutamate 
transporter C-terminal 3-bp overlap. The effect of these QMITE1 insertions in the 3′ 
UTRs of these genes could not be determined, although other MITE insertions in 3′ 
UTRs have been observed to translationally repress the affected genes [151]. 
The CbsR16 locus is a member of a second novel MITE family 
We recently identified a new sRNA termed CbsR16 while analyzing CbsR12; a sRNA 
that is significantly upregulated during C. burnetii’s intracellular infection of host cells 
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[97]. The cbsR16 gene is located immediately downstream of the cbsR12 gene, which 
shares a bi-directional Rho-independent terminator with cbsR16 (data not shown). When 
viewing the CbsR16 locus with the Artemis genome browser, it was clear that there was 
minor differential expression of the locus when taking ambiguous reads into 
consideration (Figure 2.4A). Additionally, when we analyzed CbsR16 using mfold, the 
predicted secondary structure was highly stable (Figure 2.4B). Moreover, although 
QMITE1 is significantly transcribed at more than one location in the C. burnetii genome, 
CbsR16 is transcribed at a considerably lower level (Figure S2.3), with very minor TPM 
differences between mapped unambiguous and ambiguous transcripts. This indicates that 
although other sequences homologous to CbsR16 may exist in the RSA 493 genome, 
only the locus adjacent to CbsR12 is transcribed to any significant level. The strong 
secondary structure and minor presence of ambiguously mapped reads of CbsR16, 
though, warranted a genome-wide search for similar sequences. 
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Figure 2.4: CbsR16 is lowly transcribed, with some ambiguous reads mapping to it. 
(A) Artemis view of reads mapping to the CbsR16 locus (RSA 439 genome). The x-axis 
shows the location (bp) on the chromosome and the y-axis indicates coverage of reads 
mapping to that location. Reads above the y-axis indicate antisense reads, whereas reads 
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below the y-axis indicate sense reads mapping to that genomic location. Blue lines 
signify ambiguous reads mapping to this locus, while red lines signify unambiguous 
reads. (B) mFold prediction of the CbsR16 sRNA secondary structure (∆G = -85.24 
kcal/mol). Red, blue, and green lines forming stem structures indicate G-C, A-U, and G-
U base-pairing, respectively. 
 
          A discontiguous megaBLAST search with CbsR16 resulted in 78 hits with E-
values ranging from 1e-07 to 4e-33. We initially divided these 78 hits into two groups: 
full-size sequences and smaller sequences. From these pools, we aligned those that 
covered at least 75% of the input CbsR16 sequence. The full-size versions (Figure 2.5A) 
have a 5′ sequence of ~40 nts that is apparently missing in smaller versions of the 
element (Figure 2.5B). Phylogenetic trees for these full-size and smaller versions were 
constructed and can be seen in Figure S2.6 and Figure S2.7, respectively. As with 
QMITE1, we generated representative predicted secondary structures for the full-size 
(Range 7, Figure 2.6A) and small ranges (Range 9, Figure 2.6B). Although there are no 
IHF-binding sites in the CbsR16-like sequences, the full-size ranges have TIRs and are 
flanked by unique DRs of 7-9 bp, while the smaller ranges are essentially REP elements. 
Interestingly, these REP elements were previously reported in C. burnetii, although their 
status as a truncated MITE was not recognized [105]. Taken as a whole, the size (~190 
bp), presence of TIRs and DRs, and their distribution across the RSA 493 genome 
suggest that the CbsR16-like loci are indeed MITEs. We therefore propose to designate 
this family of elements as QMITE2. A model of QMITE2 is shown in Figure 2.6C. The 
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smaller QMITE2 copies strongly resemble a REP element; i.e., they do not contain TIRs 
nor do they have discernible DRs in flanking genomic regions. 
 
Figure 2.5: CbsR16 loci have full-size and small versions. (A) MUSCLE sequence 
alignment of discontiguous megaBLAST hits that returned full-size versions of the 
CbsR16 locus. Conserved bases appear as gray blocks, while unaligned bases appear as 
green, yellow, blue, and red bands, corresponding to T, G, C, and A bases, respectively. 
An identity indictor is shown above the sequence alignment, where the height signifies 
conservation of bases at that position, with a color indicator for overall identity between 
aligned ranges (green: 100%, yellow: 20-99%, red: 0-19%). Above this identity indicator 
is the consensus sequence, appearing as colored bands indicating bases as described 
above. (B) As in (A), except the MUSCLE alignment displays the top discontiguous 
megaBLAST hits (>75% of input sequence) associated with the CbsR16 locus, excluding 
all full-size hits. An asterisk indicates equivalent positions in the full-size and small 
versions of QMITE2. 
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Figure 2.6: CbsR16 loci comprise another novel MITE family, termed QMITE2. (A) 
mFold prediction of the RNA secondary structure of a full-size version of the CbsR16 
repeated locus (range 7; predicted ∆G = -113.09 kcal/mol). Red, blue, and green lines 
forming stem structures indicate G-C, A-U, and G-U base-pairing, respectively. Red lines 
bracket the identified TIR. (B) As in (A), but depicting the secondary structure prediction 
of a small version of the CbsR16 repeated locus (range 9; predicted ∆G = -67.7 
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kcal/mol). (C) Model of QMITE2 depicting DRs as red arrow heads and TIRs as hatched 
arrow heads. Length ranges for these features are also shown. 
 
          As observed with QMITE1, QMITE2 copies may also affect certain annotated 
ORFs. Although they do not encode annotated genes like some QMITE1 copies, there is 
some overlap with neighboring functional genes, including a C-terminal 1-bp overlap 
with kdgK, a C-terminal 8-bp overlap with ogt, a C-terminal 7-bp overlap with recN, a C-
terminal 10-bp overlap with CBU_2078 Fic-Family protein, and a C-terminal 6-bp 
overlap with ruvB. Additionally, although MUSTv2 identified QMITE1 in the RSA 493 
genome, it was unable to find QMITE2 under stringent parameters. However, a full-size 
QMITE2 copy was identified using less stringent parameters (data not shown). The 
inability for MUSTv2 to identify QMITE2 most likely reflects the filtering parameters of 
the program itself. Namely, the program searches for copies of the MITE with similar 
DR’s. If a copy with a similar DR is not found, it will filter it out. QMITE2 has unique 
DR’s for each copy, making it difficult to detect. 
QMITE2 loci are hot-spots for IS1111 insertion 
While parsing various QMITE2 ranges, we found that 20 of the 21 annotated IS1111 TEs 
in the RSA 493 genome possessed a small QMITE2 located ~400 bp downstream of their 
stop codons. These small QMITE2 ranges were aligned and shown in Figure S2.8. A 
phylogenetic tree of these transposon-associated QMITE2 insertions was created and is 
shown in Figure S2.9. These ranges are nearly identical to the other small QMITE2 
ranges (Figure 2.5B), except that they are missing 10-20 bp at the 5′ end. Upon closer 
inspection, these “missing” bases are actually located 5′ of the IS1111, indicating that the 
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transposon inserted into this region of QMITE2. Indeed, this has been described before, 
although the insertion site was not previously recognized as a MITE [104]. It is worth 
noting that these QMITE2 copies are more divergent than their IS1111-free counterparts, 
implying neutral selection while they are associated with IS1111. Interestingly, of the 
twenty IS1111 insertions in QMITE2 copies, only one clearly inserted into a full-length 
QMITE2 locus, as the TIR is still discernible up- and down-stream of the Tn insertion. 
The other QMITE2 loci may also have been full-length once, but their flanking sequences 
presumably diverged rapidly after insertion. 
QMITE2 is not specific to C. burnetii 
Unlike QMITE1, QMITE2 is apparently not unique to C. burnetii. A discontiguous 
megaBLAST search using the CbsR16 sequence yielded hits in multiple 
alphaproteobacteria, including Bradyrhizobium spp. and Rhodobacter spp. These hits had 
sizes of 83-100 nucleotides in length with E-values ranging from 1E-04 to 8E-07. 
QMITE2 also appeared in one location in Lacimicrobium alkaliphilum, a 
gammaproteobacteria. These sequences were aligned to the small version of QMITE2 
(Figure 2.7) and a phylogenetic tree was constructed (Figure S2.10). The alignment 
indicates that although the majority of the sequence corresponding to the predicted stem 
structure of the small QMITE2 is conserved, the palindromic “tip” (see Figure 2.6B, 
bases 31-53) is more divergent among the alphaproteobacteria shown in the alignment. 
These results suggest that a majority of the palindromic stem structure may serve some 
function in Bradyrhizobium and Rhodopseudomonas spp., while the entirety of this stem 
is under purifying selection in C. burnetii. It’s also worth noting that the 3′ portion of 
QMITE2 is missing from the alphaproteobacterial MITEs. The 3′ end of QMITE2 
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comprises half of the TIR formed in the full-length QMITE2 suggesting that full-length 
QMITE2 never existed in the alphaproteobacterial species or was present further back in 
their evolutionary histories.  
 
Figure 2.7: QMITE2 is not unique to C. burnetii. MUSCLE sequence alignment of 
discontiguous megaBLAST hits that returned QMITE2 sequences in other organisms. 
Conserved bases appear as gray blocks, while unaligned bases appear as green, yellow, 
blue, and red bands, corresponding to T, G, C, and A bases, respectively. An identity 
indicator is shown above the sequence alignment, where the height signifies conservation 
of bases at that position with a color indicator for overall identity between aligned ranges 
(green: 100%, yellow: 20-99%, red: 0-19%). Above this identity indicator is the 
consensus sequence, appearing as colored bands indicating bases as described above. 
Ranges 12, 13, 10, 9, 14 in the sequence alignment refer to small QMITE2 ranges 
included in the BLAST as shown in Figure 2.5B. 
 
Full-length QMITE2 displays inter-strain linkage and sequence conservation in 
Coxiella 
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Due to the unique DRs produced by individual full-length QMITE2 insertions, we were 
interested to see if these DRs displayed inter-strain linkage conservation. To accomplish 
this, full-length QMITE2 ranges were found in the C. burnetii Dugway strain and the 
DRs produced by these inserts were compared to those produced by QMITE2 inserts in 
the RSA 493 strain. If there were two DRs that were identical in sequence between 
strains, we determined if the associated QMITE2 copies were linked by observing 
syntenic genome blocks that were produced via genome rearrangements as the strains 
diverged [139]. We discovered that the Dugway strain contains 12 full-length QMITE2 
copies versus 10 in RSA 493 (Table 2.1). Furthermore, seven of the nine discernible DRs 
in the RSA 493 strain had perfect homologs in the Dugway strain and displayed perfect 
linkage and sequence conservation. The single unique DR in RSA 493 without a 
counterpart in Dugway resulted from an IS1111 insertion in the corresponding position in 
Dugway’s genome. Likewise, 11 of the 12 full-length QMITE2 copies in Dugway had 
unique DRs associated with them and seven of these had perfect homologs in RSA 493, 
two had a IS1111 inserted into the corresponding position in RSA 493, one position 
belonged to a genomic segment unique to Dugway, and the final position displayed a 
QMITE2 inversion in RSA 493, leaving no discernible DR (Table 2.1). In summary, 
most DRs are conserved in both strains with a few lost via deletion, IS1111 insertion, or 
genome inversion events. 
 
Table 2.1: Full-size QMITE2 copies exhibit inter-strain linkage conservation. 
Strain Range TIR 
Length 
DR 
Length 
DR Sequence Homolog? 
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RSA 493 c1006608-1006428 25 * * No** 
 1066751-1066922 29 * * * 
 1380514-1380685 26 7 TCAGRGG No*** 
 c1168547-1168380 24 9 CCGTCAATA Yes 
 c1360856-1360689 23 9 CACATCGAT Yes 
 1988089-1988258 23 7 CAACATTW Yes 
 1586332-1586502 23 9 GTTGGCGCG Yes 
 220015-220188 25 8 GGGGTGTT Yes 
 c970302-970140 24 7 GCTACTT Yes 
 1252325-1252500 24 9 TTCTGTTTA Yes 
Dugway c334562-334393 23 9 GTTGGCGCG Yes 
 c1836762-1836594 25 8 GGGGTGTT Yes 
 2151397-2151569 23 8 CAACATTW Yes 
 117745-117908 22 * * * 
 c1299129-1298960 23 9 CCGTCAATA Yes 
 c374053-373882 31 9 AATTTTAAC No** 
 1295396-1295566 26 9 GTATCRTCC No*** 
 1561569-1561721 21 13 CCTTCTTCTTTSA No**** 
 1384775-1384900 23 9 TTCTGTTTA Yes 
 1261463-1261626 17 9 GGGCTTTCA No*** 
 c565652-565819 25 9 CACATCGAT Yes 
 c1003105-1002901 24 7 GCTACTT Yes 
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* No discernible DR; ** QMITE2 inversion in other strain; *** IS1111A insertion in 
other strain; **** Genomic segment deleted in other strain 
 
QMITE1 and QMITE2 copies in the RSA 493 and Dugway genomes 
QMITE1 and QMITE2 (full-size and small) copies were mapped against the RSA 493 
genome using Circos software (Figure 2.8) [146]. We identified 45 copies of QMITE1 
and 78 copies of QMITE2 in the RSA 493 genome that in total affect 60 annotated ORFs, 
with 19 of these ORFs being completely contained within QMITE1 copies and encoding 
the DUF1658 family of proteins (see Figure S2.5). When combined, QMITE1 and 
QMITE2 copies make up 0.93% of the RSA 493 genome. Interestingly, our analysis 
revealed that there were generally higher concentrations of QMITE insertions in the 
second “half” of the genome (~1,000,000 – 1,995,488 bp), with small QMITE “deserts”. 
Accordingly, the first half of the genome was found to contain lower concentrations of 
QMITEs, with larger deserts (e.g., 570,000 – 690,000 bp) bearing no QMITE inserts. 
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Figure 2.8:  Locations of QMITE1 and QMITE2 insertions in the C. burnetii RSA 
493 genome. The outer ring depicts the RSA 493 chromosome in 100,000 bp increments. 
The next ring depicts locations of forward strand ORFs in green, IS1111 locations in 
blue, and non-IS1111 TEs in black, followed by reverse strand ORFs in red on the next 
ring also featuring IS1111 in blue and non-IS1111 TEs in black. The next ring depicts all 
chromosomal QMITE1 locations. Green ticks indicate QMITE1 insertions oriented in the 
forward, while red ticks indicate QMITE1 insertions in the reverse orientation. The next 
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ring depicts QMITE2 insertions, with green ticks indicating forward insertions, red ticks 
indicating reverse insertions, and blue ticks indicating IS1111-associated QMITE2 
inserts. The following ring labels all of the locus tags for ORFs that have some overlap 
with either QMITE1 or QMITE2 insertions. ORFs labeled in blue are those that are 
encoded by QMITE1 insertions and represent the DUF1658 family of proteins. Finally, 
the colored links between blue-labeled ORFs are indicative of groupings of  the proteins 
coded by these genes (see Figure S2.5). 
 
          The distribution of QMITE1 and QMITE2 in the Dugway genome is displayed in 
Figure 2.9. Due to linkage conservation of QMITE1 and QMITE2 copies between 
strains, the genomic locations of the QMITE copies are generally the same as RSA 493, 
although due to divergence between strains, there are some differences in the number of 
QMITE copies. Specifically, there are 53 copies of QMITE1 and 62 copies of QMITE2 
that together comprise 0.91% of the Dugway genome. There are also 56 ORFs affected 
by MITEs in the Dugway strain. All of the functional annotated genes affected are the 
same in the two strains, except for the enhC gene, which shows a 3′ extension due to an 
indel linking the gene to a QMITE2 copy. Interestingly, a C-terminally extended EnhC 
protein has been previously described for the Dugway strain [139]. 
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Figure 2.9:  Locations of QMITE1 and QMITE2 insertions in the C. burnetii 
Dugway 5J108-111 genome. The outer ring depicts the RSA 493 chromosome in 
100,000 bp increments. The next ring depicts locations of forward strand ORFs in green, 
IS1111 locations in blue, and non-IS1111 TEs in black, followed by reverse strand ORFs 
in red on the next ring also featuring IS1111 in blue and non-IS1111 TEs in black. The 
next ring depicts all chromosomal QMITE1 locations. Green ticks indicate QMITE1 
insertions oriented in the forward, while red ticks indicate QMITE1 insertions in the 
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reverse orientation. The next ring depicts QMITE2 insertions, with green ticks indicating 
forward insertions, red ticks indicating reverse insertions, and blue ticks indicating 
IS1111-associated QMITE2 inserts. The following ring labels all of the locus tags for 
ORFs that have some overlap with either QMITE1 or QMITE2 insertions. ORFs labeled 
in blue are those that are encoded by QMITE1 insertions and represent the DUF1658 
family of proteins. Colored links are omitted because the DUF1658 protein products 
remain the same between strains and largely depend on how the genome was annotated. 
 
QMITE copies affect sRNA genes 
New bacterial sRNAs can arise from degraded bacteriophage genes [152]. Similarly, we 
show that three sRNAs of C. burnetii are derived from MITEs. These results suggest that, 
as shown in eukaryotes [153], genomic parasitic elements can serve as a source for the 
generation of novel non-coding RNAs of bacteria. For instance, QMITE1 copies have 
inserted directly downstream of promoter elements for CbsR3 and CbsR13. Moreover, a 
QMITE2 copy has apparently provided the -10 promoter element for CbsR16, while the -
35 promoter element is located directly upstream of the QMITE2 insert (Figure S2.11). 
All of these sRNAs show varying levels of expression (see Figure S2.3), indicating that 
they are being actively transcribed. Furthermore, previously published Northern blots 
have confirmed that CbsR3 and CbsR13 are transcribed and produce sRNA molecules of 
the expected size [102]. 
 
Discussion 
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We have described two novel MITE elements in C. burnetii, termed QMITE1 and 
QMITE2. Although their structures and distribution are clear, the nature of their 
transposition and origin remains indeterminate. Several lines of evidence suggest that 
QMITE copies are ancient and likely lost the ability to transpose before divergence of 
present-day C. burnetii strains. First, C. burnetii RSA 493 contains a plasmid called 
QpH1 that encodes type 4 secretion system substrates involved in virulence [154]. We 
could not detect QMITE copies in QpH1, or other C. burnetii plasmid types, indicating 
that either Coxiella gained the plasmid after the QMITEs lost the ability to transpose or 
that the plasmid is too gene-rich to contain stable QMITE copies. Second, the fact that 
QMITE copies show linkage conservation between strains suggests that they were 
present before the rearrangement of chromosomes that occurred during divergence of 
strains. Finally, the presence of QMITE deserts in C. burnetii chromosomes (see Figures 
2.8 and 2.9), especially between CBU_0664 and CBU_0715, which code for non-IS1111 
TEs, implies that horizontal gene transfer (HGT) was involved in forming these regions. 
Indeed, a recent report has shown that this region (608,000 – 660,000 bp; Figure 2.8), is 
rich in genes that were acquired via HGT, including some LPS biosynthesis genes that 
are essential to C. burnetii’s virulence [155]. The lack of QMITEs in this region indicates 
that it was acquired after QMITE1 and QMITE2 lost the ability to transpose, but before 
divergence of strains, since this region displays inter-strain linkage conservation. It is also 
worth noting that the chromosomal region harboring the icm/dot genes involved in type 
IV secretion display a paucity of QMITE inserts and is flanked by IS1111 TEs that have 
inserted into QMITE2 copies (see 1,540,000 to 1,580,000 bp in Figure 2.8). This 
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suggests that QMITE2 copies indirectly affected the evolution of C. burnetii from a free-
living to an obligate parasite by fostering genome plasticity.  
          Interestingly, QMITE insertions can also be used as a marker for the transposition 
of certain IS1111 TEs. For example, it is likely that the IS1111 transposons at 
CBU_1217a and CBU_1186 in the RSA 493 strain inserted into these positions after 
divergence from the Dugway strain, because in Dugway there are full-size QMITE2 
copies with discernible DRs that have no IS1111 TEs in these positions. Similarly, the 
CBUD_0567a IS1111 of Dugway inserted into that position after divergence, since there 
is a full-size QMITE2 copy at this position in the RSA 493 genome. 
          The uniqueness of the QMITE1 insert sequence suggests that it may have utility as 
a molecular signature for detecting C. burnetii in clinical or environmental samples. A 
current detection protocol utilizes PCR to amplify the so-called htpAB-repetitive element, 
which is part of the IS1111 TE [156]. Recent reports, however, have expressed concerns 
regarding this method due to the existence of IS1111 TEs in Coxiella-like 
endosymbionts, which may confound results obtained from environmental samples [157]. 
The QMITE1 sequence has variable ends, although it maintains a conserved core across 
insertions in the C. burnetii genome (see Figure 2.2A) that could easily serve as a 
sizeable DNA template for PCR amplification. Also, the abundance of insertion sites in 
the C. burnetii genome should ensure sensitivity of the assay. 
          Although results suggest that QMITE1 is unique to C. burnetii, a relative of 
QMITE2 was observed in very distantly-related alphaproteobacteria. However, these 
QMITE2 copies are not full-length and strongly resemble transposon-associated QMITE2 
copies (see Figure S2.8). These alphaproteobacteria, including several Bradyrhizobium 
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and Rhodopseudomonas spp., are root nodule-associated, free-living bacteria that also 
encode several copies of the IS1111 TE in their genomes. There are several possible 
scenarios that could help explain the occurrence of QMITE2 between these distantly-
related organisms. First, C. burnetii may have acquired QMITE2 from root nodule-
associated bacteria via HGT (or vice versa) during its free-living past. Indeed, C. 
burnetii’s genome contains relics of competence, including an almost-complete type IV 
pilus system that could have facilitated uptake of foreign DNA [99]. Second, QMITE2 
may be ancient, existing long before divergence of alpha- and gamma-proteobacteria. 
Finally, it is entirely possible that these alphaproteobacteria acquired QMITE2 copies via 
cut-and-paste transposition of IS1111 following HGT, which in turn left relics of 
QMITE2 scattered across their respective genomes. This latter explanation is certainly 
possible since full-size QMITE2 copies are absent in these species and the shorter 
QMITE2 copies they harbor are highly divergent. 
          All functional annotated genes affected by QMITE contain insertions located at 
their 3′ ends. The reason for this preference is unknown but may reflect the general 
tractability of the C-terminus of proteins to a change in amino acid composition. Indeed, 
when comparing these protein products to counterparts in L. pneumophila, there is no 
significant difference in the overall masses of the proteins, indicating that QMITE 
insertions neither extend nor truncate the proteins to a significant degree, although the 
amino acid composition is altered. These alterations are summarized in Table 2.2 below. 
In general, QMITE insertions into these genes increase the hypothetical pI of the encoded 
protein relative to predicted products lacking the QMITE insert. Such a chimera could 
have conceivably provided a subtle, adaptive advantage to C. burnetii as it transitioned 
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from a free-living bacterium to an obligate intracellular pathogen, as high pI proteins 
could potentially serve as proton sinks in an acidic host cell phagolysosome. In fact, 
many C. burnetii proteins have been described as having a very high pI, comparable to 
those found in the human stomach pathogen, Helicobacter pylori [99].  This may have 
been adequate to confer a selective advantage, but the alternative possibility is that 
QMITE insertions are simply under neutral selection with little to no effect on the fitness 
of the gene in question. Unfortunately, among the genes listed in Table 2.2, only 
orthologues for recN and ruvB are found in H. pylori. Similar to C. burnetii, these H. 
pylori (strain 26695) proteins have a theoretical pI of 5.84 and 5.86, respectively. This 
suggests that maintenance of an acidic pI was necessary and the minor change caused by 
the QMITE2 insert in these genes had little effect on fitness. It is also worth noting that 
there seems to be a preference for QMITE insertions at the 3′ end of DNA-binding genes 
and genes involved in DNA repair, such as ogt, recN, mutT, and ruvB. It is possible that 
these insertions are simply due to their proximity to these genomic locations during 
transposon-induced DNA repair. In fact, it has been found that transposition of TEs is 
increased upon genotoxic stress in bacteria [158]. There also does not appear to be any 
QMITE elements that affect the 5′ end of genes with known functions. This is most likely 
due to the necessity for a promoter element upstream; a feature that may not be provided 
by the QMITE insertion. Alternatively, there may be a transcription factor binding site(s) 
upstream of the ORF that is necessary for regulation of that gene. In contrast, there seems 
to be no locational preference for QMITE insertion into annotated hypothetical proteins, 
wherein QMITE insertions sometimes appear in-frame in the middle of the ORF (e.g., 
QMITE2 insertions in CBU_0752a and CBU_1269a). 
 54 
 
Table 2.2: QMITE effects on functional gene products. 
Gene QMITE 
Type 
Overl
ap 
length 
(bp) 
Amino acids conferred pI 
witho
ut 
insert 
pI 
with 
inse
rt 
Gene 
function 
ubiB 1 2 (STOP) N/A N/A Ubiquinone 
Biosynthesis 
CBU_20
20 
1 3 (STOP) N/A N/A Glutamate 
antiporter 
pntAA 1 42 AQTHRRQLKGAR(STOP) 6.93 8.79 Redox, 
proton 
transport 
mutT 1 26 LQQDIITQ(STOP) 5.1 4.96 Mutational 
DNA repair 
CBU_20
58 
1 49 LVVPAQTHRRQLKGAR(
STOP) 
9.97 10.1
5 
Proline/Beta
ine 
transporter 
nagZ 1 50 ESQQRLLSFSRFTTGG(ST
OP) 
5.76 5.88 Mureine 
tripeptide 
recycling 
kdgK 2 1 (STOP) N/A N/A Pentose 
phosphate 
pathway 
ogt 2 8 TK(STOP) 7.67 8.32 DNA 
alkylation 
repair 
CBU_20
78 
2 10 SAK(STOP) 6.16 6.29 Regulation 
of cell 
division 
recN 2 7 SV(STOP) 6.05 6.05 DNA repair 
ruvB 2 6 E(STOP) 5.85 5.73 Holliday 
Junction 
resolution; 
DNA repair 
 
          An intriguing aspect of QMITE inserts is the influence they can have on sRNAs, 
depending on where they insert into the genome. It has been suggested that a class of 
MITEs in Neisseria spp., termed the Correia repeats, may insert near sRNA genes and 
alter their functions [66, 159]. This is similar to what is observed with QMITE1, 
especially those inserts that give rise to CbsR3 and CbsR13, two confirmed sRNAs 
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harboring their own promoters upstream of the QMITE1 inserts and terminating within 
the confines of the insert itself (see Figure S2.11) [97]. When taking the unambiguous 
reads associated with all QMITE1 loci into account, the TPMs associated with QMITE1 
loci reach approximately 9,342, or 0.93% of all transcripts expressed by C. burnetii. The 
fact that these promoter elements still exist after divergence of C. burnetii into separate 
strains speaks to the potential utility of the transcripts they produce, whether they: a) act 
in trans on mRNA target(s), b) affect expression of neighboring genes, or c) are actively 
translated to produce the high pI proteins listed in Figure S2.5. 
          The truly unique aspect of QMITE inserts is the sRNAs they may produce 
wherever they insert into the genome. It has been shown that the Correia repeats of N. 
meningitidis give rise to transcripts that are produced at varying levels depending on the 
specific repeat in question [160]. Here, we confirm this notion by showing that a 
QMITE2 insert in the coding region of the lowly transcribed sRNA CbsR16 provides the 
-10 promoter element for the sRNA (see Figure S2.11). Additionally, this seems to be 
one, if not the only, QMITE2 insert that is transcribed with near-equivalence of the 
ambiguous and unambiguous TPM data (see Figure S2.3). Additionally, although sRNAs 
arising from internal QMITE1 promoters have not been established, it is likely that 
transcripts are being produced by these inserts since many more ambiguous transcripts 
are associated with these loci than unambiguous transcripts (see Figure S2.3). As seen in 
Figure S2.1, these QMITE1 insertions also have identifiable promoters on both strands 
of DNA. 
          In general, ORFs that are affected by QMITE insertion events were the same 
between the two strains analyzed. One exception occurs in the Dugway strain’s enhC 
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gene, which codes for a protein that is thought to inhibit release of peptide fragments 
during infection by L. pneumophila, C. burnetii’s closest pathogenic relative [161,162]. 
The function of EnhC in C. burnetii’s pathogenicity has not yet been established, 
although recent studies have speculated that it may play a similar role to the L. 
pneumophila counterpart [163]. In the Dugway strain, enhC is extended due to an in-
frame QMITE2 insertion at the 3′ end of the gene. Thus, the C-terminal 33 amino acids 
are presumably provided by the QMITE2 insertion, and the stop codon occurs 
immediately downstream. This same QMITE2 insert also exists in RSA 493, although an 
indel has resulted in a stop codon immediately preceding the element. It is unclear 
whether the C-terminal extension in Dugway affects EnhC function when compared to 
the altered protein product expressed by RSA 493. Conceivably, as the Dugway EnhC 
mRNA is transcribed, the highly stable stem structure conferred by QMITE2 could serve 
as a substrate for ribonuclease III (RNase III) processing. This could create an mRNA 
lacking a stop codon, which would, in turn, lead to ribosome stalling and eventual 
targeting of the nascent polypeptide for degradation [7]. Whether this process occurs as 
hypothesized is currently under investigation. 
          A variety of TEs have been previously described in C. burnetii. Here, we have 
characterized two novel MITE families that exist as multiple copies in all annotated 
strains of C. burnetii. QMITE1 is of importance because its promoter elements could 
influence expression of nearby genes. QMITE2 is noteworthy due to unique DRs that 
could allow for identification of syntenic blocks and visualization of chromosomal 
rearrangements that have occurred between C. burnetii strains as they diverged. QMITE 
loci could also be used to identify chromosomal regions derived through HGT after the 
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QMITE copies became inactive but prior to divergence of strains. The linkage 
conservation between QMITE1 and QMITE2 elements has helped us establish a timeline 
that suggests that these elements helped influence the evolution of C. burnetii on its path 
towards becoming an obligate pathogen by serving as sites for IS1111 transposition and 
inserting into and influencing annotated ORFs and sRNA genes. Finally, we have 
described the influence that QMITE insertions have had on CbsR3, CbsR13, and CbsR16 
sRNA’s, the latter of which is produced from a promoter element within a QMITE2 
insert. 
 
Supplementary Material 
 
Figure S2.1. Extended-QMITE1 sequence for discontiguous megaBLAST searches. 
Predicted sigma-70 promoter elements for: Forward -10 (red), Forward -35 (red); Reverse 
-10 (blue), Reverse -35 (blue). 
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Figure S2.2. Maximum likelihood phylogenetic tree of QMITE1 inserts. Node labels are 
indicated at the corresponding locations, and a branch length legend is shown at the 
bottom of the figure. 
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Figure S2.3. QMITE-associated TPMs obtained by RNA-Seq from C. burnetii LCVs 
grown in infected Vero cells (n=2 biological replicates). 
 
 
Figure S2.4. MUSTv2 search results indicating identified QMITE1 elements in the C. 
burnetii RSA 493 genome. Attributes of individual MITES are shown. 
 
 
Figure S2.5. MUSCLE alignment of RSA 493 DUF1658 proteins. 
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Figure S2.6. Maximum likelihood phylogenetic tree of full-size QMITE2 inserts. Node 
labels are indicated at the corresponding locations, and a branch length legend is shown 
at the bottom of the figure. 
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Figure S2.7. Maximum likelihood phylogenetic tree of small QMITE2 inserts. Node 
labels are indicated at the corresponding locations, and a branch length legend is shown 
at the bottom of the figure. 
 
 
Figure S2.8. MUSCLE alignment of transposon-associated QMITE2 inserts. 
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Figure S2.9. Maximum likelihood phylogenetic tree of transposon-associated QMITE2 
inserts. Node labels are indicated at the corresponding locations, and a branch length 
legend is shown at the bottom of the figure. 
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Figure S2.10. Maximum likelihood phylogenetic tree of QMITE2 inserts found in 
alphaproteobacteria. Node labels are indicated at the corresponding locations, and a 
branch length legend is shown at the bottom of the figure. 
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Figure S2.11. QMITE insertions in functional sRNAs of C. burnetii. 
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Chapter 3 
A CsrA-binding, trans-acting sRNA of Coxiella burnetii is necessary for 
optimal intracellular growth and vacuole formation during early 
infection of host cells 
As published in: Journal of Bacteriology. 2019 Oct 21;201(22):e00524-19. doi: 
10.1128/JB.00524-19  
 
Abstract 
Coxiella burnetii is an obligate intracellular gammaproteobacterium and zoonotic agent 
of Q fever. We previously identified 15 small non-coding RNAs (sRNAs) of C. burnetii. 
One of them, CbsR12 (Coxiella burnetii small RNA 12), is highly transcribed during 
axenic growth and becomes more prominent during infection of cultured mammalian 
cells. Secondary structure predictions of CbsR12 revealed four putative CsrA-binding 
sites in stem loops with consensus AGGA/ANGGA motifs. We subsequently determined 
that CbsR12 binds to recombinant C. burnetii CsrA-2, but not CsrA-1, proteins in vitro. 
Moreover, through a combination of in vitro and cell culture assays, we identified several 
in-trans mRNA targets of CbsR12. Of these, we determined that CbsR12 binds and 
upregulates translation of carA transcripts coding for carbamoyl phosphate synthetase A; 
an enzyme that catalyzes the first step of pyrimidine biosynthesis. In addition, CbsR12 
binds and downregulates translation of metK transcripts coding for S-adenosyl 
methionine (SAM) synthetase, a component of the methionine cycle. Furthermore, we 
 66 
found that CbsR12 binds to and downregulates the quantity of cvpD transcripts, coding 
for a type IVB effector protein, in mammalian cell culture. Finally, we found that 
CbsR12 is necessary for expansion of CCVs and affects growth rates in a dose-dependent 
manner in the early phase of infecting THP-1 cells. This is the first characterization of a 
trans-acting sRNA of C. burnetii and first example of a bacterial sRNA that regulates 
both CarA and MetK synthesis. CbsR12 is one of only a few identified trans-acting 
sRNAs that interacts with CsrA. 
 
Importance 
Regulation of metabolism and virulence in C. burnetii is not well understood. Here, we 
show that C. burnetii small RNA 12 (CbsR12) is highly transcribed in the metabolically 
active LCV compared to the non-replicative SCV. We show that CbsR12 directly 
regulates several genes involved in metabolism, along with a type IV effector gene, in 
trans. Additionally, we demonstrate that CbsR12 binds to CsrA-2 in vitro and induces 
autoaggregation and biofilm formation when transcribed ectopically in E. coli, consistent 
with other CsrA-sequestering sRNAs. These results implicate CbsR12 in the indirect 
regulation of a number of genes via CsrA-mediated regulatory activities. The results also 
support CbsR12 as a crucial regulatory component early on in a mammalian cell 
infection. 
 
Introduction 
 67 
A previous study by our group revealed 15 novel C. burnetii sRNAs that were 
differentially transcribed either in LCVs vs. SCVs, or in host cell infections vs. growth in 
ACCM-2 medium [97, 98]. Among these, Coxiella burnetii small RNA 12 (CbsR12) was 
found to be markedly upregulated in the intracellular niche as compared to ACCM-2. 
Northern blots also showed that CbsR12 was upregulated in SCVs vs. LCVs in ACCM-2, 
and revealed two distinct sizes of the sRNA, suggesting that either an alternative 
transcription start site (TSS) or ribonuclease processing of the sRNA was responsible. In 
a subsequent study, CbsR3 and CbsR13 were found to originate from transcribed loci of a 
selfish genetic element, termed QMITE1 [164]. However, despite the identification and 
verification of several CbsRs, none has been functionally characterized, to date. 
          In this study, we describe activities of a highly transcribed, infection-specific 
sRNA of C. burnetii, termed CbsR12. Our analyses show that CbsR12 binds to CsrA-2, 
but not CsrA-1 in vitro. We also establish that CbsR12 binds and up-regulates carA 
(CBU_1282) and down-regulates metK (CBU_2030) transcripts, in trans. The bacterial 
carA gene codes for carbamoyl-phosphate synthetase (small) subunit A (CarA), which 
forms a heterodimer with carbamoyl-phosphate synthetase (large) subunit B (CarB). The 
CarAB complex catalyzes the first step in pyrimidine biosynthesis and is involved in 
arginine biosynthesis in some bacteria [165]. The bacterial metK gene codes for SAM 
synthetase, an enzyme responsible for catalyzing production of SAM, the major donor of 
methyl groups during metabolism in prokaryotic cells. As a methyl donor, SAM affects 
DNA methylation and thus global transcription [166]). It has also been implicated in 
virulence, being necessary for the production of N-acyl homoserine lactones involved in 
bacterial quorum sensing (reviewed in [167]). We also implicate CbsR12 in expansion of 
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the CCV, as its size is directly correlated with levels of the sRNA. Furthermore, we find 
that CbsR12 binds ahcY (CBU_2031) and cvpD (CBU_1818) transcripts, which are 
components of the methionine cycle and a T4BSS effector protein, respectively [84]. 
Overall, this study highlights CbsR12 as a crucial component in early stages of a Coxiella 
infection. 
 
Results 
CbsR12 is a principal non-rRNA/tRNA/tmRNA transcript during C. burnetii 
infection of Vero and THP-1 cells 
CbsR12 was first described as a highly-transcribed, infection-specific sRNA that was 
upregulated in SCVs compared to LCVs when analyzed by Northern blots [97]. The 
impetus for our study came when we analyzed previous RNA-Seq data (SRP041556) [97] 
by converting raw read data into TPM, a normalized measure of gene expression [168]. 
These results showed that CbsR12 was the most highly transcribed non-tmRNA 
transcript in both LCVs and SCVs during C. burnetii infection of African green monkey 
kidney epithelial cells (Veros). Additional data from LCVs obtained from a C. burnetii 
infection of monocytic THP-1 cells corroborates the observation that CbsR12 is a 
principal transcript during infection (Rahul Raghavan, unpublished data). Moreover, we 
were surprised to find that CbsR12 was more abundant in LCVs, not SCVs (Table 3.1). 
 
Table 3.1. Top ten expressed genes
a
 across various C. burnetii growth conditions. 
Rank ACCM-2
b
 LCV 
(3dpi) 
ACCM-2
 b
 SCV 
(21dpi) 
Vero LCV 
(3dpi) 
Vero SCV 
(21dpi) 
THP-1 LCV 
(3dpi) 
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1 tmRNA 
(104,383) 
tmRNA (4,430) tmRNA 
(153,422) 
tmRNA 
(22,500) 
tmRNA 
(128,928) 
2 CBU_1183 
(32,842) 
Intergenic 
(2,632) 
CbsR12 
(79,870) 
CbsR12 
(8,521) 
RNase P RNA 
(63,637) 
3 CBU_0307 
(13,902) 
CBU_1538 
(2,133) 
RNase P RNA 
(25,715) 
CBU_0089a 
(8,012) 
CbsR12 
(33,331) 
4 CBU_1224a 
(11,023) 
Intergenic 
(1,977) 
CBU_0089a 
(13,882) 
CBU_2034 
(4,375) 
6S RNA 
(22,540) 
5 RNase P RNA 
(10,3923) 
tRNA (1,902) CbsR1 
(11,445) 
CBU_1170 
(3,704) 
CBU_0456 
(17,603) 
6 CBU_0311 
(7,544) 
CBU_0183 
(1,593) 
CBU_0718  
(10,370) 
CBU_0718 
(3,703) 
CBU_0474 
(16,267) 
7 CBU_0474 
(7,120) 
Intergenic 
(1,543) 
CBU_1932 
(9,734) 
CBU_1280a 
(3,522) 
CBU_1183 
(13,349) 
8 Intergenic 
(6,928) 
CBU_0157 
(1,390) 
CBU_1272 
(9,011) 
RNase P RNA 
(3,429) 
CBU_0307 
(12,753) 
9 CBU_0306 
(6,666) 
Intergenic 
(1,340) 
CBU_0711 
(5,530) 
Intergenic 
(3,340) 
CBU_0311 
(12,146) 
10 CbsR12 
(3,522) 
Intergenic 
(1,203) 
CBU_1170 
(4,633) 
CBU_1272 
(3,134) 
CBU_0473 
(11,449) 
a
Genes as annotated for RSA493 (NCBI Ref Seq: NC_002971.4) with corresponding 
TPM values in parentheses. 
b
ACCM-2 is an axenic growth medium (37). CbsR12 is 
indicated in boldface. N = 2 biological replicates per condition. 
 
CbsR12 is processed by ribonuclease III in vitro 
Previous Northern blot analyses showed that CbsR12 produced two bands of 
approximately 170 and 50 nucleotides, regardless of C. burnetii growth conditions or 
developmental stage [97]. We therefore wished to determine whether these RNAs arose 
from alternative TSSs for the cbsR12 gene or from RNase III processing of the full-length 
CbsR12 transcript. We first utilized 5' rapid amplification of cDNA ends (RACE) with 
total RNA derived from C. burnetii LCVs infecting Veros (3dpi) in order to determine 
 70 
the TSS of CbsR12. This experiment revealed the full-size CbsR12 (~200 nucleotides) as 
expected, but also indicated that two potential alternative TSSs existed ~110 nucleotides 
upstream of the cbsR12 gene’s Rho-independent terminator (Figure S3.1A). To 
determine whether the TSSs were generated by RNase-mediated cleavage, we treated in 
vitro-transcribed CbsR12 with recombinant C. burnetii RNase III [102] and 
commercially-available E. coli RNase III (New England BioLabs). Results showed that 
CbsR12 was similarly processed by both kinds of RNase III into two RNA fragments 
with sizes that closely resembled those in the previously-reported Northern blot analysis 
(Figure S3.1B) [97]. These results strongly suggest that the two sites are not alternative 
TSSs but are instead generated by RNase III processing. 
CbsR12 binds to C. burnetii recombinant CsrA-2, but not CsrA-1, in vitro 
The predicted secondary structure of CbsR12 also revealed four conserved single-strand 
sequence motifs among the various stem-loop structures (Figure S3.1A). This motif, 
AGGA/ANGGA, corresponds exactly to the conserved CsrA-binding motif of many 
bacteria [27, 30]. C. burnetii contains two annotated and distinct types of CsrA (termed 
CsrA-1 [CBU_0024] and CsrA-2 [CBU_1050]) that share 65% primary sequence 
identity. To test the functionality of these domains, we employed an in vitro binding 
assay and a RNA-protein EMSA to determine if CbsR12 binds to natively-purified 
recombinant CsrA-1 (rCsrA1) and/or CsrA-2 (rCsrA-2). EMSA results clearly showed 
that CbsR12 binds to rCsrA-2, but not rCsrA-1, in vitro (Figure 3.1). In addition, a 
CbsR10 negative-control sRNA did not bind either rCsrA. Furthermore, the KD for 
rCsrA-2 was determined to be 130 nM, consistent with published values for CsrA-
binding sRNAs [169]. 
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Figure 3.1: CbsR12 binds to CsrA-2, but not CsrA-1, protein in vitro. EMSAs 
showing RNA-protein interactions between biotin-labeled, in vitro-transcribed CbsR12 (0 
or 1 nM) and increasing concentrations of purified, rCsrA-1 (A) or rCsrA-2 (B). CbsR10 
(at 0 or 1 nM; right of vertical black line) is included as a negative control, as the sRNA 
contains only a single discernible CsrA-binding motif. 
 
A cbsR12 mutant shows prolonged lag phase in axenic media 
A cbsR12 mutant of C. burnetii (strain RSA439 with Tn 327, hereafter referred to as MB-
cbsR12), as well as an otherwise isogenic Tn insertional control strain (strain RSA439 
with Tn 1832, hereafter referred to as MB-WT), were previously generated using a 
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Himar1-based Tn system [86]. The location of the Tn insertion of strain MB-cbsR12 is 
shown in Figure S3.2A. We also constructed a transposon-directed complement of strain 
MB-cbsR12 (hereafter referred to as MB-cbsR12-Comp) containing the wild-type cbsR12 
gene plus ~100 bp of 5' and 3' flanking sequences, to include any potential transcriptional 
regulator element(s) that could influence cbsR12 expression. PCR was used to confirm 
the Tn insertions in the MB-cbsR12 and MB-cbsR12-Comp (Figure S3.2B). 
Furthermore, we confirmed that the cbsR12 cassette inserted into an IGR between 
CBU_1788 and CBU_1789 (RSA493: accession number NC_002971.4), and we utilized 
copy-number quantitative PCR (qPCR) to confirm the single insertional event in MB-
cbsR12-Comp (Figure S3.2C). 
          Next, we conducted growth curve analyses of MB-WT, MB-cbsR12, and MB-
cbsR12-Comp strains grown axenically in ACCM-2 (Figures 3.2A, S3.3A, S3.3B) and 
assayed production of CbsR12 at incremental time points from the LCV stage (~ 1-6 d) 
through the SCV stage (>7 d) by quantitative real-time PCR (qRT-PCR) (Figure 3.2B). 
Growth curve results showed that MB-cbsR12 displayed a prolonged lag phase from 1-3 
d post-inoculation that was not observed in MB-WT or MB-cbsR12-Comp strains 
(Figures 3.2A, S3.3A, S3.3B). Following lag phase, MB-cbsR12 grew at a slightly 
increased rate relative to the other strains (6-9 d post-infection), but failed to reach cell 
numbers seen in the other two strains throughout the assay. The “wild-type” (MB-WT) 
and complemented (MB-cbsR12-Comp) strains produced essentially indistinguishable 
growth curves. The qRT-PCR results showed that the Tn insertion in MB-cbsR12 
completely abrogated CbsR12 production (Figure 3.2B). The results also confirmed 
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cbsR12’s increased expression in LCVs compared to SCVs as copies of CbsR12 per C. 
burnetii genome were highest at 3 d post-inoculation. 
 
Figure 3.2: CbsR12 production and growth effects on C. burnetii grown in ACCM-2. 
(A). Growth curves for MB-WT, MB-cbsR12, and MB-cbsR12-Comp in ACCM-2 as 
determined by qPCR. The 0dpi time point refers to the inoculum. Values represent the 
means ± standard error of means (SEM) of three technical replicates. Data are 
representative of three independent experiments with consistent and indistinguishable 
results. (B). CbsR12 production over time for MB-WT, MB-cbsR12, and MB-cbsR12-
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Comp grown in ACCM-2 as determined by qRT-PCR. Values represent the means ± 
standard error of means (SEM) of three independent determinations. 
 
CbsR12 impacts intracellular replication of C. burnetii 
C. burnetii typically infects alveolar macrophages during human infection. We therefore 
infected a differentiated human monocyte cell line (THP-1) with MB-WT, MB-cbsR12, 
and MB-cbsR12-Comp strains. Comparative growth curves showed that MB-cbsR12 has 
a slower growth rate in exponential phase (1-3dpi) as compared to the two other strains, 
and never attained the bacterial cell numbers seen in infections with MB-WT or MB-
cbsR12-Comp (Figures 3.3A, S3.3C, S3.3D). Furthermore, CbsR12 production in THP-
1s correlated with replication efficiency of the individual strain. For example, production 
of CbsR12 in MB-WT and MB-cbsR12-Comp strains increased between 1dpi and 3dpi, 
and CbsR12 levels directly correlated to growth rates of the respective strains between 
these two time points. However, we observed a dysregulation of CbsR12 in MB-cbsR12-
Comp infecting THP-1 cells that was strikingly different than what was seen during 
axenic growth. Specifically, we observed a maintenance of CbsR12 production 
throughout infection of THP-1s (Figure 3.3B), whereas in axenic growth there was a 
progressive drop-off in synthesis after 3dpi (see Figure 3.2B). These results suggest that 
cbsR12 expression differs in this host-cell type and that a transcriptional regulatory motif 
may exist outside the bounds of the complementation insertion, resulting in dysregulation 
due to the genomic context of cbsR12 in MB-cbsR12-Comp compared to MB-WT in a 
THP-1 infection. 
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Figure 3.3: CbsR12 production and growth effects on C. burnetii infecting THP-1 
cells. (A). Growth curves for MB-WT, MB-cbsR12, and MB-cbsR12-Comp in THP-1 
cells as determined by qPCR. The 0dpi time point refers to the inoculum. Values 
represent means ± standard error of means (SEM) of three technical replicates. Data are 
representative of three independent experiments with consistent and indistinguishable 
results. (B). CbsR12 production over time for MB-WT, MB-cbsR12, and MB-cbsR12-
Comp infecting THP-1 cells, as determined by qRT-PCR. Values represent means ± 
standard error of means (SEM) of three independent determinations. 
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CCV size correlates with CbsR12 production in THP-1 infection 
To more closely examine bacterial-host cell interactions, we employed 
immunofluorescence assays (IFAs) of C. burnetii infecting THP-1 cells. C. burnetii 
colonies and CCV boundaries were visualized using anti-Coxiella (anti-Com1 [170]) and 
anti-LAMP1 antibodies at both 3dpi (late LCVs) and 7dpi (SCVs). Here, we define a C. 
burnetii colony as multiple C. burnetii inhabiting a LAMP1-decorated intracellular 
vacuole. LAMP1 is a host cell protein recruited to lysosomes and found on CCVs after 
lysosome fusion [171]. We observed a robust infection at 3dpi for MB-WT and MB-
cbsR12-Comp strains, whereas the MB-cbsR12 strain only produced a few, small CCVs 
with relatively unclear boundaries (Figure 3.4A). In contrast, the MB-cbsR12-Comp 
strain produced CCVs that were similar in size to those generated by the MB-WT strain, 
reflecting the trend observed in their respective growth curves (see Figure 3.3A). 
Quantitatively, the differences in CCV sizes between MB-cbsR12 and the other two 
strains were significant at 3dpi (Figure 3.4B). However, by 7dpi the CCVs were of 
similar size in MB-cbsR12 and MB-WT infections, indicating some compensatory or 
redundant mechanisms allowing for CCV expansion as the infection proceeded, even 
though MB-cbsR12 genome counts never reached wild-type levels (see Figure 3.3A). 
Interestingly, the MB-cbsR12-Comp strain formed consistently larger CCVs at 3dpi 
(significantly greater than MB-WT and MB-cbsR12) and 7dpi (significantly greater than 
MB-cbsR12), which meshes well with the sustained expression of cbsR12 evidenced 
throughout the course of infection (see Figure 3.3B). Taken as a whole, these results 
suggest that CbsR12 is important for optimum growth and establishment of CCVs early 
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in the course of infection of THP-1 cells, and CbsR12 can influence CCV expansion 
throughout a THP-1 infection. 
 
Figure 3.4: CbsR12 affects CCV expansion in infected THP-1 cells. (A). 
Representative IFAs of MB-WT, MB-cbsR12 and MB-cbsR12-Comp infecting THP-1 
cells at 3dpi and 7dpi. C. burnetii was probed with anti-Com1 antibodies coupled to 
Alexa Fluor 488 (green), CCV boundaries were labeled with anti-LAMP1 antibodies 
coupled to rhodamine (red), and host cell nuclei were labeled with DAPI (blue). (B). 
Sizes of individual CCVs in log10(pixels) for MB-WT, MB-cbsR12, and MB-cbsR12-
Comp. Measurements were taken from 46 individual images of random fields of view 
spanning three different experiments for each C. burnetii strain. Crossbars represent 
means ± standard error of means (SEM) (** = P < 0.01, one-way ANOVA). Scale bars = 
20 µm. 
 
CbsR12 binds to carA, metK, and cvpD transcripts in vitro 
Although CbsR12 was identified as a CsrA-binding sRNA, nothing was known about the 
CsrA regulon in C. burnetii, making it difficult to ascribe intracellular phenotypes to 
regulation by CsrA. Therefore, we wanted to determine if CbsR12 could act by regulating 
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mRNAs in trans. To identify potential mRNA targets of CbsR12, we first employed three 
in silico sRNA target discovery algorithms. Each algorithm takes into consideration the 
extent of sRNA-mRNA hybridization, conservation of the sRNA, and the accessibility of 
both the sRNA and its target, although TargetRNA2 and IntaRNAv2 prioritize 
accessibility while CopraRNA prioritizes comparative interaction predictions among 
different strains of the indicated bacterium. From these search results, we omitted genes 
annotated as hypothetical and chose cvpD, metK, carA, purH, rpsA, and dnaA as potential 
targets based on conserved predictions (Table 3.2). To get a sense of CbsR12’s ability to 
bind to these potential mRNA targets, we next performed a RNA-RNA hybridization 
followed by EMSAs. The results clearly showed that CbsR12 bound to carA, metK, and 
cvpD transcripts in vitro, but did not interact with rpsA, purH, or dnaA transcripts 
(Figure 3.5). We further tested CbsR12’s specificity for these transcripts by performing 
dose-dependent and unlabeled-chase experiments. Results of the EMSA analyses showed 
that CbsR12 specifically bound carA, metK, and cvpD transcripts in a dose-dependent 
manner (Figure S3.4). 
 
Table 3.2. CbsR12 target
a
 prediction using various algorithms 
Rank TargetRNA2 IntaRNA CopraRNA 
1 CBU_1041 (0.001) cvpD (0.000017) cvpD (0.00001) 
2 prlC (0.001) CBU_0537 (0.00018) CBU_0537 (0.000039) 
3 suhB (0.001) CBU_1161 (0.00018) CBU_0922 (0.00053 
4 mutS (0.002) CBU_0922 (0.00091) CBU_0103 (0.00074) 
5 bioD (0.003) CBU_2028 (0.0012) CBU_2028 (0.00078) 
6 trmD (0.003) CBU_0103 (0.0013) rpsA (0.0013) 
7 dnaA (0.005) rpsA (0.0022) metK (0.0014) 
8 yciL (0.007) metK (0.0023) purH (0.0019) 
9 metK (0.008) purH (0.003) CBU_1741 (0.0025) 
10 CBU_0558 (0.01) carA (0.015) carA (0.0067) 
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a
Target genes identified through algorithms, ranked. Calculated p-values for each target 
are indicated in parentheses. Genes involved in subsequent experiments are indicated by 
bold-face type. 
 
 
Figure 3.5: CbsR12 targets carA, metK, and cvpD transcripts in vitro. RNA-RNA 
EMSA showing hybridization reactions with 10 nM biotin-labeled CbsR12 and 5 nM in 
vitro-transcribed segments of carA, metK, cvpD, purH, rpsA or dnaA. Anti-CbsR12 
represents a 10 nM positive control consisting of a transcript equal in size, but antisense, 
to the CbsR12 transcript. Arrows indicate un-bound bio-CbsR12 (blue) and bio-CbsR12 
bound to RNA targets (red). 
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CbsR12 binds to metK, carA, cvpD, and ahcY transcripts in C. burnetii cells 
To determine the CbsR12 targetome within C. burnetii cells, we employed a Crosslink-
Seq technique previously used to detect intracellular mRNA targets of E. coli sRNAs 
[152]. For this procedure, we used C. burnetii LCVs grown in ACCM-2 to produce 
sufficient volumes to capture CbsR12 target RNAs for cDNA library preparation and 
RNA-Seq analysis. Hybridized RNAs in lysates from both MB-WT and MB-cbsR12 
strains were chemically cross-linked, captured by anti-CbsR12 probes, and analyzed by 
RNA-Seq in order to identify RNAs enriched in MB-WT compared to MB-cbsR12. 
Crosslink-Seq results confirmed that CbsR12 targeted carA, metK, and cvpD transcripts 
in C. burnetii cells (Figure 3.6), as demonstrated in vitro (see Figure 3.5). We also 
discovered an additional mRNA target, ahcY, coding for adenosylhomocysteinase, 
another component of the methionine cycle. Interestingly, ahcY was also predicted as an 
mRNA target by IntaRNA, although the p-value was not significant (p = 0.13). 
Additionally, ahcY is in an operon with and downstream of metK. To address whether 
ahcY is actually a target of CbsR12, or if it is a result of CbsR12’s binding to a 
polycistronic mRNA, we used the Artemis genome browser to observe Crosslink-Seq 
reads aligned to the C. burnetii RSA439 genome. This analysis showed distinct segments 
of these genes to which the captured reads mapped, suggesting they are separate binding 
events (Figure S3.5B). We also confirmed the other identified targets by the same 
method (Figures S3.5A, S3.5C). 
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Figure 3.6: CbsR12 targets several C. burnetii transcripts, including those of metK, 
carA and cvpD. Volcano plot highlighting mRNAs that occur at different levels between 
Crosslink-Seq experiments with strains MB-WT and MB-cbsR12. Labeled transcripts are 
indicated by a green dot and are significantly enriched in MB-WT versus MB-cbsR12, 
identifying them as targets of CbsR12. Black dots represent transcripts not significantly 
different between the strains tested. Orange dots represent transcripts having a log2-fold 
change > 1, but a false discovery rate (FDR) > 0.05. There were no transcripts indicated 
by red dots, which would represent mRNAs with a FDR < 0.05 but a log2-fold change in 
levels < 1. Data shown are representative of two biological replicates each of MB-WT 
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and MB-cbsR12 Crosslink-Seq experiments. The potential CbsR12-binding site in the 
coding region of the ahcY transcript is inset. 
 
          Next, we wanted to determine whether CbsR12-mediated regulation of predicted 
in-trans mRNA targets would occur independently of CsrA. To this end, we searched for 
potential CsrA-binding (AGGA/ANGGA) motifs within the 100 bases up and 
downstream of the start codons of carA, metK, cvpD, and ahcY. This search showed that 
carA, metK and cvpD contained single potential CsrA-binding sites whereas cvpD had 
none. Moreover, the motifs of carA and metK did not occur in predicted ribosome-
binding sites (RBS), suggesting that CsrA is unlikely to regulate the corresponding 
transcripts [33] (Table 3.3). Thus, CbsR12 regulation of carA, metK, and cvpD 
transcripts likely occurs as a direct result of in-trans binding by CbsR12 and 
independently of CsrA. In contrast, the ahcY sequence has two potential regulatory 
ANGGA CsrA-binding sites, so we cannot exclude the possibility of indirect regulatory 
effects caused by CbsR12-mediated sequestering of CsrA. As such, we did not further 
explore CbsR12-mediated regulation of ahcY. 
 
Table 3.3. Predicted CsrA motifs in CbsR12 targets 
CbsR12 Target 
Gene 
Locus Tag
a 
Base Range
b
 CsrA 
Motifs
c
 
Position of 
Motif
d
 
carA CBU_1282 c(1234872-
1235073) 
1 (+71) – (+75) 
metK CBU_2030 1936983-1937183 1 (-12) – (-8) 
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cvpD CBU_1818 1748916-1749116 0 N/A 
ahcY CBU_2031 1938166-1938366 2 (+1) – (+5),  
(+13) – (+17) 
a
Locus tags as annotated for RSA493 (NCBI Ref Seq: NC_002971.4).
 b
Base range 
indicates 100 nts up and downstream of the annotated start codon for RSA493 (NCBI Ref 
Seq: NC_002971.4). 
c
Consensus CsrA-binding motifs are AGGA or ANGGA. 
d
Position 
of CsrA-binding motifs relative to the first nucleotide of the start codon (+1). 
 
CbsR12 negatively affects the quantity of cvpD transcripts and regulates synthesis of 
CarA and MetK  
Next, we set out to determine if CbsR12 regulates carA, metK, and cvpD transcripts in C. 
burnetii. First, we performed 5' RACE on the three transcripts in total RNA extracted 
from LCVs infecting mammalian cells (3dpi). 5' RACE results for the MB-WT cvpD 
gene indicated three apparent TSSs, including a TSS for the full-length transcript, several 
questionable “TSSs” within the CbsR12-binding site, and an alternative TSS for a short 
transcript downstream of the CbsR12-binding site and with its own predicted promoter 
element (Figure S3.6A). Interestingly, putative RBSs and start codons exist downstream 
of TSSs for both the full-length and short transcripts. Moreover, the two start codons are 
in-frame with each other and the existence of putative RBSs supports the possibility that 
translation occurs from both elements. The questionable “TSSs” within the CbsR12-
binding region likely result from CbsR12-mediated RNase III degradation of cvpD 
mRNA, because 5' RACE results for MB-cbsR12, a strain that lacks CbsR12, did not 
produce TSSs in this region. We predict that CbsR12 down-regulates production of full-
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length CvpD since the CbsR12-binding site occurs in the coding region. However, 
CbsR12 would predictably have no effect on production of the putative truncated CvpD, 
as the CbsR12-binding site occurs upstream of the alternative TSS (Figures S3.6A, 
S3.6B).  
To determine if CbsR12 binds to and causes degradation of full-length cvpD 
transcripts, we performed qRT-PCR on MB-WT, MB-cbsR12, and MB-cbsR12-Comp 
LCVs obtained from infected THP-1 cells. These results clearly showed that the absence 
of CbsR12 in strain MB-cbsR12 led to a significant increase in full-length cvpD 
transcripts in LCVs (3dpi) (Figure S3.6C). At 7dpi, MB-WT and MB-cbsR12 levels 
were not significantly different, presumably due to reduced CbsR12 production in MB-
WT SCVs (see Figure 3.3B). However, cvpD expression was significantly lower in MB-
cbsR12-Comp, most likely due to the maintained production of CbsR12 in the strain’s 
SCVs (see Figure 3.3B). Whether or not two different forms of CvpD are produced from 
cvpD is unknown, although it appears that CbsR12 may negatively regulate the full-
length cvpD transcript. 
In order to determine if CbsR12 binds to and regulates carA and metK in a cellular 
environment, we devised a reporter assay in E. coli that measures the effects of CbsR12 
production on translation of carA-luc or metK-luc fusion constructs. 5' RACE results for 
both MB-WT and MB-cbsR12 strains revealed that carA has two potential TSSs, a 
finding that is consistent with transcription of E. coli carA [165]. Based on the position of 
the TSSs, CbsR12 could only regulate the full-length carA transcript and not the shorter 
mRNA, whose transcription starts immediately upstream of the RBS and downstream of 
the CbsR12-binding site (Figure 3.7A). From these results, we hypothesized that CbsR12 
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binds to the 5' UTR of carA and upregulates translation by relieving the secondary 
structure that occludes the predicted RBS (Figures 3.7A, 3.7B). Results of the E. coli 
reporter assay confirmed our hypothesis, because translation of luciferase enzyme from a 
carA5'UTR-luc fusion was significantly upregulated in the presence of CbsR12 relative to 
a strain lacking the sRNA (Figure 3.7C). 
 
Figure 3.7: CbsR12 targets and upregulates translation of a carA-luciferase fusion 
construct. (A). Secondary structure of the carA 5' UTR as predicted by mFold. Red 
asterisks indicate TSSs for the shorter transcripts as determined by 5' RACE. (Nucleotide 
1 was determined to be the TSS for the full-length transcript by 5' RACE). Colored lines 
represent the start codon (green), predicted RBS (red), and determined CbsR12-binding 
sites (blue). (B). Representation of CbsR12 binding to the carA transcript as determined 
by IntaRNA, with respective base numbers indicated. The top strand in the model 
represents the carA sequence, while the bottom strand represents the complementary 
CbsR12 sequence. (C). carA-luc reporter assay indicating relative luminescence units 
produced by pBESTluc constructs with: 1) no luciferase production (Frameshifted 
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Luciferase), 2) pBESTluc vector (pBEST), 3) pBESTluc with the carA 5' UTR upstream 
of luc but lacking cbsR12 (pBEST + carA 5' UTR), and 4) carA 5' UTR upstream of luc 
plus the cbsR12 gene driven by a Ptac promoter (pBEST + carA 5' UTR + cbsR12). 
Values represent means ± standard error of means (SEM) of three independent 
determinations (* = P < 0.05, student's t test). 
 
In contrast, CbsR12 was predicted to downregulate MetK translation by binding 
to the coding region of the transcript, immediately downstream of its start codon (Figure 
3.8A). As is often the case with this type of sRNA-mediated regulation, RNase III would 
likely be recruited and the metK transcript cleaved, resulting in downregulation of the 
encoded protein product. Unexpectedly, 5' RACE analyses of metK mRNA also 
identified apparent alternative “TSSs” within the CbsR12-binding region, suggesting that 
the truncated mRNAs resulted from CbsR12-mediated RNase III processing (Figures 
3.8A, 3.8B). Indeed, 5' RACE analysis of RNA from strain MB-cbsR12 infecting THP-1 
cells did not detect the “TSSs”, suggesting they are a product of RNase III processing. 
Results of the reporter assays in E. coli confirmed our hypothesis, as the presence of 
CbsR12 significantly down-regulated translation of luciferase from the metK-luc fusion 
construct compared to a strain lacking the sRNA (Figure 3.8C). 
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Figure 3.8: CbsR12 targets and downregulates translation of a metK-luciferase 
fusion construct. (A). Secondary structure of the metK 5' UTR and initial coding 
sequence as predicted by mFold. Red asterisks indicate apparent alternative “TSSs” 
determined by 5' RACE. (Nucleotide 1 was determined to be the TSS for the full-length 
transcript by 5' RACE). Colored lines represent the start codon (green), a predicted RBS 
(red), and the determined CbsR12-binding site (blue). (B). Representation of CbsR12 
binding to the metK transcript as determined by IntaRNA with base numbers indicated. 
The top strand in the model represents the metK sequence, while the bottom strand 
represents the complementary CbsR12 sequence. (C). metK-luc reporter assay indicating 
relative luminescence units produced by pBESTluc constructs with: 1) no luciferase 
production (Frameshifted Luciferase), 2) pBESTluc vector (pBEST), 3) pBESTluc with 
the CbsR12 binding site cloned in-frame into luc but lacking the cbsR12 gene (pBEST + 
metK) and 4) pBESTluc with the CbsR12 binding site cloned in-frame into luc plus the 
cbsR12 gene driven by a Ptac promoter (pBEST + metK + cbsR12). Values represent 
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means ± standard error of means (SEM) of three independent determinations (* = P < 
0.05, student's t test). 
 
 Although we determined that CbsR12 targets carA and metK transcripts in vitro 
and in E. coli cells, we were curious whether the absence of CbsR12 would also result in 
differential amounts of CarA and MetK proteins in C. burnetii. To this end, we 
performed Western blots with polyclonal antibody generated against recombinant C. 
burnetii CarA and MetK. As predicted, when proteins from whole-cell lysates of MB-
WT, MB-cbsR12, and MB-cbsR12-Comp strains were compared, we found that CarA 
was synthesized in MB-WT and MB-cbsR12-Comp strains at comparable levels, but was 
undetectable in protein profiles of strain MB-cbsR12 (Figures 3.9A, S3.7A). In sharp 
contrast, MetK was highly synthesized in strain MB-cbsR12 but was produced at 
relatively lower and comparable levels in the MB-WT and MB-cbsR12-Comp strains 
(Figures 3.9B, S3.7B). 
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Figure 3.9: CarA and MetK proteins are differentially synthesized in MB-WT, MB-
cbsR12, and MB-cbsR12-Comp strains. (A). Proteins (30 µg total) from MB-WT, MB-
cbsR12, and MB-cbsR12-Comp LCVs (mid-log phase; 96h for MB-WT and MB-cbsR12-
Comp and 144h for MB-cbsR12) grown in ACCM-2 were resolved on a 10-20% 
acrylamide gradient SDS-PAGE gel, blotted, probed with rabbit anti-CarA antibodies, 
and detected with chemiluminescence. The black arrow indicates CarA. (B). Proteins (60 
µg total) from MB-WT, MB-cbsR12, and MB-cbsR12-Comp LCVs (mid-log phase; 96h 
for MB-WT and MB-cbsR12-Comp and 144h for MB-cbsR12) grown in ACCM-2 were 
resolved on a 10-20% acrylamide gradient SDS-PAGE gels, blotted, probed with rabbit 
anti-MetK antibodies, and detected with chemiluminescence. The black arrow indicates 
MetK.  
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Discussion 
In this report, we show that CbsR12, a multifunctional sRNA that binds to mRNAs and to 
the regulatory protein CsrA-2, is important for proper Coxiella replication and CCV 
expansion during infection of human macrophage-like THP-1 cells. 
          Induction of cbsR12 expression in mammalian cell culture vs. in vitro conditions 
(see Table 3.1) led us to label CbsR12 as “infection-specific” and as a result we 
hypothesized that it played an important regulatory role in infection of host cells. The 
cbsR12 sequence is conserved among all C. burnetii strains sequenced to date, 
underscoring the potential for an important regulatory role, but from an evolutionary 
viewpoint. Interestingly, though, the cbsR12 gene is missing or degenerate in Coxiella-
like endosymbionts [172], suggesting that the sRNA is important for a mammalian 
infection but is dispensable in endosymbionts that reside in arthropods. 
          Interestingly, CbsR12 binds rCsrA-2, but not rCsrA-1, in a dose-dependent 
manner, in vitro. Why CsrA-1 does not bind to consensus motifs present in CbsR12  is 
unclear, especially since both CsrA-1 and CsrA-2 maintain the critical L4 and R44 RNA-
binding residues, although CsrA-1 has these residues at L4 and R46 [173]. There are 
several examples of pathogens harboring multiple copies of CsrA [174, 175]. For 
example, RsmF of P. aeruginosa is a homolog of RsmA (CsrA) and functions by binding 
a subset of mRNAs that RsmA also binds [175]. However, an rsmF mutant did not 
display a phenotype during infection [175]. Similarly, In C. burnetii, a transposon-
mediated csrA-1 mutant was shown to have no intracellular phenotype [87]. It is also 
conceivable that CsrA-1 diverged during C. burnetii’s adaptation to an intracellular 
lifestyle and is no longer functional. It is also possible that CsrA-1 binds to a non-
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canonical motif not present in CbsR12, although such CsrA homologs have not been 
described, to our knowledge. Regardless, it is necessary to examine the CsrA-1 and 
CsrA-2 regulons in order to determine their respective roles during infection. 
          In L. pneumophila, a close relative of C. burnetii, successful infection depends on a 
LetAS-RsmYZ-CsrA regulatory cascade. LetAS is a TCS that regulates production of 
two sRNAs, RsmY and RsmZ, which in turn act as RNA “sponges” that soak up CsrA 
and modulate its activity [33]. We determined that CbsR12 possesses only four CsrA-
binding sites, similar to the RsmY/Z sRNAs of L. pneumophila. Interestingly, L. 
pneumophila RsmY/Z was implicated in the formation of cell aggregates and biofilms 
when the sRNAs were ectopically overproduced in E. coli, mimicking the effects of E. 
coli's own CsrA-binding sRNAs [31]. Likewise, when we overproduced CbsR12 in E. 
coli reporter assays (Figures 3.7, 3.8), we observed a similar autoaggregative phenotype 
(Figure S3.8A). Moreover, CbsR12 induced biofilm production in E. coli, reflecting a 
CsrA-depleting phenotype (Figure S3.8B). Together, these results suggest that CbsR12 is 
a CsrA-sequestering, RsmY/Z-like sRNA, although further research is necessary to 
determine the exact influence of CbsR12 on the regulatory roles of CsrA-2. 
          C. burnetii has several potential transcription factors that are known to upregulate 
bacterial expression, including IHF [149], response regulator PmrA [176], and 
transcription factor DksA [177]. However, only PmrA has been well-studied, to date [91]. 
It is interesting to note that the cbsR12 gene contains a close approximation to a PmrA-
binding site (consensus sequence with less conserved nucleotides in lowercase: cTTAA-
N2-TT-N2-cTTAA) [178] immediately upstream of its predicted -10 promoter element 
(cbsR12 sequence: gTTTA-N2-TT-N1-gTTAA). However, the presence of this sequence 
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does not explain the prolonged CbsR12 production observed during a THP-1 infection by 
MB-cbsR12-Comp since the putative PmrA-binding sequence is present in the cbsR12 
cassette that was inserted. We predict that expression of cbsR12 is regulated by an 
unidentified TCS in a fashion similar to the L. pneumophila LetAS TCS regulation of 
RsmYZ sRNAs [33]. In fact, the LetAS TCS is not unlike the GacAS TCS involved in 
RsmYZ-CsrA cascades of other bacteria [179]. C. burnetii codes for four different GacA 
response regulators that could bind upstream elements of cbsR12 and regulate its 
expression [99]. This upstream regulator may, in turn, help to explain the dysregulation 
of expression seen in MB-cbsR12-Comp during infection of THP-1 cells (see Figure 
3.3B) that is not apparent during axenic growth (see Figure 3.2B). Alternatively, 
expression of cbsR12 could be upregulated by PmrA, and some other regulator may be 
involved in its down-regulation, in conjunction with RNase III-mediated decay (see 
Figure S3.1). Together, these would aid in suppression of CbsR12 as the LCV-to-SCV 
transition occurs, effectively freeing sequestered CsrA-2 to regulate the fate of target 
transcripts. 
          It is worth noting that we have identified a second sRNA, Coxiella burnetii small 
RNA 1 (CbsR1), that possesses 5 putative CsrA-binding sites with an ANGGA motif 
(Figure S3.9B) [97]. Similar to CbsR12, CbsR1 is also produced at high levels in LCVs 
infecting Vero cells (see Table 3.1). Furthermore, cbsR1 harbors a putative LetA-binding 
site similar to that of L. pneumophila RsmY (Figure S3.9A) [31]. Together, these 
observations suggest that CbsR1 and CbsR12 may represent orthologs of RsmYZ, 
although further exploration of CbsR1 and its cooperativity with CbsR12 is required. If 
CbsR1 does indeed serve as a CsrA-binding sRNA, its potential, redundant regulatory 
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role may help to explain why MB-cbsR12 CCVs expanded to wild-type sizes as the 
infection progressed (see Figure 3.4B). 
          We also found that CbsR12 binds carA transcripts (see Figures 3.5, 3.7) and 
upregulates production of C. burnetii CarA (see Figure 3.9A). Pyrimidine metabolism in 
C. burnetii presumably requires CarAB to catalyze the conversion of L-glutamine into 
carbamoyl phosphate and glutamate, since it is unable to shunt this process through the 
arginine dihydrolase pathway; C. burnetii apparently lacks the necessary enzymes [180]. 
CbsR12-mediated upregulation of CarA in LCVs would result in increased production of 
pyrimidines that the pathogen requires for robust intracellular growth. 
          In E. coli, carA expression is tightly controlled by a series of transcriptional 
regulators and the two distinct promoters that are regulated by feedback from arginine 
and pyrimidines [165]. 5' RACE analysis showed two distinct TSSs for C. burnetii carA 
mRNA, with the full-length transcript containing two CbsR12-binding sites and a shorter 
putative transcript lacking the site (see Figure 3.7A). We do not believe that the shorter, 
alternative TSS is due to RNase III-mediated degradation resulting from CbsR12 binding 
because this alternative TSS remained in 5' RACE analysis of the MB-cbsR12 strain. We 
do not know conditions under which the shorter transcript is produced, but it may involve 
feedback from arginine/pyrimidine in accordance with carA regulation in E. coli. 
          We also showed that CbsR12 binds to metK transcripts and downregulates 
production of C. burnetii MetK protein (see Figures 3.5, 3.8, 3.9B). MetK is a key 
component of the methionine cycle, which converts methionine to SAM via MetK, SAM 
to S-adenosylhomocysteine (SAH) via various methylases, SAH to homocysteine via 
AhcY, and homocysteine to methionine via MetH/MetE. Cells produce homocysteine as 
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an input molecule through a series of reactions involving activated homoserines 
(reviewed in [181]). C. burnetii is a semi-auxotroph for methionine, since it can 
potentially grow without methionine in axenic media, albeit at a slower growth rate 
[182]. Interestingly, C. burnetii lacks several components of the methionine synthesis 
pathway, most notably the ability to produce activated homoserines. Most bacteria 
activate homoserine through addition of an O-succinyl group catalyzed by MetA or an O-
acetyl group catalyzed by MetX (reviewed in [181]). C. burnetii apparently lacks genes 
coding for these enzymes. An ABC methionine transporter has been hypothesized [182] 
but not verified in Coxiella. If this is indeed a functional transporter, CbsR12’s negative 
regulation of metK transcripts makes sense in the context of the sRNA’s high level in 
LCVs, because any amount of scavenged methionine would be critical to growth. 
Shifting the equilibrium from SAM synthesis to methionine retention would be necessary 
as C. burnetii rapidly produces proteins to expand its intracellular niche. 
          SAM is a major methyl donor, is necessary for regulation of numerous enzymes, 
and has been implicated as a major contributor to virulence [183, 184]. Some bacteria 
lack metK and instead transport SAM directly [185]. There are many uncharacterized 
transporters encoded in the C. burnetii genome, so it is conceivable that a SAM 
transporter is present [99]. This would allow for SAM scavenging even when MetK 
production is downregulated by CbsR12. Furthermore, if SAM transport occurs, C. 
burnetii could synthesize methionine without having to scavenge it, since the amino acid 
can be synthesized from SAM without activated homoserine via the methionine cycle. 
          We also determined that CbsR12 actively targets ahcY transcripts (see Figure 3.6). 
AhcY is a component of the methionine cycle and catalyzes conversion of SAH into 
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homocysteine and adenosine. Based on the location of the CbsR12-binding site in the 
coding region of the ahcY transcript (Figure 3.6 inset), we predict that CbsR12 
negatively regulates AhcY translation. The underlying reason for this negative regulation 
is unknown, although it could help to suppress adenosine and/or homocysteine 
accumulation in LCVs. 
          cvpD mRNA was also identified as a CbsR12 target through Crosslink-Seq (see 
Figure 3.6), and this was confirmed by RNA-RNA hybridization / EMSA and qRT-PCR 
analyses (see Figures 3.5, S3.6C). In this study, we found that CbsR12 was necessary for 
CCV expansion in early stages of a THP-1 infection. The mechanism for this is unclear, 
although it may involve regulation of cvpD, which is required for C. burnetii’s 
intracellular replication and CCV expansion in infected THP-1 and HeLa cells [84]. 
CbsR12 is predicted to target the coding region of the cvpD transcript and would 
negatively regulate translation. However, in the context of cbsR12’s expression pattern, 
this is an unclear association, as one would expect upregulation of CvpD synthesis at a 
time when CbsR12 is highly produced in LCVs. However, 5' RACE analysis of cvpD 
transcripts in MB-WT and MB-cbsR12 provides a potential explanation, as an alternative 
cvpD promoter downstream of the CbsR12-binding site occurs that also possesses a 
putative RBS and start codon (see Figure S3.6A). From these results, we hypothesize 
that there are two gene isoforms of cvpD that are transcribed and differentially expressed 
depending on the C. burnetii morphotype. Due to high expression of cbsR12 in LCVs, the 
longer cvpD transcript isoform would be downregulated by RNase III. As expression of 
cbsR12 decreases as the infection proceeds, the longer transcript isoform would 
accumulate. qRT-PCR data support this explanation, since a lack of CbsR12 in MB-
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cbsR12 significantly increased the quantity of long cvpD isoform transcripts (see Figure 
S3.6C). This hypothesis could be confirmed if the two putative CvpD products could be 
identified and distinguished. 
          The 2007-2010 Dutch outbreak involving C. burnetii yielded several newly 
annotated genomes specific to that epidemic [186]. Curiously, 7 of 13 strains analyzed 
contained a frameshift deletion in cvpD, leading to premature stop codons [186]. Among 
these, strains 18430 (NZ_CP014557.1), 14160-001 (NZ_CP014551.1), 701CbB1 
(NZ_CP014553.1), and 2574 (NZ_CP014555.1) had single-base deletions that only 
affected the long cvpD isoform. These strains were isolated from aborted placentas of 
ruminants and cattle in the Netherlands and France [186]. Additional related strains 
include the Heizberg (NZ_CP014561.1), Henzerling (NZ_CP014559.1), and RSA 331 
(NC_010117.1). These strains, which were isolated from patients with acute Q fever in 
northern Italy and Greece in the mid 1900’s, harbored 4-bp frameshift deletions near the 
middle of the cvpD coding region, affecting both long and short cvpD isoforms and 
introducing premature stop codons [186, 187]. Apparently, CvpD was dispensable for 
virulence in the latter strains, whereas the Dutch outbreak strains harbored intact cvpD 
genes, or cvpD genes with a 1-bp frameshift deletion only affecting the longer gene 
isoform. Thus, in these Dutch isolate strains it appears that CbsR12 regulation of cvpD is 
dispensable. Granted, there are many genotypic differences between RSA439 and the 
Dutch isolates [186], and some compensatory mechanism(s) may exist for the absence of 
cvpD. Alternatively, cvpD may be necessary during infection of human cell lines and 
dispensable in host-animal infections. Regardless, the role and regulation of the CvpD 
effector requires further investigation. 
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          cbsR12's high level of expression during infection likely facilitates and regulates 
the many functions we have described. CbsR12 not bound to CsrA-2 presumably acts in 
trans to facilitate efficient replication through translational up-regulation of CarA and 
down-regulation of MetK, and perhaps potentiates expansion of the CCV by means of 
cvpD transcript regulation. Furthermore, regulation is most likely independent of CsrA, 
because these genes lack multiple CsrA-binding sites necessary for regulation (see Table 
3.3). It is worth noting that the CsrA-binding sites of CbsR12 do not overlap with metK 
and cvpD binding sites. Hence, it is feasible that CbsR12 may still regulate metK and 
cvpD in trans while bound to CsrA-2; in fact, a chaperone-like function such as this has 
recently been ascribed to CsrA [188]. 
          CbsR12 is unique in that is one of only a few identified trans-acting sRNAs that 
also binds CsrA (reviewed in [189]). We hypothesize that CbsR12’s role in regulating C. 
burnetii replication and CCV expansion is due to a combination of in-trans mRNA 
(metK, carA, cpvD) targeting and regulation of CsrA-2 function. Our lab is currently 
working to elucidate the CsrA-1/CsrA-2 regulons, along with regulation of the putative 
CbsR12-CsrA-2 cascade of C. burnetii and the nature of CsrA-CbsR1 binding to clarify 
the interplay between CbsR12’s roles as a trans-acting and CsrA-sequestering sRNA. 
 
Materials and Methods 
Bacterial strains, cell lines and growth conditions 
Strains, primers, and plasmids used in this study are listed in Figure S3.10. E. coli was 
grown in lysogeny broth (LB) supplemented with ampicillin (100 µg/mL) or kanamycin 
(50 µg/mL), as needed. When necessary, overnight cultures were expanded to 100 mL 
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LB, grown for 2 h, then supplemented with 1 mM IPTG for induction. C. burnetii Nine 
Mile phase II (strain RSA439, clone 4), MB-WT, MB-cbsR12, and MB-cbsR12-Comp 
were grown in ACCM-2 medium [98] supplemented with ampicillin (5 µg/mL) or 
kanamycin (350 µg/mL) at 5% CO2, 2.5% O2, 92.5% N2 37°C, and 100% humidity with 
continuous shaking at 75 RPM [98]. SCVs collected from Vero cells were used for all C. 
burnetii infections and growth curve experiments. Briefly, C. burnetii was used to infect 
Vero cell monolayers for 7d at 5% CO2 and 37°C, after which the cultures were removed 
to room temperature and the flask lids tightened and covered for two additional weeks 
[190]. Following this, SCVs were harvested with digitonin, as previously described 
[100].  
          African green monkey kidney (Vero) epithelia (CCL-81; American Type Culture 
Collection; ATCC) and human monocytic leukemia (THP-1) cells (TIB-202; ATCC) cell 
lines were maintained in RPMI medium (Gibco) supplemented with 10% fetal bovine 
serum (FBS, RMBIO) in a humidified atmosphere with 5% CO2 at 37°C. THP-1 cells 
were differentiated to macrophages by supplementing the growth medium with 200 nM 
phorbol myristate acetate (PMA, Sigma) overnight.  
Plasmid construction 
pBESTluc was used as a backbone for all reporter assay constructs and was included in 
the Luciferase Assay System kit (Promega). pBEST + metK was created by inserting 
nucleotides corresponding to the first 10 codons of C. burnetii metK immediately 
downstream of the luc start codon using a Q5 Site-Directed Mutagenesis Kit, as 
instructed (New England Biolabs). cbsR12 was cloned into pBESTluc using primers 
containing XhoI and AfeI restriction sites on the forward and reverse primers, 
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respectively. The forward primer also encoded a Ptac promoter and lac operator. The 
PCR product was cloned into pBEST + metK using unique XhoI and AfeI restriction sites 
in an irrelevant IGR. A frameshifted luc construct was created as a byproduct of the metK 
Q5 mutagenesis of pBESTluc and contained a 1-bp frameshift deletion in the 5' end of 
luc. PBEST + carA 5' UTR was created using primers specific to the 5' UTR of carA with 
HindIII and BamHI restriction sites on the forward and reverse primers, respectively. The 
forward primer also encoded the Ptac promoter. Nucleotides corresponding to the lac 
operator were inserted using a Q5 Site-Directed Mutagenesis Kit to create the final 
pBEST + carA 5' UTR construct. The cbsR12 gene was inserted into this construct in the 
same fashion as for pBEST + metK + cbsR12. 
          Recombinant CarA and MetK were generated by PCR amplification of carA and 
metK using forward and reverse primers containing BamHI and HindIII restriction sites, 
respectively. The resulting amplicons were cloned into compatible restriction sites of 
pQE30 (Qiagen) by standard protocol. 
Axenic growth of C. burnetii 
For growth curves and Crosslink-Seq experiments, 3.33 x 10
4 
genomic equivalents 
(GE)/mL of MB-WT, MB-cbsR12, or MB-cbsR12-Comp were inoculated into 300 mL 
ACCM-2 in a 1-liter flask with either chloramphenicol (5 μg/mL), kanamycin (350 
μg/mL) or both. GE/mL was initially determined from frozen cell stocks by qPCR as 
previously described [190], although different dotA primers were used (Figure S3.10). 
Cell viability was determined using a BacLight Bacterial Viability kit as instructed 
(Thermo Scientific). 
C. burnetii infection of differentiated THP-1 cells 
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THP-1 cells were seeded onto 4-well chambered glass slides (Labtek) or T-75 flasks. 
After 2d of growth, 200 nM PMA was added along with fresh medium and cells were 
allowed to differentiate overnight. The PMA-supplemented medium was removed and 
fresh medium restored, after which differentiated THP-1 cells were allowed to recover 
for 4 h prior to C. burnetii infection at an MOI of 10. Initial infections were rocked for 2 
h at room temperature before returning cells to 5% CO2 and 37°C. At 1dpi the 
supernatant was removed, extracellular C. burnetii was washed away with warmed 1X 
PBS, and fresh medium was added. 
Total RNA and genomic DNA extraction and purification 
C. burnetii grown in ACCM-2 was centrifuged at 15,000 x g at 4°C for 15 min, after 
which pellets were resuspended in 1 mL TRI Reagent (Ambion). The suspension was 
incubated for 1 h at room temperature, frozen for 2 h at -80°C, thawed for 30 min at room 
temperature, then pipetted vigorously until homogenized. 100 µL BCP (Acros Organics) 
was added, the solution vortexed for 30 sec, incubated for 5 min at room temperature, and 
centrifuged at 12,000 x g at 4°C for 10 min. The aqueous phase was then collected and 
300 µL 100% ethanol added. The mixture was immediately vortexed for 10 sec, and a 
RiboPure RNA Purification kit (Ambion) was used to collect, concentrate, and wash the 
resulting RNA. RNA was collected in nuclease-free H2O and treated with DNase I for 1 h 
at 37°C. After RNA precipitation in 100% ethanol, the purified RNA was run on a 
NanoDrop spectrophotometer (Thermo Scientific) to determine concentration and purity. 
          In order to purify total RNA from C. burnetii grown in THP-1 cell lines, growth 
medium was first removed and replaced with 1 mL TRI Reagent. Flasks containing TRI 
Reagent were rocked for 1 h at room temperature, after which cells were mechanically 
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scraped and collected into a 15-mL conical tube. The mixture was frozen overnight at -
80°C, thawed to room temperature for 30 min, and the RNA purification procedure 
continued as described above. 
          Genomic DNA was purified from TRI Reagent mixtures according to manufacturer 
protocols (Ambion). The resulting DNA was purified using a Nucleotide Removal kit as 
instructed (Qiagen). 
Quantitative PCR (qPCR) and quantitative real-time PCR (qRT-PCR) 
qPCR and qRT-PCR experiments were performed as previously described [100] using 
300 nM of primers specific to cbsR12 and a volume of iQ SYBR Green Supermix (Bio-
Rad). The resulting reactions were cycled on a MyiQ Single-Color Real Time PCR 
Detection System (version 1.0 software) (Bio-Rad). CbsR12 cDNA copy number was 
normalized against dotA copy number derived from C. burnetii genomic DNA to obtain 
copy numbers / GE values. Growth curve GE/mL and GE/flask values were obtained 
from genomic DNA purified from the same cells from which total RNA was purified.  
          For ACCM-2 growth curves, 30 mL aliquots of a 300-mL culture were removed at 
each time point. gDNA was extracted and resuspended in 30 μL nuclease-free H2O. 1 μL 
gDNA was used in subsequent qPCR reactions producing GE/mL values. For THP-1 
growth curves, 8 separate T-75 flasks for each C. burnetii strain tested were inoculated 
simultaneously. At the specified time point, one flask was taken and 30 μL gDNA was 
again extracted. 1 μL gDNA was used in subsequent qPCR reactions and the GE/flask 
values were calculated. Each growth curve and qPCR reaction were performed in 
triplicate. 
RNase III assay 
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RNase III assays were performed as previously described [102] using 200 nM CbsR12 
substrate and the C. burnetii IVS RNA as a positive control [102]. Resulting reactions 
were electrophoresed on a 7% denaturing polyacrylamide gels and stained with 2 μg/mL 
acridine orange to visualize bands. 
Identification of transcription start sites 
5' RACE analysis of carA, metK, cvpD, and cbsR12 transcripts was performed on MB-
WT and MB-cbsR12 RNA extracted from infected Vero (cbsR12, carA, and metK) or 
THP-1 (cvpD) cells at 3dpi using a 5' RACE System kit (Invitrogen) according to 
manufacturer protocols and with gene-specific primers (see Figure S3.10). Resulting 
PCR products were cloned into pCR2.1-TOPO as instructed (Invitrogen) and then 
sequenced with M13 universal primers by Sanger automated sequencing. In general, 
three biological replicate total RNA samples were obtained from MB-WT and MB-
cbsR12 infections of Vero and THP-1 cells. From these pools, 5' RACE was performed 
as above and 4 clones from each replicate were sequenced, producing 12 total clones 
analyzed for each total RNA pool for each gene analyzed. 
In silico and bioinformatics analyses 
RNA target predictions were carried out using TargetRNA2 [42], IntaRNA [43], and 
CopraRNA [44] algorithms with default settings. RNA was folded using mFold [145] and 
visualized with Visualization Applet for RNA [191]. Analyses of RNA-Seq data were 
carried out as previously described [164]. Briefly, raw fastq files were concatenated, 
quality-filtered with the FASTX toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) then 
clipped, aligned, and filtered with Nesoni version 0.128 tools 
(http://www.vicbioinformatics.com/software.nesoni.shtml). TPM were calculated using 
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custom perl and python scripts that can be accessed through GitHub 
(https://github.com/shawachter/TPM_Scripts). Crosslink-Seq enrichment was 
accomplished by processing .bam files using featureCounts [192], followed by use of the 
DESeq2 package in R version 3.4.4 to obtain differentially expressed genes [193]. The 
Artemis genome browser was used to visualize generated alignment files 
(http://www.sanger.ac.uk/science/tools/artemis) [147]. 
          All IFA images were processed and analyzed using Fiji [194] and Cell Profiler 
[195], respectively. Figures were created using R version 3.4.4, Inkscape 
(https://inkscape.org/release/inkscape-0.92.4/) and GIMP 
(https://www.gimp.org/downloads/). 
RNA-RNA hybridization and EMSA 
Regions of target genes were first selected for PCR amplification. The following regions 
were chosen based on inclusion of predicted 5’ UTRs and CbsR12-binding sites (+1 
nucleotide designation is the first nucleotide of the annotated start codon): carA (-143) – 
(-1), metK (-26) – (+110), cvpD (-41) – (+101), purH (-100) – (+44), dnaA (-97) – (+61), 
and rpsA (-65) – (+77). PCR products (1g) of desired templates were in vitro-
transcribed overnight at 37°C with 2.5 mM Ribonucleotide Solution Mix (New England 
Biolabs) and when needed, 0.5 mM Bio-16-UTP (Invitrogen) using a MAXIscript T7 
Transcription kit (Invitrogen). Resulting reactions were incubated for 1 h at 37
o
C with 1 
µL TURBO DNase (Invitrogen), heated for 4 min at 85°C then immediately plunged in 
ice, and electrophoresed on a 7% polyacrylamide gel for 75 min at 100V. Gels were 
stained with a 2 μg/mL acridine orange solution and visualized bands were excised and 
eluted overnight into probe elution buffer (0.5M AmAc, 1mM EDTA, 0.2% SDS) at 
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37°C. The resulting solution was precipitated with ethanol overnight at -20
 o
C, washed 
with 70% ethanol, and resuspended in nuclease-free H2O. RNA concentrations were 
determined using a NanoDrop spectrophotometer. Following this, 10 nM biotin-labeled 
CbsR12 and, unless otherwise noted, 5 nM target RNA were combined and heated for 5 
min at 85°C. A high-salt TMN buffer (100 mM NaCl, 50 mM MgCl2, 100 mM Tris-Cl, 
0.05% Tween-20) was then added and reactions were immediately plunged on ice for 30 
sec and then incubated for 30 min at 37
o
C. A non-denaturing loading dye (0.25% 
bromophenol blue) was added and the resulting RNA mixtures were resolved on a 7% 
polyacrylamide gel for 1 h 20 min at 100V. RNA was transferred to a BrightStar-Plus 
Positively Charged Nylon Membrane (Ambion) using an electro-blot transfer system 
(Bio-Rad) and cross-linked with short-wave UV light in a GS Gene Linker UV Chamber 
(Bio-Rad). A North2South Chemiluminescent Hybridization and Detection Kit (Thermo 
Scientific) was used to detect resulting bands. The blot was imaged on a LAS-3000 
imaging system (Fujifilm). 
RNA-protein electrophoretic mobility shift assay 
CbsR12-CsrA1/2 EMSAs were performed as previously described for CsrA-binding 
RNAs [169]. Biotin-labeled CbsR12 was synthesized in vitro as above for RNA-RNA 
EMSAs. C. burnetii csrA-1 and csrA-2 genes were cloned into pQE30, expressed, and 
resulting proteins natively purified as previously described [102]. 1 nM biotin-labeled 
CbsR12 diluted in TE buffer (10mM Tris-HCL, 1mM EDTA) was heated at 75°C for 3 
min and equilibrated to room temperature for 10 min. Purified CsrA1/2 diluted in CsrA-
binding buffer (1 µl in 10mM Tris-HCl, 10mM MgCl2, 100mM KCl, 10mM DTT, 10% 
glycerol, and 10 U RNasin [Promega]) was added, and reactions were incubated for 30 
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min at 37°C. Samples were immediately resolved on 10% non-denaturing polyacrylamide 
gels for 3h. Membrane transfer and imaging were performed as in RNA-RNA EMSAs 
described above. The KD for CsrA-2 was determined as previously described [169]. 
Reporter assay 
A Luciferase Assay System kit (Promega) was used. All pBESTluc constructs were 
transformed into E. coli Top 10 F'. Resulting E. coli strains were grown overnight at 
30°C in 10 mL LB containing ampicillin (100 µg/mL) and 1% glucose in order to 
mitigate the autoaggregative effects of CbsR12. An aliquot (4.5 mL) of the overnight 
culture was inoculated into 40.5 mL LB with 100 µg/mL ampicillin and grown for 1.5 h 
at 30°C. IPTG was added (to 1 mM) and culture aliquots (100 l) were removed at 0, 1, 
and 2 h time points. 80 µL LB and 20 µL CCLR lysis solution (1X CCLR, 25 mg BSA, 
12.5 mg lysozyme, 7.5 mL water) were added to the aliquots and gently inverted until the 
solution clarified. 50 µL of the resulting lysate was aliquoted to a 96-well plate, 100 µL 
of luciferase assay substrate was added, and luminescence was immediately read with a 
SpectraMax M5 Plate Reader (Molecular Devices). 
Crosslink-Seq analysis 
RNA-RNA crosslinking was performed essentially as previously described [152, 196], 
except TRI Reagent was utilized for total RNA extraction as described above and 10 
nmol of two distinct biotinylated in vitro-transcribed anti-CbsR12 RNAs were used as 
probes. The resulting captured RNA was sent to the Yale Center for Genomic Analysis 
for RNA-Seq analysis. 
Immunofluorescence assay 
 106 
IFAs on infected THP-1 cells were performed as previously described with modifications 
[86]. Briefly, 4-well chambered glass slides were coated for 30 min with a 0.2% solution 
of Sigmacote (Sigma). THP-1 cells were inoculated into chambered slides and incubated 
overnight or until 60% confluence was reached and then differentiated with 200 nM 
PMA. Confluent cells were then infected with MB-WT, MB-cbsR12, or MB-cbsR12-
Comp strains at a MOI of 10. At 1dpi, infections were stopped by washing cells three 
times for 5 min in pre-warmed 1X PBS, after which fresh medium was added. At 3 or 7 
dpi, the growth medium was removed and cells were fixed with ice-cold 100% methanol 
for 5 min at room temperature. Cells were washed three times for 5 min each with ice-
cold 1X PBS, blocked for 1 h at room temperature with a 2% BSA solution in 1X PBS, 
and then incubated with anti-Com1 (1:1000) and anti-LAMP1 (1:50, H4A3 was 
deposited to the Developmental Studies Hybridoma Bank by August, J.T / Hildreth, 
J.E.K) antibodies for 2 h. Cells were washed and incubated with Alexa Fluor 488 (1:200, 
Thermo Scientific) and goat anti-mouse rhodamine antibodies (1:200, Thermo Scientific) 
along with DAPI (300 nM, Thermo Scientific) for 1 h. Cells were then washed three 
times for 5 min each in ice-cold 1X PBS and immediately imaged. Images were 
processed with Fiji [194]. Cell Profiler was used to measure CCV areas, as previously 
described [197]. Measurements were taken from 46 individual images of random fields of 
view spanning three different experiments for each C. burnetii strain. 
Protein synthesis, purification and antibody production 
Recombinant Coxiella RNase III was synthesized from a previously-generated pQE30 
construct and purified as before [102]. C. burnetii carA and metK genes were cloned in-
frame into pQE30 (Qiagen) and the resulting N-terminal His6-tagged proteins synthesized 
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and purified as previously described for C. burnetii RNA helicase [101]. Purified 
recombinant CarA and MetK proteins were submitted to General Bioscience, Inc., for 
rabbit polyclonal antibody production. 
Western blot 
Western blots were performed as previously described [97] with minor modifications. 
MB-WT, MB-cbsR12, and MB-cbsR12-Comp strains were grown to mid-log phase (4 d 
for MB-WT and MB-cbsR12-Comp, 6 d for MB-cbsR12) in ACCM-2. Proteins at 30 µg 
(CarA blot) or 60 µg (MetK blot) were resolved on 10% - 20% acrylamide gradient Tris-
Glycine SDS-PAGE gels. Duplicate gels were run in parallel for Coomassie brilliant blue 
staining (CBB; 0.1% (w/v) in 50% methanol, 7% (v/v) acetic acid) in order to present a 
loading control. Blots were incubated with primary antibody solution (1X PBS pH7.4, 
0.3% (v/v) Tween-20, 1:500 CarA / 1:5000 MetK primary antibody) for 2 h with rocking 
at room temperature. Blots were washed five times for 5 min in 1X PBS, then incubated 
for 1 h in secondary antibody solution (1X PBS + 1:2000 goat anti-rabbit::HRP). Blots 
were again washed five times for 5 min in 1X PBS and immediately developed using 
SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific) according to the 
manufacturer's protocol. Imaging was performed on a ChemiDoc XRS+ System (Bio-
Rad). 
E. coli biofilm induction assay 
E. coli biofilm induction assays were performed as previously described [31]. 96-well 
plates were inoculated with an overnight culture of either pBEST or pBEST + carA 5’ 
UTR + cbsR12 E. coli strains (see Figure S3.10). Cultures were allowed to grow for 3 h 
until induction with 1mM IPTG, after which cultures were allowed to grow an additional 
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21 h before subsequent staining with crystal violet. The average OD570 readings of 10 
wells were obtained by spectrophotometry.  
Generation of a CbsR12-complemented strain 
MB-cbsR12 was complemented as previously described, with modifications [198]. 
Briefly, wild-type cbsR12 along with 100 bp of flanking sequences were PCR-amplified 
using primers containing EcoRI and BamHI restriction sites. The amplicon was cloned 
into compatible restriction sites of pMini-Tn7-KAN by standard protocol [199]. The 
resulting plasmid was transformed into electrocompetent E. coli PIR1 cells for 
propagation. The pMini-Tn7-CbsR12-KAN plasmid (20 g), along with 10 g of a 
second plasmid containing the transposase, pMini-TnS2-ABCD, were transformed into 
MB-cbsR12 in a single electroporation reaction (25 kV, 500 ohms, 25 F). 
Electroporated cells were allowed to recover 5 d in ACCM-2 supplemented with 1% 
FBS, then dilutions were plated onto ACCM-2 agar containing kanamycin (375 g/mL). 
Isolated colonies were picked and re-cultured on ACCM-2 agar plates for several rounds. 
Colony-PCR was used to screen for the MB-cbsR12-Comp strain, and the location of the 
cbsR12 cassette was determined by PCR and Sanger automated sequencing. qPCR of 
MB-cbsR12-Comp genomic DNA utilizing primers specific to cbsR12 was used to ensure 
that a single Tn insertion event occurred. 
Data availability 
The sequencing reads from the Crosslink-Seq experiments are available at the NCBI 
sequencing read archive (accession number: PRJNA522455). 
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Supplementary Material 
 
Figure S3.1: CbsR12 is processed by RNase III. (A). CbsR12 secondary structure as 
predicted by mFold. Nucleotide 1 was determined to be the TSS for the full-size 
transcript by 5' RACE. Red asterisks indicate apparent alternative TSSs by 5' RACE. 
Dotted line indicates the putative RNase III processing area. Blue solid lines indicate 
consensus CsrA-binding sites. (B). RNase III assay of in vitro-transcribed CbsR12 with 
the C. burnetii IVS RNA as a positive control. Results from treatment with E. coli (Ec) 
RNase III (New England BioLabs), recombinant C. burnetii (Cb) RNase III or no-
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enzyme controls are shown. Arrows indicate RNase III-processed (blue) and un-
processed (red) CbsR12 RNA. 
 
 
Figure S3.2: Location of the MB-cbsR12 transposon insertion to inactivate cbsR12. 
(A). The cbsR12 gene and promoter elements are highlighted by the indicated colors, 
while the location of the Himar Tn insertion producing the MB-cbsR12 strain is marked 
by a black arrow. Red arrows denote primer-binding sites for PCR confirmation of the 
lesion (forward and reverse primers above and below their annealing sequences, 
respectively). (B). PCR products confirming Tn insertion in cbsR12 of MB-cbsR12 (red 
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arrow) by loss of the ~250 bp amplicon and reintroduction of cbsR12 in MB-cbsR12-
Comp (blue arrow). (C). Copy number qPCR analysis confirming a single additional 
insertion of cbsR12 in the MB-cbsR12-Comp strain. Values represent the means ± 
standard error of means (SEM) of three independent determinations. 
 
 
Figure S3.3: Additional biological replicates for ACCM-2 and THP-1 growth 
curves. Growth curves for MB-WT, MB-cbsR12, and MB-cbsR12-Comp strains in 
ACCM-2 (A, B) or THP-1 cells (C, D) as determined by qPCR. The 0dpi time point 
refers to the inoculum. Values represent means ± standard error of means (SEM) of three 
technical replicates. 
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Figure S3.4: CbsR12 competitively binds carA, metK, and cvpD transcripts in a 
dose-dependent manner. RNA-RNA EMSAs showing hybridization reactions between 
biotin-labeled CbsR12 (Bio-CbsR12) and an in vitro-transcribed segment of carA (A), 
metK (B), or cvpD (C). Anti-CbsR12 represents a positive control consisting of a 
transcript equal in size but antisense to the CbsR12 transcript. A cold-chase sample 
containing Bio-CbsR12 + un-labeled CbsR12 + CarA/MetK/CvpD shows competitive 
(specific) binding relative to Bio-CbsR12 plus target alone, while increasing the dose of 
carA/metK/cvpD transcript (from 2 nM to 10 nM) increases the amount of retarded 
sample signal on the blot. Arrows indicate un-bound Bio-CbsR12 (blue) and Bio-CbsR12 
bound to its RNA targets (red). 
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Figure S3.5: Artemis views of CbsR12 binding to carA, metK, ahcY, and cvpD 
transcripts. Artemis representation of Crosslink-Seq results for MB-WT. Red and blue 
lines represent the two biological replicates. (A). CbsR12 crosslinking with carA reads 
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(blue arrow). (B). CbsR12 crosslinking with metK reads (blue arrow) and ahcY reads (red 
arrow). (C). CbsR12 crosslinking with cvpD reads (blue arrow). 
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Figure S3.6: CbsR12 downregulates the quantity of transcripts arising from the 5' 
end of cvpD in LCVs from infected THP-1 cells. (A). cvpD gene sequence from the 5' 
TSS to the predicted downstream alternative start codon. Indicated colors highlight the 
TSSs, the CbsR12-binding site, the putative downstream promoter, putative RBSs, and 
start codons. Red arrows show primer annealing regions for qRT-PCR (forward and 
reverse primers above and below their respective annealing sequences). (B). 
Representation of CbsR12 binding to the cvpD transcript as determined by IntaRNA with 
base numbers indicated. The top strand in the model represents the metK transcript 
sequence, while the bottom strand represents the complementary CbsR12 sequence. (C). 
qRT-PCR of the 5' end of cvpD from MB-WT, MB-cbsR12, and MB-cbsR12-Comp 
LCVs (3dpi) and SCVs (7dpi) infecting THP-1 cells. Values represent means ± standard 
error of means (SEM) of three independent determinations (** = P < 0.01, one-way 
ANOVA, *** = P < 0.001, one-way ANOVA). 
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Figure S3.7: Coomassie blue-stained SDS-PAGE gels corresponding to Figure 3.9 to 
demonstrate loading consistency. (A). Proteins (30 µg total) from MB-WT, MB-
cbsR12, and MB-cbsR12- Comp LCVs (mid-log phase; 96h for MB-WT and MB-
cbsR12-Comp and 144h for MB-cbsR12) grown in ACCM-2 were resolved on a 10-20% 
acrylamide gradient SDS-PAGE gel and stained with Coomassie brilliant blue R. (B). 
Proteins (60 µg total) from MB-WT, MB-cbsR12, and MB-cbsR12-Comp LCVs (mid-log 
phase; 96h for MB-WT and MB-cbsR12-Comp and 144h for MB-cbsR12) grown in 
ACCM-2 were resolved on a 10-20% acrylamide gradient SDS-PAGE gel and stained 
with Coomassie brilliant blue R. 
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Figure S3.8: CbsR12 in E. coli leads to an autoaggregative phenotype and biofilm 
formation. (A). Overnight cultures of E. coli Top10 F' harboring pBEST + carA5’UTR 
or pBEST + carA5’UTR + cbsR12 were inoculated into 3 mL LB supplemented with 
ampicillin (100 µg/mL), grown for 2 h at 37⁰ C with shaking, then induced with 1 mM 
IPTG for 3 h before photography. The red arrow indicates autoaggregation of E. coli in 
the presence of CbsR12. (B). in vitro biofilm formation assay of E. coli Top10 F’ 
harboring pBEST or pBEST + carA5’UTR + cbsR12. Crystal violet staining is indicative 
of adherence due to biofilm induction. Values represent the average OD570 readings of 
10 wells ± standard error of means (SEM) of three independent determinations (* = P < 
0.05, student’s t test, ** = P < 0.01, student’s t test). 
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Figure S3.9: CbsR1 is an additional C. burnetii sRNA with RsmY/Z-like 
characteristics. (A). The cbsR1 gene, predicted promoter elements, and putative LetA-
binding site are highlighted by the indicated colors. (B). CbsR1 secondary structure as 
predicted by mFold. Nucleotide 1 was predicted to be the TSS for the full-size transcript 
by analysis of RNA-Seq datasets. Blue solid lines indicate putative CsrA-binding sites. 
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Figure S3.10: Strains, plasmids, and primers used in the study. 
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Chapter 4 
Novel small RNAs expressed by Bartonella bacilliformis under multiple 
conditions reveal potential mechanisms for persistence in the sand fly 
vector and human host 
As published in: 
bioRxiv preprint server. 2020 doi: 10.1101/2020.08.04.235903 
 
Abstract 
Bartonella bacilliformis, the etiological agent of Carrión’s disease, is a Gram-negative, 
facultative intracellular alphaproteobacterium. Carrión’s disease is an emerging but 
neglected tropical illness endemic to Peru, Colombia, and Ecuador. B. bacilliformis is 
spread between humans through the bite of female phlebotomine sand flies. As a result, 
the pathogen encounters significant and repeated environmental shifts during its life 
cycle, including changes in pH and temperature. In most bacteria, small non-coding 
RNAs (sRNAs) serve as effectors that may post-transcriptionally regulate the stress 
response to such changes. However, sRNAs have not been characterized in B. 
bacilliformis, to date. We therefore performed total RNA-sequencing analyses on B. 
bacilliformis grown in vitro then shifted to one of ten distinct conditions that simulate 
various environments encountered by the pathogen during its life cycle. From this, we 
identified 160 sRNAs significantly expressed under at least one of the conditions tested. 
sRNAs included the highly-conserved tmRNA, 6S RNA, RNase P RNA component, SRP 
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RNA component, ffH leader RNA, and the alphaproteobacterial sRNAs αr45 and speF 
leader RNA. In addition, 153 other potential sRNAs of unknown function were 
discovered. Northern blot analysis was used to confirm the expression of eight novel 
sRNAs. We also characterized a Bartonella bacilliformis group I intron (BbgpI) that 
disrupts an un-annotated tRNACCU
Arg
 gene and determined that the intron splices in vivo 
and self-splices in vitro. Furthermore, we demonstrated the molecular targeting of 
Bartonella bacilliformis small RNA 9 (BbsR9) to transcripts of the ftsH, nuoF, and gcvT 
genes, in vitro. 
 
Introduction 
Bacteria often utilize sRNAs to rapidly and efficiently regulate gene products involved in 
multiple biological processes. sRNAs are small (< 500 nts) non-coding transcripts that 
typically serve to up- or down-regulate translation of proteins by binding to the respective 
mRNA in a cis or trans fashion [reviewed in [1]]. This fine-tuning of protein production 
can enhance tolerance to stressors, including temperature [8] and pH [200]. To our 
knowledge, sRNA research in Bartonella is represented by a single report on B. henselae 
[201]. We therefore utilized total RNA-Sequencing (RNA-Seq) to interrogate B. 
bacilliformis transcriptomes to identify sRNAs expressed under a variety of conditions, 
including temperatures and pH levels consistent with the sand fly vector and human host. 
In doing so, we discovered 153 novel sRNAs expressed under at least one of the 
conditions tested. Furthermore, we characterized two of the sRNAs. The first RNA is a 
group I intron related to similar elements found in other alphaproteobacteria, while the 
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other is a novel Bartonella-specific sRNA expressed only under conditions that simulate 
the sand fly vector. 
 
Materials and Methods 
Bacterial culturing 
Bacterial strains, primers, and plasmids utilized in this study are described in Table S4.1. 
B. bacilliformis strain KC583 (passages #4-7) was cultivated on HIBB plates, comprised 
of Bacto heart infusion agar (Becton Dickinson; Franklin Lakes, NJ) containing 4% 
defibrinated sheep blood and 2% sheep serum (Quad Five, Ryegate, MT), by volume, as 
previously described [131]. Following 4 d of growth, 4 confluent B. bacilliformis plates 
per biological replicate were either shifted to different temperatures for 2 h, harvested and 
shifted to different pH levels in an HIBB liquid medium for 2 h, harvested and shifted to 
a human blood sample for 2 h, or harvested and used to infect cultured human umbilical 
vein endothelial cells (HUVECs; PCS-100-013; American Type Culture Collection; 
Manassas, VA) for 24 h. Escherichia coli (TOP10) was grown for 16 h at 37⁰ C with 
shaking in lysogeny broth (LB), or on LB plates, supplemented with kanamycin (25 
μg/ml) and ampicillin (100 μg/ml), when required. 
HUVEC culturing and infection 
HUVECs were cultured and maintained as previously described [131]. B. bacilliformis 
infections were carried out for 24 h after which the medium was removed and cells were 
treated with gentamicin (10 μg/ml) for 1 h. Remaining viable extracellular B. 
bacilliformis cells were removed by washing 5 times for 10 min with phosphate-buffered 
 123 
saline (PBS; pH 7.4) solution. Finally, cells were harvested into TRI Reagent (Ambion; 
Austin, TX), as previously described for infected Vero cells [202]. 
Human blood infection 
Blood was drawn into vials containing sodium citrate to prevent coagulation. 1-ml 
aliquots were dispensed into fresh tubes, after which the lids were replaced with gas-
permeable membranes. Blood samples were equilibrated at 37⁰ C (HB37 samples) or 
37⁰ C in a blood-gas atmosphere (HBBG samples) for 1 h. Four HIBB plates of 
confluent B. bacilliformis for each equilibrated blood vial were harvested into PBS, 
pelleted at 16,000 x g for 5 min at 4⁰ C and washed twice in PBS with identical 
centrifugation steps. Cell pellets were resuspended into 300 μl equilibrated blood, then 
dispensed back into the corresponding tube. The tubes were incubated at the appropriate 
condition for 2 h, then 1 ml RNALater solution (Thermo Fisher; Waltham, MA) was 
immediately added. Total RNA extraction was done as described below. 
Total RNA/genomic DNA isolation and preparation for RNA-Seq 
Upon shifting B. bacilliformis for the designated time periods, cells were either harvested 
directly into one volume of RNAlater solution (Thermo Fisher) or centrifuged at 10,000 x 
g at room temperature for 2 min, after which the pellet was resuspended in a volume of 
RNAlater. The cells were incubated at room temperature for 1 h then frozen at -80⁰ C for 
≥ 2 h. The cells were thawed, centrifuged at 10,000 x g at 4⁰ C for 10 min, and 
resuspended in 1 ml of TRI Reagent (Sigma-Aldrich; St. Louis, MO). The cells were 
incubated at room temperature for 1 h then frozen at -80⁰ C for ≥ 2 h. Finally, cells were 
thawed and total RNA and genomic DNA isolation were done as previously described 
[202]. Total RNA pools from human blood infections were globin-depleted using a 
 124 
GLOBINclear kit (Ambion) according to manufacturer’s specifications. HUVE, HB37, 
and HBBG samples were enriched for bacterial RNA using a MICROBEnrich kit 
(Ambion). RNA (1 μg) from three independent biological replicates of each condition 
was sent to the Yale Center for Genomic Analysis (Pl25, Pl30, Pl37, pH06, pH07, and 
pH08 samples) or GENEWIZ (PlBG, HUVE, HB37, and HBBG samples) for bacterial 
rRNA depletion, stranded-library preparation, and HiSeq2500 (Illumina; San Diego, CA) 
2x150 bp sequencing. 
Data analysis 
Raw reads were quality filtered and aligned as previously described [202]. Briefly, raw 
fastq files were concatenated, quality filtered with the FASTX toolkit 
(http://hannonlab.cshl.edu/fastx_toolkit/), and then clipped, aligned, and filtered with 
Nesoni version 0.128 tools (http://www.vicbioinformatics.com/software.nesoni.shtml). 
TPM were calculated using a custom Python script that can be accessed through GitHub 
(https://github.com/shawachter/TPM_Scripts). Stranded alignments were separated using 
SAMtools [203] and visualized using the Artemis genome browser [147]. 
          sRNA identification was performed using the Artemis genome browser. RNA 
peaks were manually curated from IGRs and protein-coding gene regions. A read 
threshold for sRNA expression was devised for each condition tested based on reads that 
aligned to the rpoD gene (RpoD sigma factor), since TPM data suggest this gene is 
consistently expressed across all conditions. Using this method, putative sRNAs were 
identified, base ranges approximated, and sRNAs further characterized with putative 
promoters by manual searches using the conserved alphaproteobacterial sigma-70 
promoter element, CTTGAC-N17-CTATAT [204]. Rho-independent terminators were 
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identified using ARNold terminator prediction software (http://rna.igmors.u-
psud.fr/toolbox/arnold/).   
          Since TPM calculations were done in the context of the total transcriptome and 
were not strand-specific, it was necessary to further refine TPM values for cis-anti 
sRNAs. This was done by considering the TPM value and proportion of the protein-
coding gene to which the sRNA was antisense and subtracting the gene’s approximate 
TPM contribution with the following formula:  
𝑠𝑅𝑁𝐴 𝐴𝑑𝑗𝑢𝑠𝑡𝑒𝑑 𝑇𝑃𝑀 = 𝑠𝑅𝑁𝐴 𝑇𝑜𝑡𝑎𝑙 𝑇𝑃𝑀 −  [
𝐺𝑒𝑛𝑒 𝑇𝑜𝑡𝑎𝑙 𝑇𝑃𝑀
(
𝐺𝑒𝑛𝑒 𝐿𝑒𝑛𝑔𝑡ℎ
𝐺𝑒𝑛𝑒 𝑠𝑅𝑁𝐴 𝑜𝑣𝑒𝑟𝑙𝑎𝑝 𝐿𝑒𝑛𝑔𝑡ℎ
)
] 
This was accomplished with a custom python script located in a GitHub repository 
(https://github.com/shawachter/TPM_Scripts). After this calculation, sRNAs whose 
TPMs were < 300 were considered not expressed for the purposes of the UpSet plot. This 
TPM value was chosen because it most accurately reflected the read threshold used in the 
initial manual sRNA search. All TPM values were included in the heatmap and 
determination of condition-specific sRNAs. Differentially-expressed sRNAs were 
determined by featureCounts [192] and the DESeq2 package of R version 3.4.4 [193]. 
For DESeq2 analysis, the p-value distribution of the significantly differentially expressed 
genes (DEGs) was re-sampled using fdrtools in order to more accurately achieve the 
desired null distribution [205]. This effectively made the analysis more stringent by 
providing fewer significant DEGs. 
          Infection-specific and sand fly-specific sRNAs were identified based on expression 
patterns as described in Results. The IntaRNA 2.0 sRNA target prediction algorithm was 
used to determine potential genes regulated by the sRNAs [43]. Only mRNA targets with 
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a predicted IntaRNA 2.0 p-value < 0.01 were included in the potential targets list. Further 
targets with FDR values of < 0.05 were given special indications since these predicted 
bindings were considered especially strong. GO enrichment was performed utilizing the 
biobam Blast2GO program in the OmicsBox program suite 
(https://www.blast2go.com/blast2go-pro/download-b2g) using functional annotation of 
the B. bacilliformis KC583 genome as the background [206]. KEGG enrichment was 
performed using DAVID Bioinformatics Resources [207]. 
          Figures were made using R version 3.4.4 and various Bioconductor packages 
including UpSetR [208], gplots (https://cran.r-
project.org/web/packages/gplots/index.html), ggplot2 [209], and fdrtool [205]. Raw PNG 
images were modified into figures using Inkscape (https://inkscape.org/release/inkscape-
0.92.4/) and Gimp (https://www.gimp.org/downloads/). 
Identification of transcription start sites 
5' RACE analyses of BbgpI and BbsR9 were performed using total RNA from B. 
bacilliformis shifted to liquid medium at pH 7 using a 5' RACE System kit (Invitrogen; 
Carlsbad, CA) according to manufacturer’s protocols and with gene-specific primers 
(Table S4.1). Resulting PCR products were cloned into pCR2.1-TOPO as instructed 
(Invitrogen), after which six arbitrary clones were sequenced with M13 universal primers 
by Sanger automated sequencing. 
Northern blots 
Northern blot analyses were carried out using total RNA extracted from B. bacilliformis 
under the noted conditions. Northern blot probes were synthesized in vitro by engineering 
probe-specific PCR primers to contain a T7 promoter then utilizing a MAXIscript T7 
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Transcription kit (Invitrogen) supplemented with 0.5 mM Bio-16-UTP (Invitrogen).  B. 
bacilliformis total RNA (2 μg) was resolved on a 1% denaturing agarose gel for 130 min 
at 57 V in 1X MOPS running buffer (Quality Biological; Gaithersburg, MD). The gel was 
washed in nuclease-free H2O for 10 min, followed by another wash in 20X SSC buffer 
(3M NaCl, 0.3M sodium citrate, pH 7.0) for 15 min. RNA was transferred overnight to a 
BrightStar-Plus nylon membrane (Ambion) in 20X SSC via upward capillary transfer. 
RNA was crosslinked to the membrane using a GS Gene Linker UV chamber (Bio-Rad; 
Hercules, CA) at 150 mJ. Membrane pre-hybridization and probe hybridization were 
done with a North2South Chemiluminescent Hybridization and Detection Kit (Thermo 
Fisher) according to manufacturer’s protocol. 50 ng of the appropriate in vitro-transcribed 
biotin-labeled probe was hybridized to the membrane at 67°C overnight. Membranes 
were washed 3 times for 15 min at 67°C in 1X Hybridization Stringency Wash Buffer 
(Thermo Fisher), developed, and imaged with a ChemiDoc XRS+ system (Bio-Rad). 
qRT-PCR 
qRT-PCR was done on cDNA synthesized from 16 ng B. bacilliformis total RNA (for 
each 25 µl reaction) collected from various conditions using the Luna Universal One-
Step RT-qPCR kit (New England BioLabs; Ipswich, MA) according to the manufacturer. 
B. bacilliformis total RNA was serially diluted and used as a standard curve, while 
primers targeting the rpoD housekeeping gene were used for normalization of gene 
expression between conditions. qRT-PCR was performed on a CFX Connect Real-Time 
System (Bio-Rad). cDNA from sRNAs of interest was analyzed for copy number, then 
divided by the copy number from the rpoD gene to achieve the sRNA transcripts / rpoD 
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transcript values. 
Mutagenesis and RNA-RNA EMSAs 
Mutagenesis of gcvT, nuoF, and ftsH target sequences was carried out in vitro using a Q5 
mutagenesis kit (New England BioLabs) with specified primers (Table S4.1). Primers 
engineered with a T7 promoter sequence were used to amplify the gcvT (-100 to +100), 
nuoF (-86 to +100), ftsH (-100 to +105), RS02100 (-76 to +100), trmD (-50 to +100), and 
hflK (-70 to +100) target sequences, where nucleotide +1 represents the first nucleotide of 
the protein-coding sequence. PCR products were cloned into pCR2.1-TOPO as instructed 
(Invitrogen). Resulting plasmid DNA was used as the template for Q5 mutagenesis. Q5 
clones were sequenced, re-amplified with T7-engineered primers, and in vitro transcribed 
using the MAXIscript T7 Transcription kit (Invitrogen) with or without 0.5 mM Bio-16-
UTP (Invitrogen), as required. Dose-dependent RNA-RNA EMSAs were performed as 
previously described [202] using 2 nM biotin-labeled BbsR9 and varying concentrations 
of in vitro-transcribed, unlabeled target RNA. 
Data availability 
Aligned sequencing reads (BAM files) from all RNA-Seq experiments are available at 
the Sequencing Read Archive database (accession number PRJNA647605). 
Ethics statement 
The Institutional Biosafety Committee at the University of Montana granted approval for 
the experimental use of human blood (IBC 2019-05). Formal consent was obtained in 
verbal form from the blood donor (co-author MFM). 
 
Results 
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Identification of B. bacilliformis sRNAs 
We first analyzed the total transcriptomic profiles of B. bacilliformis following a timed 
shift from normal culture conditions (4-d incubation on HIBB plates at 30⁰ C) to various 
in vitro conditions that mimic the sand fly vector and human host (Table 4.1). 
Specifically, we controlled for several environmental variables, including temperature, 
pH, solid vs. liquid media, and the presence of a human blood-gas atmosphere. Following 
quality control analysis of the resulting RNA-Seq datasets and correlation of variation 
analysis (Table S4.2), we discarded replicates that did not correlate well with others from 
the same condition. A principle component analysis (PCA) plot of the remaining RNA-
Seq datasets confirmed statistical clustering of biological replicates (Figure S4.1).  
  
Table 4.1: Conditions used to prepare B. bacilliformis cultures for RNA-Seq 
experiments. 
Conditions Medium Designation Shift Time Simulation 
pH 7.4, 25⁰ C HIBB plates Pl25 2 hours 
Sand fly 
ambient 
temperature 
pH 7.4, 30⁰ C HIBB plates Pl30 2 hours 
Sand fly 
ambient 
temperature 
pH 7.4, 37⁰ C HIBB plates Pl37 2 hours Human host 
pH 7.4, 37⁰ C 
with blood gas
a HIBB plates PlBG 2 hours Human host 
pH 6.0, 30⁰ C HIBB liquid pH06 2 hours 
Sand fly post-
blood meal 
pH 7.4, 30⁰ C HIBB liquid pH07 2 hours 
Human host / 
sand fly blood 
meal mid-
digestion 
pH 8.2, 30⁰ C HIBB liquid pH08 2 hours 
Sand fly initial 
blood meal 
pH 7.4, 37⁰ C HUVECs in HUVE 24 hours Human 
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with blood gas
 
EGM-Plus 
medium 
endothelial cell 
infection 
pH 7.4, 37⁰ C Human blood HB37 2 hours 
Human 
erythrocyte 
infection 
pH 7.4, 37⁰ C 
with blood gas
 Human blood HBBG 2 hours 
Human 
erythrocyte 
infection 
HIBB, Bacto heart infusion blood agar containing 4% defibrinated sheep blood and 2% 
sheep serum (vol/vol); HUVECs, human umbilical vein endothelial cells; EGM-Plus 
(Lonza), endothelial cell growth medium containing 2% fetal bovine serum and bovine 
brain extract. 
a
 Blood gas is comprised of 5% CO2, 2.5% O2, and 92.5% N2 at 100% humidity to 
simulate human blood. 
 
          Next, we visualized alignments for each RNA-Seq dataset and manually curated 
transcript peaks that could correspond to novel sRNAs. Peaks were found in IGRs, 
antisense to annotated genes (cis-anti) or as leader RNAs in 5' UTRs of annotated genes. 
The peaks were further refined based on proximity to neighboring peaks and a threshold 
read coverage based on expression of a housekeeping gene, rpoD (encoding sigma factor 
RpoD). We discovered 160 potential sRNAs, including seven highly-conserved sRNAs 
of other bacteria/alphaproteobacteria (Table S4.3). Of the 153 other potential sRNAs, 81 
were located antisense to annotated genes, 57 were encoded in IGRs, and the remaining 
15 were potential leader RNAs. Leader RNAs were included in the study because further 
analysis would be needed to determine if they are true leader RNAs, stand-alone sRNAs, 
or perhaps both. We also identified putative promoter elements for each identified sRNA 
based on approximated TSS’s. Next, we constructed an UpSet plot to visualize the 
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numbers of significantly expressed sRNAs shared between various combinations of 
conditions (Figure 4.1) [210]. Results of this analysis suggested that, while 19 of the 160 
identified sRNAs were expressed regardless of circumstance, the majority of sRNAs 
were expressed under specific conditions. Following this, we calculated TPM for each 
sRNA under all ten conditions in the context of the total transcriptomes (Table S4.4). 
TPM is a normalized measure of gene expression, and although it is not always 
appropriate to compare TPM values across different RNA-Seq experiments [168], we 
constructed a heatmap to get a broad sense of sRNA expression patterns (Figure S4.2). 
These results revealed three distinct clusters of conditions with similar sRNA expression 
patterns and allowed us to identify interesting sRNAs for further characterization. 
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Figure 4.1: Most B. bacilliformis sRNAs are expressed under specific conditions. An 
UpSet plot is shown and displays the number of sRNAs shared among various 
combinations of conditions tested. The bar graph to the left indicates the quantity of 
sRNAs with a TPM >300 under the conditions shown. The connected nodes indicate 
shared conditions giving rise to the number of sRNAs expressed as indicated by the bar 
graph at the top. 
 
Verification of select B. bacilliformis sRNAs 
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Of the 160 putative sRNAs discovered in B. bacilliformis, we assigned name designations 
to 22 of them based on appraisal of general relevance, including six widely-conserved 
sRNAs, such as BbtmRNA (B. baciliformis tmRNA), and 15 novel Bartonella-specific 
sRNAs. We also gave a name designation to the B. bacilliformis group I intron (BbgpI), 
a group I intron with related elements previously identified, but not characterized, in 
other alphaproteobacteria [211]. To corroborate RNA-Seq expression results and verify 
sRNA expression, we chose eight novel sRNAs at random and conducted Northern blot 
analyses. Results of the Northern blots confirmed the expression of all eight sRNAs 
(Figure 4.2). 
 
Figure 4.2: Northern blot analyses confirm expression of eight putative B. 
bacilliformis sRNAs. Eight separate Northern blots were run under identical 
experimental conditions (see Chapter 4: Materials and Methods). RNA ladders from the 
respective blots were aligned with each other for presentation of the resolved total RNA. 
sRNA designations are shown above each blot. Exposure times (minutes, m; seconds, s) 
and origin of the RNA are indicated below each blot. 
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          We analyzed the differential expression of B. bacilliformis genes across the ten 
tested conditions by performing relevant pairwise comparisons (Table 4.2) using the 
DESeq2 package in R version 3.4.4 [193]. For this analysis, transcriptomes from all ten 
conditions were compared simultaneously, while specific, relevant pairwise comparisons 
were made (Table 4.2). Results showed the greatest number of significant differentially 
expressed sRNAs by comparing solid-to-liquid media and host cell types. Other sRNA 
candidates were also found to be differentially regulated by these comparisons (see Table 
S4.3). We then utilized quantitative reverse transcription PCR (qRT-PCR) to validate the 
DESeq2 results. In doing so, we confirmed eleven sRNAs to be significantly 
differentially expressed under the relevant conditions (Figure S4.3). 
 
Table 4.2: DESeq2 comparisons made. 
Comparison Controlled Conditions No. sRNA DEGs 
Pl30
a
 vs. Pl25 Temperature 0 
Pl30
a
 vs. Pl37 Temperature 2 
Pl25
a
 vs. Pl37 Temperature 0 
Pl30
a
 vs. pH07 Solid/liquid media 12 
pH07
a
 vs. pH08 pH level 0 
pH07
a
 vs. pH06 pH level 0 
pH06
a
 vs. pH08 pH level 7 
Pl37
a
 vs. PlBG Blood gas 1 
PlBG
a
 vs. HBBG Solid/liquid media, human/sheep blood 6 
PlBG
a
 vs. HUVEC Solid/liquid media, cell type 18 
pH07
a
 vs. HUVEC Temperature, cell type 6 
pH07
a
 vs. HB37 Temperature, human/sheep blood 3 
HBBG
a
 vs. HUVEC Cell type 17 
DEGs, significant differentially expressed genes. 
a
Reference dataset 
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Condition-specific sRNAs target mRNAs enriched in specific pathways 
We grouped several sRNAs based on their expression patterns across the ten conditions 
tested by using heatmap comparisons combined with data from the DESeq2 analysis. For 
example, multiple sRNAs were significantly and strictly expressed under conditions used 
to simulate or actually infect human cells (i.e., PlBG, HUVEC, HB37, and HBBG; see 
Table 4.1). These sRNAs were classified as human “infection-specific” based on their 
restricted upregulation (defined by TPM greater than the mean TPM plus one standard 
deviation) in at least two of these four conditions. Based on this definition, we identified 
24 infection-specific sRNAs (see Table S4.4).  
          We were also curious to determine if the predicted mRNA targets of the infection-
specific sRNAs significantly corresponded to particular gene classifications to provide 
clues regarding their upregulation under infection-specific conditions. Using gene 
ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment 
analyses and the IntaRNA 2.0 sRNA target prediction program [43], we determined that 
the predicted mRNA targets of these sRNAs (Table S4.5) were enriched for several GO 
terms, including protein/amide transport and nucleotidyltransferase activity (Figure 
4.3A). The pool of mRNA targets was also enriched for the 
glycerophospholipid/glycerolipid metabolism and nucleotide excision repair KEGG 
pathways (Figure 4.3B). 
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Figure 4.3: Condition-specific sRNA targets are enriched in several GO terms and 
KEGG pathways. A) Faceted bar graph of GO enrichment terms for infection-specific 
and sand fly-specific sRNA targets. Height of the bars indicates the number of sRNA 
targets containing that GO term, while the color displays the significance of enrichment. 
B) Faceted dot plot of KEGG enrichment terms for infection-specific and sand fly-
specific sRNA targets. The enrichment score refers to the ratio of the number of gene 
targets corresponding to a particular pathway to the total number of genes in that 
pathway. Dot colors represent significance (p-value) of enrichment for that particular 
KEGG pathway. 
 
          We also determined that eight sRNAs were only expressed under conditions 
simulating the sand fly vector (i.e., Pl25, pH06, pH07, and pH08; see Table 4.1). Despite 
the fact that Pl25 clustered separately from pH06, pH07, and pH08 on the heatmap 
(Figure S4.2), we included it in the sand fly-specific conditions due to upregulation of 
several sRNAs under both pH06/pH08 and Pl25 conditions (BB026-1, BB103-2, BB103-
3, and BB124; Table S4.4). These and other sRNAs were classified as “sand fly-specific 
sRNAs” based on their restricted upregulation in at least two of these four conditions. 
The predicted mRNA targets of the sand fly-specific sRNAs (Table S4.6) were enriched 
for the flavin adenine dinucleotide (FAD) binding GO term (Figure 4.3A) and the amino 
acid biosynthesis KEGG pathway (Figure 4.3B). 
BbgpI is a group I intron that splices in vivo and self-splices in vitro 
BB009 was initially identified as a sRNA of interest based on its high expression across 
multiple conditions (Table S4.4). A BLAST search of the BB009 gene sequence 
 138 
(hereafter referred to as BbgpI) showed that it was highly homologous to a group I intron 
conserved in several other alphaproteobacteria and encoded in host tRNACCU
Arg
 genes 
[211]. Since B. bacilliformis has no annotated tRNACCU
Arg
 gene, we initially assumed that 
BbgpI was encoded in an IGR. However, such a location would be novel for group I 
introns, which are selfish genetic elements found in tRNA, rRNA, and rarely, protein-
coding genes (reviewed in [74]).  
          To address this discrepancy, 5' RACE was utilized to determine the 5' end of the 
putative spliced-out RNA segment. From these results, we determined that BbgpI was 
flanked by CCT DRs, identical to those produced by the tRNACCU
Arg
 alphaproteobacterial 
group I intron (Figure S4.4A) [211]. Also, the predicted secondary structure of BbgpI 
possessed conserved group I intron stem structures (Figure S4.4B). Finally, we scanned 
the locus and flanking sequences with the tRNAscan-SE 2.0 web server and identified a 
tRNACCU
Arg
 gene (Figure S4.4C), but only when a sequence with BbgpI spliced out was 
used [212]. Taken together, these results suggest that BbgpI is a member of a conserved, 
alphaproteobacterial group I intron family and disrupts an unannotated tRNACCU
Arg
 gene 
(locus: c42404-42711) of B. bacilliformis. 
          Although homology and structural results suggested that BbgpI was a group I 
intron, it was unclear whether BbgpI was able to self-splice or whether a protein cofactor 
was required [211]. To address this question, we examined BbgpI’s ribozyme activity in 
vitro. Following in vitro transcription, cDNA synthesis, and PCR analysis with the 
primers shown in Figure S4.4A, we determined that BbgpI self-splices in vitro and is 
spliced in vivo (Figure 4.4), in keeping with other group I introns. 
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Figure 4.4: BbgpI self-splices in vitro and is spliced in vivo. 
A) PCR analysis of an in vitro-transcribed (IVT) region of B. bacilliformis (Bb) genomic 
DNA (gDNA) containing BbgpI. Ethidium bromide-stained agarose (1%) gels are shown.  
PCR on the resulting cDNA using “Nested Primers” (see Figure S4.4A) produced 
unspliced DNA (450-bp band), a partially-spliced product of ~390 bp, plus a 218-bp band 
corresponding to the BbgpI flanking region where BbgpI self-spliced out (indicated by 
the red arrow). PCR on a Bb IVT RNA negative control did not produce product. B) As 
in A) but utilizing cDNA synthesized from B. bacilliformis total RNA using “Splice 
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Flank Primers” (see Figure S4.4A). A 308-bp amplicon was produced from gDNA, 
whereas a 76-bp band, corresponding to the BbgpI flanking region with BbgpI spliced 
out, was produced from cDNA generated from total RNA (indicated by the red arrow). 
PCR on a Bb total RNA negative control did not produce product. 
 
BbsR9 is a sand fly-specific sRNA 
BB092 (hereafter referred to as BbsR9) was initially identified as a sRNA of interest due 
to its restricted high-level expression under conditions that simulated the sand fly vector 
(Table 4.1, Table S4.4). In addition, BbsR9 was found to have well-defined, predicted 
sigma-70 promoter and Rho-independent terminator regions, and it was conserved among 
several other Bartonella spp. (Table S4.3). To elucidate the BbsR9 gene, the TSS was 
determined by 5' RACE. These results showed two possible sites with equal 
representation among the six clones sequenced (Figure S4.5A). We therefore wished to 
determine if two distinct transcripts of BbsR9 were made or if there was a single, 
dominant transcript for the sRNA. In addition, we wanted to confirm BbsR9 expression 
across the conditions examined. To this end, we set out to determine if BbsR9 would 
remain highly expressed in sheep blood shifted to 37⁰ C or if we would see a 
downregulation of the sRNA, as in B. bacilliformis shifted to human blood at 37⁰ C 
(HB37/HBBG; see Table S4.4). Northern blot analyses showed BbsR9 transcript and, 
together with the intensity of the signal, indicated a single, dominant TSS (bolded 
underlined in Figure S4.5A). Interestingly, we saw a distinct downregulation of BbsR9 
when B. bacilliformis was shifted to sheep blood at 37⁰ C compared to 30⁰ C (Figure 
S4.5B). This decrease in RNA suggests that BbsR9 is primarily expressed under 
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conditions that simulate the sand fly vector and not the human host. Taken as a whole, 
results of the Northern blots and RNA-Seq suggest that both a liquid medium (Pl30 vs. 
pH07; see Table S4.4) and a temperature below 37⁰ C upregulate BbsR9. 
BbsR9 targets transcripts of ftsH, nuoF, and gcvT in vitro 
Since BbsR9 expression was restricted to sand fly-like conditions, we were interested in 
characterizing its mRNA targets to shed light on the sRNA’s role in regulation. To that 
end, we first utilized the TargetRNA2 [42], IntaRNA [43] and CopraRNA [44] 
algorithms to determine potential mRNA targets (Table 4.3). From these results, we 
selected transcripts of ftsH, nuoF, gcvT, trmD, hflK, and a predicted DNA response 
regulator (RS02100) as potential targets for characterization based on shared predictions 
between algorithms and the strength of predicted binding events.  
 
Table 4.3:  mRNA targets for BbsR9, as predicted by the indicated algorithms. 
Rank TargetRNA2 IntaRNA CopraRNA 
1 nuoF (0.0001) gcvT (0.0033) RS06660 (0.0013) 
2 RS01360 (0.012) RS01025 (0.0043) nuoF (0.0103) 
3 czrB (0.004) trmD (0.0060) RS02895 (0.0113) 
4 ftsE (0.010) ftsH (0.0071) gcvT (0.0153) 
5 RS05725 (0.012) RS02100 (0.0090) RS02955 (0.0232) 
6 rplX (0.033) DUF475 (0.0125) efp (0.0286) 
7 flgC (0.043) Pseudogene (0.0132) ftsH (0.0288) 
8 aroP (0.044) tonB (0.0136) trmD (0.0477) 
9 
 
hflK (0.0148) 
 
10 
 
nuoF (0.0276) 
 
p-values < 0.05 are indicated in parentheses; bolded gene targets were chosen for further 
study. 
 
 142 
          To demonstrate physical interactions between BbsR9 and the chosen mRNA 
candidates, RNA-RNA EMSAs were done using in vitro-transcribed BbsR9 and 
segments of the target mRNAs of interest with their predicted sRNA target regions. 
Results of the EMSAs showed that BbsR9 bound mRNAs of ftsH, nuoF, and gcvT in 
vitro, as judged by the novel hybrid RNA species showing markedly slower migration 
during gel electrophoresis (Figure 4.5). Hybrid RNAs were not observed for the other 
three candidate mRNAs, suggesting that sRNA binding did not occur. 
 
Figure 4.5: BbsR9 targets transcripts of ftsH, nuoF and gcvT in vitro.  
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RNA-RNA EMSA of biotin-labeled in vitro-transcribed BbsR9 binding to in vitro-
transcribed mRNA segments of the ftsH, nuoF, gcvT, trmD, BARBAKC583_RS02100 
and hflK genes. Red and blue arrows indicate bands corresponding to BbsR9 bound and 
unbound to target RNAs, respectively. Base values of the RNA size standard (ladder) are 
shown on the left. 
 
          We further characterized BbsR9-mRNA interactions by mutagenizing the predicted 
sRNA-binding regions of ftsH, nuoF, and gcvT (Figure 4.6). The predicted ftsH-binding 
region was extensive, so we created two distinct mutants for this target as well as a 
double-mutant (Figure 4.6). RNA-RNA EMSAs conducted with the mutagenized target 
mRNAs showed complete elimination of BbsR9 binding to all three targets in vitro 
regardless of increasing target quantity present in the hybridization reaction (Figure 4.7). 
As expected, wild-type targets showed dose-dependent hybridization and signal intensity. 
Interestingly, abrogation of ftsH transcript binding by BbsR9 was only observed with 
mutation 1 (Mut1) alone or in combination with mutation 2 (Mut2), whereas Mut2 alone 
did not prevent BbsR9 binding to the RNA (Figure 4.7). In consideration of the RNA 
secondary structure predictions and the EMSA results, we conclude that BbsR9 primarily 
targets mRNA transcripts via multiple GC-rich regions of a large, predicted stem-loop 
structure (see Figure 4.6) [145]. 
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Figure 4.6: BbsR9 binds its targets through several GC-rich predicted seed regions.  
A) Mfold secondary structure prediction of BbsR9 (ΔG = -46.9 J mol
-1
) with predicted 
seed regions for ftsH, nuoF, and gcvT transcript binding indicated by red, blue, and green 
lines, respectively. B) Predicted IntaRNA BbsR9 target seed regions of the indicated 
transcripts. For the mRNA targets, nucleotide position +1 represents the first nucleotide 
of the respective start codon. Mutagenized bases of each mRNA are indicated in red. 
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Figure 4.7: BbsR9 binds to ftsH, nuoF, and gcvT transcripts via specific GC-rich 
seed regions. 
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RNA-RNA EMSAs showing dose-dependency of biotin-labeled BbsR9 binding to wild-
type but not mutated, in vitro-transcribed segments of A-C) ftsH, D) nuoF and E) gcvT. 
Mutated regions correspond to those shown in Figure 4.6B, and “Dbl” specifies the 
double ftsH mutant. Red and blue arrows indicate bands corresponding to BbsR9 bound 
and unbound to target RNAs, respectively. All lanes contained 2 nM biotin-labeled 
BbsR9 in addition to increasing amounts of the indicated target (2 nM, 4 nM, 8 nM, and 
16 nM). 
 
Discussion 
In this study, we performed an extensive transcriptomic analysis of B. bacilliformis 
grown in vitro then shifted to one of 10 distinct conditions that mimic environments 
encountered by the bacterium during its natural life cycle. We chose these conditions in 
order to control for a variety of environmental factors that may directly influence 
expression of certain sRNAs. For example, temperature (25⁰C, 30⁰C, 37⁰C), pH levels 
(pH 6, pH 7.4, pH 8.2), solid/liquid substrates, and presence of a blood-gas atmosphere 
(5% CO2, 2.5% O2, and 92.5% N2 at 100% humidity) were all examined. In addition, we 
included RNA-Seq experiments from experimental infections of low-passage human 
vascular endothelial cells (HUVE) and fresh human blood samples (HB37 and HBBG). 
From these experiments, we discovered 160 sRNAs expressed by B. bacilliformis in at 
least one of the conditions tested. 
          Although we initially approached sRNA discovery using an automated approach, 
some clear-cut sRNAs were missed during the process. This issue led us to manually 
curate the 10 stranded RNA-Seq alignments, scanning each annotated gene, leader 
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region, and IGR for aligned reads forming peaks that could represent novel sRNAs. 
These peaks were required to surpass a pre-determined read coverage threshold 
determined independently for each condition based on reads aligned to the rpoD (locus 
tag: BARBAKC583_RS04670) gene, which was consistently expressed across all 10 
conditions (TPM ~300; Table S4.4). We remained consistent by using rpoD as the 
housekeeping gene in qRT-PCR analyses (Figure S4.3) and employing a 300 TPM 
threshold for the purpose of the UpSet plot (Figure 4.1). 
          The putative sRNAs identified were organized into three categories (IGR, cis-anti, 
or leader) depending on location of the corresponding sRNA locus. Each sRNA category 
has implications for its potential function. For example, IGR sRNAs are likely trans-
acting with small seed regions that often bind multiple mRNAs. Cis-anti sRNAs most 
likely target the gene to which they are antisense, so target identification via algorithms 
such as IntaRNA would not be useful. Putative leader sRNAs are peaks that were 
identified sense to and in the 5' UTRs of protein-coding genes. Although the identified 
peaks appeared distinct from those within the actual coding sequence, the possibility 
remains that these peaks are not trans-acting sRNAs. More likely, these leader RNAs 
may serve as cis-acting regulatory components, like riboswitches, which are co-
transcribed with the downstream protein-coding gene and harbor regulatory stem-loops 
that influence translation of the respective transcript [213]. Determining whether the 
identified leader sRNAs are cis- and/or trans-acting elements would require further 
experiments such as Northern blots and 5' RACE experiments to see if there is read-
through into the downstream gene. 
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          We performed Northern blot analyses on the putative leader sRNAs, BbspeF and 
BbsR7, and found that these are likely cis-acting leader RNAs, since the RNA sizes 
suggest read-through into the downstream gene (Figure 4.2). Northern blot analysis also 
verified the existence of six other sRNAs, although some of the results raise additional 
questions. For example, the presence of BbsR2 was detected, but the apparent band of 
~450 bases is considerably larger than its predicted 284-base band (see Figure 4.2, Table 
S4.3). Although we identified a putative promoter element for BbsR2, we did not identify 
a Rho-independent terminator, so it is possible that the sRNA extends further 
downstream than predicted. It was also unclear whether BbsR3-1 / BbsR3-2 represented 
two distinct sRNAs. However, Northern blot analysis utilizing a probe against BbsR3-1 
confirmed that there was a single transcript produced whose length (~600 bp) was equal 
to the sum of the predicted sizes of BbsR3-1 and BbsR3-2, indicating that this locus 
probably produces a single sRNA species (Figure 4.2). The BbsR7 blot also requires 
explanation. Here, several bands were identified, including smaller bands of ~200 bases 
and a larger band of ~600 bases. Since BbsR7 is predicted to be a leader sRNA, it is 
possible that the smaller bands represent the sRNA being independently expressed, while 
the larger band may represent BbsR7 being co-transcribed with the downstream gene 
(BARBAKC583_RS01695), which is 225 bp long (Figure 4.2). We also probed in the 
BbsR11-1 / BbsR11-2 region to determine if the two corresponding RNA-Seq peaks 
represented two distinct sRNAs. In this case, the Northern blot showed a single band that 
corresponded only to the predicted size of BbsR11-1 (Figure 4.2), suggesting that the 
locus harbors two distinct sRNAs. Northern blots for BbgpI and BbsR9 produced single 
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bands (Figure 4.2) that corresponded well to the estimated sizes of their respective peaks 
by RNA-Seq. 
          Among the sRNAs analyzed by Northern blot, Bbar45 and BbspeF are intriguing, 
non-coding RNA elements worthy of further characterization. Bbar45 belongs to the αr45 
sRNA family first described in Sinorhizobium meliloti, but it is widely conserved in other 
Rhizobiales [214]. Functional characterization of sRNAs in the αr45 family has not been 
performed, although the S. meliloti αr45 can be co-immunoprecipitated with Hfq [215]. 
Since Hfq is an RNA chaperone that facilitates sRNA-mRNA interactions, we 
hypothesize that the S. meliloti αr45 sRNA may be trans-acting [16]. Here, we confirmed 
that Bbar45 is independently expressed from BbspeF, which lies immediately 
downstream (Figure 4.2). While this observation was previously observed in S. meliloti, 
it was unclear whether it was the case for other alphaproteobacteria [214]. Based on 
Northern blot results showing a transcript >700 bases (Figure 4.2), BbspeF is likely a 
leader RNA that is not independently expressed from its downstream gene. The speF 
leader RNA was initially discovered during a search for alphaproteobacterial 
riboswitches and was named for its upstream location relative to the Bacillus subtilus 
speF ortholog, which codes for an ornithine decarboxylase protein involved in polyamine 
biosynthesis [216]. However, metabolites of the polyamine biosynthesis pathway of B. 
subtilus were not shown to bind to the speF leader in vitro, leaving the element’s function 
unclear [216]. More experiments are needed to determine the regulatory role of the 
BbspeF leader as well as the function of the Bbar45 sRNA in B. bacilliformis. 
          An RNA secondary structure prediction of BbsR14 showed two stem-loops with 
nearly identical sequences of TTCCTCCTAA. Remarkably, these are anti-SD motifs 
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most often found in 16S rRNA, where they function in translational initiation. The 
presence of SD sequences outside of a RBS is rare, as they are selected against in the 
context of mRNAs, since they can cause ribosome stalling due to hybridization with 16S 
rRNA [217, 218]. One way in which sRNAs regulate translation is to bind directly to the 
RBS to occlude the ribosome and inhibit translational initiation [1]. In most cases, this is 
accomplished via a seed region that overlaps the SD sequence and extends up and/or 
downstream [6]. The predicted BbsR14 secondary structure displays unique potential 
seed regions solely comprised of anti-SD sequences. We speculate that this arrangement 
could provide opportunities for indiscriminate translational repression by the BbsR14 
sRNA.  
          We also analyzed each of the identified B. bacilliformis sRNAs and discovered that 
BB019, BB113, and BB125-2 possessed a single anti-SD sequence (CCTCCT). 
Interestingly, of the four sRNAs that contain anti-SD sequences, BbsR14 and BB113 
were significantly upregulated at pH08 relative to pH06 (see Table S4.3). Conditions of 
pH08 and pH06 were designed to simulate the initial and late stages of the sand fly after 
feeding, respectively. Thus, downregulation of translation may be advantageous for 
bacterial survival during initial stages within the sand fly’s midgut. As B. bacilliformis 
persists in the sand fly and infection proceeds, “gearing up” for a subsequent mammalian 
infection may occur as the insect prepares for another blood meal. Supporting this notion, 
we also identified 6S RNA as a sand fly-specific sRNA that was upregulated at pH08 vs. 
pH06, although not significantly (see Table S4.4). 6S RNAs function by binding to and 
sequestering the RNA polymerase holoenzyme [11]. The resulting global repression of 
transcription during the initial stages of sand fly infection and, to a lesser extent, 
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throughout a sand fly infection, could conceivably promote persistence of B. bacilliformis 
in the insect. 
          The mRNA target enrichment analyses for potential sand fly and infection-specific 
sRNAs provided insight into the regulation of pathways necessary for bacterial survival 
in these disparate environments. For example, targets of sand fly-specific sRNAs were 
significantly enriched for genes involved in the FAD-binding GO term and the 
biosynthesis of amino acids KEGG pathway (Figure 4.3). FAD-binding proteins include 
a wide array of proteins that participate in numerous biological processes. Enrichment of 
these genes may reflect a relatively low availability of FAD during residence in the sand 
fly. B. bacilliformis encodes a bifunctional riboflavin kinase/FAD synthetase 
(BARBAKC583_RS05700), and although this gene is relatively lowly expressed in all 
conditions tested, there is a downregulation of its expression under sand fly-like 
conditions (pH07, average TPM = 49.04) compared to human blood infections (HBBG, 
average TPM = 84.94). Enrichment of genes involved in the biosynthesis of amino acids 
is possibly explained by the likely downregulation of transcription and translation under 
sand fly-like conditions, where B. bacilliformis enters into a stationary phase that may 
promote persistence. 
          The human infection-specific sRNA targets were enriched in multiple GO terms 
associated with transferase activities, transporters, and the phospholipid biosynthetic 
process and KEGG pathways associated with glycerolipid/glycerophospholipid 
metabolism and nucleotide excision repair (Figure 4.3). Among these, there is a clear 
regulation of cell wall constituents during human infection conditions that would 
presumably be associated with morphological changes to the bacterium in the human host 
 152 
or perhaps as a means of expressing outer membrane proteins/transporters that aid in 
bacterial growth and replication during infection. This may very well also be in response 
to stressors encountered under these conditions, since nucleotide excision repair also 
seems to be significantly regulated by infection-specific sRNAs. 
          When analyzing mRNA targets of the infection-specific sRNAs, it was clear that 
numerous sRNAs were predicted to target the same mRNA in several cases (see Table 
S4.5). For example, of the 19 presumed trans-acting, infection-specific sRNAs, three 
independently target BARBAKC583_RS04310 transcripts, coding for 
lysylphosphatidylglycerol synthetase; an enzyme previously shown to augment a 
pathogen’s defense against host cationic antimicrobial immune peptides [219]. 
Additionally, four of the 19 predicted trans-acting, infection-specific sRNAs target 
BARBAKC583_RS00395 transcripts, coding for cobaltochelatase subunit CobT, which 
is involved in the synthesis of cobalamin (vitamin B12), an essential coenzyme for many 
biological reactions [220]. It is difficult to ascribe roles to these mechanisms without 
knowing whether the sRNA-mediated regulation is positive or negative, although it is 
worth noting that redundant targeting is not a result of sRNA duplication, and each 
predicted binding site on these transcripts is unique. We hypothesize that redundant 
regulation of particular mRNAs may serve to “hyper-regulate” protein production in 
response to subtle differences in environmental cues. This kind of redundant regulation of 
mRNAs from multiple “sibling sRNAs” has been described in other pathogens, so further 
research into the function of sibling sRNAs of B. bacilliformis could be fruitful [221]. 
          We found conservation of some sRNAs among other alphaproteobacteria species 
using discontinuous megaBLAST analysis (Table S4.3). Unfortunately, we were only 
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able to analyze IGR and leader sRNAs, since cis-anti sRNAs showed broad sequence 
conservation due to their close linkage to protein-coding genes. The majority of analyzed 
sRNAs was unique to B. bacilliformis, while the BB036 sRNA group was unique to the 
KC583 strain of B. bacilliformis. Five other sRNAs were widespread in Bartonella spp., 
including BbsR9 which was characterized in this study. Conservation of BbsR9 in other 
Bartonella spp. further highlights its potential importance. Since Bartonella spp. are 
typically transmitted to mammals by various arthropods (ticks, sand flies, fleas, lice, etc.), 
it is possible that BbsR9 plays a role in persistence in many vectors. Seven more sRNAs 
were found in additional alphaproteobacteria, including ubiquitous sRNAs like 6S RNA 
and tmRNA, conserved alphaproteobacteria sRNAs like Bbar45, and the tRNAArg
CCU
 
group I intron. 
          BbgpI is a member of a tRNACCU
Arg
 group I intron family first identified in 
Agrobacterium tumefaciens and later found in other alphaproteobacteria [222, 211]. 
Group I introns are selfish genetic elements that insert into tRNAs, rRNAs, and protein-
coding genes. Although group I introns are ribozymes and RNA splicing is auto-catalytic, 
they sometimes require protein co-factors for self-splicing in vitro, and it is presumed that 
all group I introns require protein co-factors to some extent for splicing in vivo [74]. 
Here, we have demonstrated that BbgpI self-splices in vitro and is spliced in vivo. 
Furthermore, we have shown that BbgpI is not located in an IGR as presumed, but rather 
within an unannotated tRNACCU
Arg
 gene. Since the flanking tRNACCU
Arg
 gene retains all 
necessary tRNA domains (see Figure S4.4C), we predict that the tRNA is functional 
following intron splicing. This novel tRNA gene might have implications for future 
analyses of B. bacilliformis involving codon bias, conservation of tRNA genes, amino 
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acid scavenging, etc. Furthermore, this discovery suggests further optimization may be 
required for current tRNA scanning algorithms. 
          We also characterized the targeting and molecular interactions of BbsR9, as the 
sRNA was only appreciably expressed under pH06, pH07, and pH08 conditions (Table 
S4.4). For reference, these conditions reflect a liquid blood / serum environment at 30⁰ C 
(Table 4.1) and simulate the sand fly’s midgut following a blood meal. It is interesting to 
note that the Pl30 condition is identical to pH07 except that Pl30 represents a solid 
medium. Furthermore, Northern blot analyses indicated that, in addition to the liquid 
medium requirements, BbsR9 expression was restricted to temperatures < 37⁰ C (Figure 
S4.5B). The regulatory mechanisms that facilitate such an expression pattern warrant 
further investigation. 
          We verified several mRNA targets of BbsR9 using RNA-RNA EMSAs. Among 
the targets were transcripts of the ftsH, nuoF, and gcvT genes. First, ftsH codes for the 
FtsH zinc metalloprotease; a membrane-anchored, universal protease with various 
functions. FtsH has been extensively studied in E. coli, where it is the only protease 
essential for survival [reviewed in 223]. FtsH has also been described as required for 
regulation of optimal ratios of phospholipids and LPS in the outer membrane [223]. 
Whether BbsR9 regulation of ftsH transcripts is involved in bacterial protein turnover 
and/or modulation of membrane architecture in the context of the sand fly is unknown, 
but would be interesting to investigate. Second, the nuoF gene codes for the NADH-
quinone oxidoreductase subunit F, a component of the type I NADH dehydrogenase 
enzyme and the initial step in the electron transport chain. NuoF is a component of the 
peripheral fragment of the NADH dehydrogenase complex and plays a role in oxidation 
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of NADH to generate a proton motive force [reviewed in 224]. Regulation of nuoF 
transcripts could conceivably play a role in helping to establish the stationary phase as B. 
bacilliformis persists in the sand fly. Finally, we determined that BbsR9 targets 
transcripts of gcvT, which codes for the glycine cleavage system aminomethyltransferase, 
GcvT. The glycine cleavage system responds to high concentrations of glycine, breaking 
the amino acid down to CO2, ammonia, and NADH [225]. In addition to redox reactions, 
NADH can be used to produce energy through cellular respiration. Of note is the 
potential interplay between sRNA targeting of nuoF and gcvT transcripts in this regard. 
Interestingly, the glycine cleavage system has been implicated in contributing to bacterial 
persistence in animal and plant hosts [226]. In fact, gcvT is essential for persistence of a 
closely-related pathogen, Brucella abortus, in its animal host [227]. However, to our 
knowledge, the role of a glycine cleavage system in pathogen persistence in its arthropod 
vector has not been explored, to date. It is conceivable that B. bacilliformis utilizes 
regulation of nuoF and gcvT to fine-tune levels of NAD+/NADH, thereby contributing to 
regulation of metabolism and persistence of the bacterium in the sand fly. 
          This study has provided further insight into the regulation of numerous processes 
by B. bacilliformis in response to conditions encountered in the context of its sand fly 
vector and human host. We believe the results provide a strong foundation for future 
studies examining sRNA-mediated regulation in B. bacilliformis and the regulatory 
mechanisms required for vector-host transmission. 
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Supplementary Material 
 
Figure S4.1: B. bacilliformis RNA-Seq PCA plot. Axes indicate the percentage of total 
variance that can be accounted for by two principle components. Colored dots indicate 
the retained biological replicates of the RNA-Seq analyses, and their distance apart is 
representative of overall relatedness in gene expression profiles. Experimental conditions 
are shown on the right. 
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Figure S4.2: B. bacilliformis sRNAs group into specific expression patterns. Heatmap 
of B. bacilliformis sRNA TPMs across the tested conditions (shown at the bottom). 
sRNAs group vertically based on similarity in expression patterns. Conditions group 
horizontally based on similarity in overall expression patterns. The log10 of the TPM 
value for each sRNA is indicated by a color gradient. 
 
 
Figure S4.3: qRT-PCR confirmation of differential expression of several identified 
sRNAs. Faceted bar graph displaying the number of sRNA transcripts / rpoD transcript 
for select, differentially-expressed sRNAs and BB024, which was not shown to be 
differentially expressed. The condition / source of the total RNA is noted on the x-axis. 
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Significance was determined by students t-test (N = 9; * = p<0.05, ** = p<0.01, *** = 
p<0.001). 
 
 
Figure S4.4: BbgpI is a group I intron inserted into an unannotated tRNACCU
Arg
 
gene of B. bacilliformis. A) Nucleotide sequence of BbgpI (bolded and underlined) and 
flanking chromosomal regions. Primer binding sites used for in vitro transcription (IVT) 
and PCR assays designed to show splicing of BbgpI in vitro and in vivo are indicated. B) 
Sequence of BbgpI outlining the conserved, characteristic stem structures (P1 to P9) with 
putative base pairings highlighted in green and yellow. Nucleotides predicted to 
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participate in base pairing are bolded and underlined. C) Sequence coding for the 
tRNACCU
Arg
 immediately flanking BbgpI. The two bolded underlined nucleotides 
represent the ends of the spliced out BbgpI. Conserved tRNA features are also outlined. 
 
 
Figure S4.5: BbsR9 is a sand fly-specific sRNA. A) Nucleotide sequence of the bbsR9 
gene with predicted promoter elements and Rho-independent terminator plus 
experimentally-determined TSS’s, highlighted in various colors or underlined, 
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respectively. An asterisk indicates the alternative TSS found by 5' RACE analysis. B) 
Northern blot analysis of BbsR9 expression under the indicated conditions. The RNA 
ladder (2 min exposure) and resolved total RNA samples (30s exposure) were from the 
same blot but imaged using different exposure times. 
 
Table S4.1: Bacterial strains, primers, and plasmids used in the study. 
 
Purpose Name Sequence Tm Length Reference
Northern blots Bb_gpI_Probe_F TAATACGACTCACTATAGGGGGACTGTCTCTTC 60.6 33 This Study
Bb_gpI_Probe_R GGGGAAAGCTTCACAGGAAACTATATGCC 60.8 29 This Study
Bb_sRNA9_Probe_F TAATACGACTCACTATAGGGGAATTGGGAACC 60.2 32 This Study
Bb_sRNA9_Probe_R CAATATATTGTTCTCGTATATCAGGTACAGGGTC 57.7 34 This Study
Bb_sRNA2_Probe_F TAATACGACTCACTATAGGGCCCCAACAAACTCTTG 62.7 36 This Study
Bb_sRNA2_Probe_R GGCTGTCTTCGTATCAAAGATAATGATTTATGGG 58.8 34 This Study
Bb_sRNA7_Probe_F TAATACGACTCACTATAGGGCCCGATGAAAAAATAC 60.3 36 This Study
Bb_sRNA7_Probe_R GGTATACGGGATAAAAATTCTACTAAAATGTTTATTTTGGAGG 59.3 43 This Study
Bb_ar45_Probe_F TAATACGACTCACTATAGGGCTATAGCTGAAAGAC 59.4 35 This Study
Bb_ar45_Probe_R GTCGCACGTGCCTGTGG 59.9 17 This Study
Bb_SpeF_Probe_F TAATACGACTCACTATAGGGGGAATAACGGTATTG 59.6 35 This Study
Bb_SpeF_Probe_R GAGATAACTAAAGAGGCACACCTCATTG 57.1 28 This Study
Bb_sRNA3-1_Probe_F TAATACGACTCACTATAGGGCTAAAATACAATATGGG 58.6 37 This Study
Bb_sRNA3-1_Probe_R CTGATTAGGATTTTTCAAAAATTAAAGAATATAGCGGCC 58.5 39 This Study
Bb_sRNA11-2_Probe_F TAATACGACTCACTATAGGGGCGGCACAATATATTG 61.4 36 This Study
Bb_sRNA11-2_Probe_R GAAAGAATCCGGGAATTGGGAACCCAGATTC 62.2 31 This Study
5' RACE BbgpI_GSP1 GCCAGCCTATTGGTTTAAG 51.1 19 This Study
BbgpI_GSP2 CTGGACTGTCTCTTCACCTTGAAGCTTTATAC 59.8 32 This Study
BbsR9_GSP1 GGGAACCCAGATTCTTC 49.5 17 This Study
BbsR9_GSP2 GAATAGGGGCTACATGGACCTAGGAAATAG 59.3 30 This Study
qRT_PCR BB_rpoD_qRT_F CGATCCGGTGCGTATGTATTTG 63 22 This Study
BB_rpoD_qRT_R GTTTCACGTCCTGCCTCAATG 63 21 This Study
BB_6S_qRT_F CTGCTCTTCTCGACAGGAAATAC 63 23 This Study
BB_6S_qRT_R ATTCCGGGAACCTACACAAG 62 20 This Study
BB_tmRNA_qRT_F GGCGAAATAGGATCGACAAGAG 62 22 This Study
BB_tmRNA_qRT_R GACGTGCTTCCGCATAGTTG 63 20 This Study
BB_ar45_qRT_F TCCGCTGGTTCCCAAATG 62 18 This Study
BB_ar45_qRT_R ACCGTCGTTGCTTCAAGATG 63 20 This Study
BB_BB026-4_qRT_F GGTTAGATTCGTAATATCAATGAGGAG 61 27 This Study
BB_BB026-4_qRT_R GATGCTGGTGTGCCATTTAC 61 20 This Study
BB_BB027-1_qRT_F AATAGGAGATTTGATATGGATCCTG 60 25 This Study
BB_BB027-1_qRT_R TAGCAGCAGTAGTAGGCTTTAG 61 22 This Study
BB_BB027-2_qRT_F ATAACGGCTGCAGTAGTAGGG 63 21 This Study
BB_BB027-2_qRT_R ACTGCCACCATTCCTATGAAATTAG 63 25 This Study
BB_BB092_qRT_F CGTATATCAGGTACAGGGTCTTAG 62 24 This Study
BB_BB092_qRT_R CCAGATTCTTCTTCCCTAATGAATAG 62 26 This Study
BB_BB026-1_qRT_F GGCTGTCTTCGTATCAAAGATAATG 62 25 This Study
BB_BB026-1_qRT_R CCCAACAAACTCTTGAACCAAAG 63 23 This Study
BB_BB103-2_qRT_F CATCTCAATTCTTCAACGAGGAGAG 63 25 This Study
BB_BB103-2_qRT_R ACCAATTTGGGCAATATACTGGAAG 63 25 This Study
BB_BB103-3_qRT_F CTGATACGAAACGATATGAGTAGAAG 61 26 This Study
BB_BB103-3_qRT_R ACGCGATTATTCATGGATCAGTG 63 23 This Study
BB_BB024_qRT_F AGGTGTAGCGTCTTCTCCTAC 63 24 This Study
BB_BB024_qRT_R CCAAACCACATATCCTGCAATC 62 22 This Study
BB_BB060_qRT_F AAACTGTTGGGTAGTAGCAAGG 62 22 This Study
BB_BB060_qRT_R CCCTACCTCCAAGTCAAAGATG 62 22 This Study
Group I intron Splicing Bb_Intron_Splice_NEW_F GTGTCTGCGTAGCTCAGTAGGATAG 58.1 25 This Study
Bb_Intron_Splice_NEW_R GGTGTCTACGGCAGGATTTGAAC 58 23 This Study
Bb_Intron_F+T7 TAATACGACTCACTATAGGGCATTTATCGCAAAAGATG 60.5 38 This Study
Bb_Intron_R_Long GGATTTGGGTCTTCTGGGACTTCAATG 59.4 27 This Study
Bb_Intron_Nested_F CACATTGATTCATACTTATCTAAATTGATTCACC 55 34 This Study
Bb_Intron_Nested_R CCTAAAATGAGTAAAACTTTTTTCATGATATTTTCC 55 36 This Study
Q5 mutagenesis / EMSAs BbsR9_F+T7 TAATACGACTCACTATAGGGCTGGATGCGGCAC 64.6 33 This Study
BbsR9_R CAAGAAAGAATCCGGGAATTGGGAACCCAG 62.5 30 This Study
Bb_FtsH_F+T7 TAATACGACTCACTATAGGAAAGATTAAGAAACCGC 58.9 36 This Study
Bb_FtsH_R CACCATTGCTGGCGCGTTG 60.5 19 This Study
Bb_NuoF_F+T7 TAATACGACTCACTATAGGGAGTTCAGAAAAATGCTAG 59.7 38 This Study
Bb_NuoF_R CAATAATCCAATCACGGCCTTTTTCG 57 26 This Study
Bb_GcvT_F+T7 TAATACGACTCACTATAGGAATGATATAATTGGGGG 58.3 36 This Study
Bb_GcvT_R CCTGCAAAAGCACCAAATTTTGCC 58.5 24 This Study
Bb_0612RR_F+T7 TAATACGACTCACTATAGGTGTTGTTGGCATTGGGAC 62.8 37 This Study
Bb_0612RR_R CCCCATCACAAGCAATATCAGCTGC 60.3 25 This Study
Bb_TrmD_F+T7 TAATACGACTCACTATAGGAAAGAGGACATGCTTTG 60.1 36 This Study
Bb_TrmD_R GACCATATTCCCCGCTCTAAAGCG 59.5 24 This Study
Bb_HflK_F+T7 TAATACGACTCACTATAGGAGACTCTATAAGTAGTTG 57.3 37 This Study
Bb_HflK_R CCGGAACCAAAAGGATTCTTAGGTG 57.8 25 This Study
BbsR9_Anti_F+T7 TAATACGACTCACTATAGGCAAGAAAGAATCCGGG 61.4 35 This Study
BbsR9_Anti_R GGTACAGGGTCTTAGGTCCCC 58.7 21 This Study
Q5_FtsH_Mut1_F ACATATCTGATAAATGGGCCAAATATG 61 27 This Study
Q5_FtsH_Mut1_R TTGTTCGAAGAAGTCTTTATAGC 56 23 This Study
Q5_FtsH_Mut2_F ACATTCTTCGAGAACCTGTATC 58 22 This Study
Q5_FtsH_Mut2_R TTGTTAGCATATAATCTTGTCTCAG 57 25 This Study
Q5_NuoF_Mut_F AAATATGCTAGCTGATAAAGATC 57 23 This Study
Q5_NuoF_Mut_R TTTGATTTCCTTTATCACCGAC 56 22 This Study
Q5_GcvT_Mut_F AAACAGAAGTTGTCGCACTATG 60 22 This Study
Q5_GcvT_Mut_R TTTGATCATTAAGTTTGAAAAACTTTAAATAAC 57 33 This Study
Q5_FtsH_DBL_R TTGTTCGAAGAATGTTTGTTAGC 57 23 This Study
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Table S4.2: Quality control results for B. bacilliformis RNA-Seq analyses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment Raw reads Reads after Filter, Trim, and Pairing % Reads Discarded Reads with Bowtie Alignments Bowtie Ambiguous Reads Bowtie Unambiguous Reads featureCounts Assigned Reads % Ambiguous Reads % Reads with alignments
Pl25-1 27456299 19381531 29.40952821 19259963 15456384 3803579 5005237 80.25136912 99.37276369
Pl25-2 26751499 20410930 23.7017335 20242734 6106703 14136031 21216644 30.16738253 99.17595132
Pl25-3 29674598 22015946 25.80878096 21868359 12367018 9501341 N/A 56.552108 99.32963589
Pl30-1 32477931 24510162 24.53287126 24286427 7555333 16731094 N/A 31.10928174 99.08717454
Pl30-2 24793860 17701522 28.6052192 17613689 14915011 2698678 3318580 84.67851908 99.50381103
Pl30-3 30826768 23509074 23.73811617 23272863 4084481 19188382 22756550 17.55040194 98.99523478
Pl37-1 28604496 21510901 24.79888127 21334528 7177523 14157005 N/A 33.64275507 99.18007619
Pl37-2 28000000 21457560 23.36585714 21137084 6885979 14251105 18471790 32.57771507 98.50646579
Pl37-3 31215787 23553447 24.54636175 23218990 12797482 10421508 11913139 55.11644563 98.58000827
pH06-1 25786111 20047573 22.25437562 19059991 1100188 17959803 19954630 5.772237773 95.07380769
pH06-2 24396811 18378162 24.66981853 17540083 700167 16839916 19016429 3.991811213 95.43981058
pH06-3 23771077 17572118 26.07773724 3693991 1639030 2054961 N/A 44.37016766 21.0218882
pH07-1 24411875 18695408 23.41674697 17406219 1200794 16205425 13930221 6.89864927 93.10424785
pH07-2 26051988 20215780 22.40215987 19223158 600622 18622536 14354650 3.124471016 95.08986544
pH07-3 25747656 19883785 22.7743877 18096033 450605 17645428 N/A 2.49007614 91.00899552
pH08-1 24800450 17562342 29.18538978 2177927 1321785 856142 N/A 60.69005068 12.4011194
pH08-2 27032587 20701159 23.42146536 19330064 772789 18557275 16932480 3.997860535 93.3767235
pH08-3 20319866 15693461 22.76789128 13822106 794086 13028020 13152053 5.745043483 88.07557492
HUVE-1 47751481 20940177 56.14758629 232722 181151 51571 73518 77.84008388 1.111365964
HUVE-2 37532653 17616747 53.06287834 268246 201862 66384 98155 75.25256667 1.522676122
HUVE-3 40748520 18015913 55.7875648 381259 310618 70641 101436 81.47165051 2.116234687
PlBG-1 16404919 7117417 56.61412897 5654883 217769 5437114 8478003 3.850990374 79.45133747
PlBG-2 17299526 7265107 58.00401121 5635336 198919 5436417 8461078 3.529851636 77.56714388
PlBG-3 18410720 8451627 54.09398981 6497556 237713 6259843 9391536 3.658498672 76.87935116
HB37-1 41282856 20609226 50.07800332 11071031 10268079 802952 801918 92.74726988 53.71881021
HB37-2 41671146 21428176 48.57790568 11149925 10401491 748434 734112 93.28754229 52.03394353
HB37-3 50959552 25411079 50.13480692 13882484 12993736 888748 743190 93.59806213 54.63161954
HBBG-1 46693159 22819698 51.12839121 10077985 8780305 1297680 1407121 87.12361648 44.16353363
HBBG-2 16812873 8000076 52.4169605 3336897 3025888 311009 356387 90.67969434 41.71081625
HBBG-3 38931496 18430339 52.65956643 10488831 9477791 1011040 983573 90.36079426 56.91067864
Replicates removed from global analysis
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Table S4.3: Putative sRNAs identified in B. bacilliformis by RNA-Seq analyses. 
 
 
Name Start End Length Strand RFAM Designation Conserved in α? Given Name Location Putative Promoter Sequence** Predicted Rho-Independent Terminator**** Anti-SD Sequence? Peak TPM Peak TPM Condition DESeq2 Differential Expression
BB001 1565 1990 426 R Cis-anti CTTGAAG-N17-CAAAAT N/A No 496.2816733 Pl25
BB002 4992 5346 355 F Cis-anti ATTGCC-N10-CATTTT N/A No 17276.28927 pH07 #pH07 vs Pl30
BB003 23471 23637 167 F No Leader* CTTATC-N17-CTCTAA N/A No 5292.6659 HUVE $pH08 vs pH06, #HB37 vs pH07, #HUVE vs pH07, #HBBG vs PlBG
BB004 32276 32563 288 R Cis-anti Cannot Decipher N/A No 1058.11888 HUVE #HUVE vs PlBG
BB005 35430 35620 191 F No IGR GAAGAG-N13-GTAAAA N/A No 416.2446332 Pl25
BB006 42480 42726 247 R Yes BbgpI Group 1 intron GATTCATAC-N18-CTTTAT*** N/A No 9939.711374 HUVE
BB007 50218 50430 213 R No IGR GTGCTA-N19-CAAAAT N/A No 2922.443742 Pl30 #HUVE vs PlBG
BB008 68255 68455 201 R Cis-anti AAAGAA-N17-CAAAAA N/A No 647.3358684 HUVE
RF01793 76870 76922 53 F ffH leader Yes Leader* CTGGGAC-N11-GTATAA CACCCGACGACGCGTTGCGTTCTCGGGTGTTATTTTGGTTT No 850.8311306 HUVE
BB009 86533 86877 345 F Cis-anti CTGTTAG-N19-GAAAAA N/A No 1065.599064 HUVE #HUVE vs HBBG, #HUVE vs PlBG
BB010 97732 98160 429 R Cis-anti CTGTC-N14-CAAAAT N/A No 650.427422 Pl25
BB011 101286 101502 217 F No IGR GATCGTC-N16-GTATAA N/A No 707.1929022 HUVE
BB012 105538 105915 378 R Cis-anti CTCTAG-N18-CTTTTT N/A No 461.4989028 Pl30 $HBBG vs PlBG
BB013 112234 112614 381 F Cis-anti GTTGAT-N13-GTTAAA N/A No 1333.821864 Pl30
BB014 133192 133383 192 F No Leader* GTTCTT-N20-CAGATAT N/A No 425.4313761 HUVE
BB015 137410 137664 255 F No IGR TTTGAA-N18-CAATTT N/A No 692.8676713 HUVE
BB016 152703 152910 208 F No Leader* Cannot Decipher N/A No 345.6360544 HUVE
BB017 165406 165713 308 F Cis-anti GTTTGCC-N17-GTTTAA N/A No 320.9188772 Pl30
BB018 174210 174396 187 F No IGR CACGTT-N17-CTATAA N/A No 713.5680009 pH08 #pH08 vs pH06
BB019 177094 177355 262 R No IGR GTGCTT-N16-GTATAA N/A Yes; 1 (CCTCCT) 711.1817861 Pl30
BB020 181780 182124 345 F No IGR TATGAG-N14-CAAAAAT N/A No 464.9245512 PlBG
BB021 201988 202232 245 F No IGR CAAGAA-N17-GATATA N/A No 1795.004731 HUVE $pH07 vs Pl30
BB022 202233 202467 235 F No Leader* Cannot Decipher N/A No 1287.866693 HUVE
RF00013 206709 206871 163 R 6S RNA Yes Bb6S 6S RNA CTAGTC-N17-CTATAAT N/A No 402121.5657 pH08 $HUVE vs pH07, #pH07 vs Pl30
BB023 208306 208580 275 R No Leader* CTTCTT-N15-GATTTT N/A No 2172.245172 Pl25
BB024 214513 214777 265 F No BbsR1 Leader* CTTGCAC-N19-TATTT N/A No 2906.471248 HBBG #Pl37 vs Pl30
BB025 218599 218718 120 F No Leader* GGCAC-N15-CATTAT N/A No 13148.5228 HUVE
BB026_1 220801 221084 284 F No BbsR2 IGR CATGTA-N18-GATATT N/A No 12820.65011 Pl25 #pH07 vs Pl30, $HUVE vs HBBG, $HUVE vs pH07
BB026_2 221246 221514 269 R No BbsR3-1 IGR GATTTA-N17-CAAATA N/A No 2419.190792 Pl25
BB026_3 221512 221820 309 R No BbsR3-2 IGR GATTTG-N18-GATATA N/A No 6879.351935 HUVE #HUVE vs PlBG
BB026_4 221947 222234 288 F No BbsR4 IGR CTATGTG-N10-CATTAT N/A No 13303.01973 HUVE #HUVE vs HBBG, #pH07 vs Pl30, #HUVE vs PlBG
BB026_5 222235 222425 191 R No IGR CAACAA-N18-CAAATA N/A No 1991.765384 HUVE #pH07 vs Pl30, #HUVE vs HBBG, #HUVE vs PlBG
BB026_6 222725 223048 324 R No IGR GTTCTT-N22-CTTACT N/A No 1058.003412 Pl30 #HUVE vs PlBG
BB027_1 223964 224233 270 R No BbsR5 IGR Cannot Decipher N/A No 11853.57524 HUVE #HUVE vs HBBG, #pH07 vs Pl30, #HUVE vs PlBG
BB027_2 224237 224539 303 R No BbsR6 IGR CAAACTG-N19-CATAAT N/A No 11219.10742 HUVE #HUVE vs HBBG, #pH07 vs Pl30, #HUVE vs PlBG
BB028 262399 262562 164 R Cis-anti CTTGAA-N16-CTAAAA N/A No 307.2329244 Pl25
BB029 263407 263730 324 R No IGR CATCAT-N17-CATTAA N/A No 487.6770919 HBBG
BB030 279639 279909 271 F No IGR GCTGAC-N16-GTTATA N/A No 698.5395197 Pl30
BB031 280558 280767 210 F No Leader* Cannot Decipher N/A No 417.5108195 Pl30
BB032 284831 285238 408 R Cis-anti CAATTT-N16-CTATACT N/A No 340.8093002 Pl30
BB033 286460 286750 291 R Cis-anti GATTCAG-N15-CATTAT N/A No 454.4660937 Pl30
BB034 296552 296829 278 R Cis-anti CATGTA-N19-CTAATT N/A No 342.3876178 Pl30
BB035 300016 300280 265 F No IGR GTTATG-N17-GATATAAT N/A No 1171.63052 HBBG
BB036_1 303123 303376 254 R No; Only KC583 IGR CTGCAC-N12-CTTTTT N/A No 710.178005 Pl30
BB036_2 303097 303405 309 F No; Only KC583 IGR CTTTCC-N18-GATAAT N/A No 616.6129156 Pl30
BB036_3 303381 303550 170 R No; Only KC583 IGR CTTGGG-N16-CAAAAGT N/A No 960.8786332 Pl25
BB036_4 303790 304035 246 F No; Only KC583 IGR GAAGTA-N12-CTTTTT N/A No 771.0831325 HUVE #HUVE vs PlBG
BB037 320278 320469 192 F Cis-anti GTTTGAAG-N14-CTTTAAT N/A No 351.982407 HBBG
BB038 345872 346134 263 R No IGR CAATGTA-N16-CAATAA N/A No 735.9567972 Pl30
BB039 348864 349306 443 F No BbsR7 Leader* CTTGCA-N21-CATATAT N/A No 3708.411037 HBBG $HUVE vs HBBG
BB040 364947 365233 287 R Cis-anti CTTTAT-N17-GTAAAA N/A No 433.1188295 Pl30
BB041 371607 372062 456 R Cis-anti CATGTG-N17-CTTTTT N/A No 538.6591709 Pl30
BB042 385701 386036 336 R Cis-anti CTAAC-N14-CAATAT N/A No 774.3039086 Pl30
BB043 390191 390526 336 R Cis-anti CCTAAC-N16-GTAAAA N/A No 526.7062237 Pl30
BB044 417847 418086 240 F Cis-anti CAAATA-N17-CAATAT N/A No 434.8789108 Pl30
BB045 422851 423150 300 R No IGR CAAAAG-N15-CTATAT N/A No 735.9480016 HUVE
BB046 428891 429229 339 R No IGR Cannot Decipher N/A No 365.7986215 Pl30
BB047 435331 435585 255 R Cis-anti GAAAGCC-N14-CAAAAA N/A No 485.7051311 Pl30
BB048 452671 452952 282 F No IGR CATGAA-N18-CTCTTA N/A No 503.7204688 HBBG
BB049 456023 456304 282 R Cis-anti GTGAGAC-N17-GTAAAT N/A No 943.3427482 HUVE
BB050 489865 490191 327 R Cis-anti CTGCAC-N16-GATAAT N/A No 560.6879339 Pl30
BB051 490903 491111 209 F Cis-anti GTAAAC-N14-GAAAAA AGCTTACCTGTTTCTTTTAAATCGGGTAAGGAGAGATGAGCTATTTTCTT No 360.3237013 PlBG
BB052 498847 499083 237 F Cis-anti CAAAAAC-N14-CAATAT N/A No 372.0046788 HUVE #HBBG vs PlBG
BB053 500909 501262 354 R Cis-anti ATTAAG-N16-CAAATT N/A No 355.9714491 Pl25
BB054 511310 511467 158 F Cis-anti GGTAA-N14-GTAATT N/A No 368.8290748 Pl25
BB055 531995 532227 233 F No IGR CATCAA-N14-GATAT TCAGCCTAATCACTAAGGTTGAATTTCATTT No 379.6425804 PlBG
BB056 560531 560858 328 R Cis-anti GTTGAG-N15-GTTTAA N/A No 1801.852905 HUVE
BB057 563437 563763 327 F No IGR GATTATCG-N18-GTTATT N/A No 716.3879653 Pl25
BB058 568738 568983 246 R Cis-anti CTATAC-N17-GTAAAA N/A No 979.7847614 Pl30
BB059 570985 571338 354 R Cis-anti GTTTCAA-N17-CTTTAC N/A No 399.325032 Pl30
BB060 587515 587806 292 F Yes; Only Bartonella spp. BbsR8 Leader* TTTCAG-N19-CATTTT N/A No 2353.470966 HBBG $pH08 vs pH06, #HB37 vs pH07, #HUVE vs pH07, #HBBG vs PlBG
BB061 594424 594678 255 F Cis-anti CTAGCC-N14-CATAAT N/A No 400.9741484 Pl37
BB062 601997 602269 273 R Cis-anti CTTTCC-N11-CAATAA N/A No 574.1521929 Pl30 #HUVE vs PlBG
BB063 614479 614769 291 F Cis-anti CTTGAT-N16-GTAATT N/A No 1664.856056 HUVE
BB064 617574 617939 366 R Cis-anti GAATG-N20-GTAAAT N/A No 375.459916 Pl30
BB065 636778 637032 255 F Cis-anti GAAGTG-N18-CAATAT N/A No 366.4170991 Pl25
BB066 644476 644755 280 F No IGR CTTAAT-N18-GATTAA N/A No 714.1882733 HUVE
BB067 655501 655800 300 R Cis-anti CTTTAC-N15-CATTTA N/A No 381.0416561 Pl25
BB068_1 721160 721467 308 R Cis-anti CAACAC-N18-CTAATAT N/A No 824.707146 Pl30
BB068_2 721465 722043 579 R Cis-anti GCTGTA-N19-CTATTA N/A No 532.5312284 Pl25
BB069 739764 740082 319 F Cis-anti CTTCAG-N14-GAAATA N/A No 477.6685311 Pl30
BB070 786325 786705 381 F Cis-anti GAATTG-N21-GATTAA N/A No 678.7599738 Pl25 #pH08 vs pH06
BB071 789268 789466 199 F Yes; Only Bartonella spp. Leader* TTTGTG-N18-GTTTAT N/A No 1627.280536 Pl25
BB072 790468 790830 363 R Cis-anti Cannot Decipher N/A No 316.0681082 Pl30
BB073 791491 791700 210 R Cis-anti CTACAC-N18-GTTTAA N/A No 519.9037998 HUVE
BB074 804697 804969 273 R Cis-anti CAATTC-N18-CATAAA N/A No 1098.905034 Pl30
BB075 819616 819870 255 R Yes; Only Bartonella spp. IGR AAAGTC-N16-CTTAAT TGGTTCGGATATTCGGACCATTTT No 420.7543702 PlBG
BB076 834748 835083 336 R Cis-anti GCAGAC-N16-CTATAA N/A No 350.5645079 Pl37
BB077 836431 836757 327 F Cis-anti CATTG-N16-GTATAT N/A No 800.0383303 Pl25
BB078_1 844892 845173 282 F Cis-anti Cannot Decipher N/A No 384.5918016 Pl30
BB078_2 845180 845497 318 F Cis-anti CCTGTA-N19-GATATT N/A No 339.6999519 Pl30
BB079 855197 855424 228 R Cis-anti ATGGA-N16-CTATAT N/A No 413.5966927 Pl30
BB080 867684 867937 254 R No IGR CTTCAA-N14-CTATA N/A No 769.9230033 Pl30
BB081 893155 893571 417 R Cis-anti CTTGAT-N19-CTATAT N/A No 781.0749478 Pl30
BB082 897559 897876 318 F Cis-anti CAATCAG-N13-GAAATT N/A No 1183.09352 Pl30
BB083 912647 912921 275 F No IGR Cannot Decipher CCTCTTCGAAGTGGAGGTTATTTTTTT No 611.6681933 pH08
BB084 916424 916831 408 R Cis-anti AAGGAG-N12-CATATA N/A No 650.8805063 Pl25
BB085_1 921473 921817 345 R Cis-anti GTTGAT-N17-GATATA N/A No 361.150714 HUVE
BB085_2 921977 922303 327 R Cis-anti CAAGTT-N15-CAAAAT N/A No 633.245647 Pl30 $Pl37 vs Pl30
BB086 933217 933624 408 F No IGR TATGAT-N18-CTATT N/A No 637.0525186 HUVE #HUVE vs HBBG, $PlBG vs Pl37, #HUVE vs PlBG
BB087 941224 941847 624 R Cis-anti GCAGAA-N17-CTTTTA N/A No 499.0692369 Pl30
RF01849 955017 955372 356 F tmRNA Yes BbtmRNA tmRNA Cannot Decipher N/A No 314430.1099 HB37 $HUVE vs HBBG, #pH07 vs Pl30
RF00010 988347 988732 386 R Rnase P RNA Yes Rnase P Cannot Decipher N/A No 457521.8377 Pl37 $HUVE vs HBBG
BB088 990118 990253 136 F No IGR TTTTAC-N14-CTATAA N/A No 335.1273341 Pl30
BB089 992341 992595 255 R No IGR GAGAG-N19-GATATT N/A No 316.3931867 PlBG
BB090 1034595 1034803 209 R Cis-anti CTAGCC-N11-CATTTT N/A No 442.0277833 Pl25
BB091 1045088 1045342 255 R Cis-anti GAAGAA-N19-CATAAA N/A No 463.1306877 HBBG #HBBG vs PlBG
BB092 1051920 1052052 133 R Yes; Only Bartonella spp. BbsR9 IGR ATTGAC-N15-GTATAA*** TCTGGGTTCCCAATTCCCGGATTCTTTCTT No 13936.21138 pH08 #pH07 vs Pl30, pH07 vs HUVE
BB093 1055361 1055559 199 R No Leader* TTTTGTA-N13-CATTAAT N/A No 1911.894896 HBBG
BB094 1057607 1057843 237 R Cis-anti CTAAAA-N19-CATATT N/A No 390.3329281 Pl25
BB095 1071748 1072200 453 R Cis-anti CTTCAA-N18-GTTTAT N/A No 434.2029275 Pl37
BB096 1079900 1080116 217 F Cis-anti CGACAT-N21-GTAAAA N/A No 847.52094 PlBG
BB097 1083853 1084188 336 R Cis-anti GATGTAC-N15-GTTATT N/A No 472.2336635 HUVE
BB098 1103684 1103956 273 R Cis-anti GTACTA-N14-CAATAT N/A No 948.8994593 Pl30
BB099 1116571 1116807 237 R Cis-anti GTAAATC-N16-GAATAA N/A No 376.046376 HBBG
RF00518 1119924 1120074 151 R speF leader Yes; Only Bartonella spp. BbspeF Leader Cannot Decipher N/A No 3120.285529 PlBG #pH08 vs pH06
RF02347 1120082 1120229 148 R ar45 Yes Bbar45 IGR GATTGC-N17-CTTATA N/A No 3236.169339 PlBG #pH07 vs Pl30
BB100 1120921 1121265 345 F Cis-anti CTTGAT-N18-GAAATT N/A No 1207.950247 Pl30
BB101_1 1124085 1124530 446 R Cis-anti CATTG-N18-CTTTTT N/A No 384.3275378 HUVE
BB101_2 1124568 1124689 122 F No IGR GTTAAA-N17-CATAAA AGCTCACACAATATGTGAGCTTTTTT No 324.1249053 Pl25
BB102 1129498 1129887 390 R Cis-anti Cannot Decipher N/A No 596.2911073 Pl30
BB103_1 1131141 1131342 202 F No BbsR10 IGR ATTGAC-N20-GTTATT TACCATGATTGGTATTTTTTT No 43933.97802 HB37 $HUVE vs HBBG
BB103_2 1131369 1131526 158 F No BbsR11-1 IGR CATGGTG-N14-CAATTT N/A No 16854.32834 Pl25 $HUVE vs HBBG
BB103_3 1131528 1131747 220 F No BbsR11-2 IGR CTTTTC-N15-CAAATT CCCTGCCTATTTGGGGTTTTT No 13789.28927 Pl25 $HUVE vs HBBG
BB103_4 1132079 1132331 253 R No IGR GATAAAAC-N14-CAATAT N/A No 3763.101715 HUVE #HB37 vs pH07, #HUVE vs pH07, #HUVE vs PlBG
BB104_1 1133539 1133739 201 R No IGR GTTCTA-N14-CTTTAA N/A No 2329.960124 HBBG #pH07 vs Pl30
BB104_2 1133800 1134198 399 R No IGR AATGGG-N11-CATTTT N/A No 3223.724178 HBBG $HUVE vs HBBG
BB105_1 1134984 1135170 187 R No IGR CATAAA-N17-CAAATA N/A No 9354.669137 HB37 $HUVE vs HBBG, #HBBG vs PlBG
BB105_2 1135171 1135386 216 R No IGR CTTGAA-N17-GTATTT N/A No 1169.877316 HBBG
BB106 1142717 1143115 399 R Cis-anti GATTA-N16-CTAAAA N/A No 363.8787504 HUVE
BB107_1 1154245 1154411 167 R No IGR TAATTG-N12-CTATAT N/A No 2724.520796 Pl25
BB107_2 1154407 1154540 134 R No IGR CAATAT-N20-CTTTT N/A No 3357.102372 Pl25 #HUVE vs PlBG
BB107_3 1154533 1154694 162 R No IGR CTTGCG-N12-CTTTTT N/A No 3482.169956 HUVE #HUVE vs PlBG
BB108 1159243 1159542 300 F Cis-anti Cannot Decipher N/A No 983.7782236 pH08 $HUVE vs HBBG
BB109 1201930 1202214 285 F No BbsR12 Leader* GATCAG-N19-CATTTT N/A No 6402.064419 Pl30
BB110 1204027 1204317 291 F Cis-anti CATGAC-N15-CAATAT N/A No 3573.184729 Pl30
BB111 1206802 1207035 234 R Cis-anti GAAAT-N15-CAAAAA N/A No 585.7390241 Pl30
BB112 1208356 1208691 336 R No IGR CTTTAC-N19-CAAATT N/A No 516.0034285 HUVE #HBBG vs PlBG, #HUVE vs PlBG
BB113 1228413 1228502 90 R No IGR CAACTA-N18-CAATTA N/A Yes; 1 (CCTCCT) 347.5906739 pH08 #pH08 vs pH06
BB114 1231513 1231794 282 R Cis-anti CTTAAA-N18-GATATT N/A No 749.7778248 Pl25
BB115 1232243 1232549 307 R No IGR GGACAG-N10-CTAATAT AGTGCAGCTAAGAGTCTTCATGCTGCACTATTATATTTT No 603.5837774 HUVE
BB116 1233880 1234161 282 F Cis-anti GAAATT-N14-CATTAA N/A No 463.5127007 Pl30 #pH08 vs pH06
BB117 1249516 1249932 417 F Cis-anti CAATC-N16-GTTAAA N/A No 476.5439599 Pl30
BB118 1257316 1257687 372 F Cis-anti CTTCTT-N13-CTAATT N/A No 1008.298517 HUVE #HUVE vs HBBG, #HUVE vs pH07, #HUVE vs PlBG
BB119 1261442 1261755 314 R No IGR GTTTTA-N17-CTTTTT N/A No 2207.422201 PlBG
BB120 1263272 1263490 219 R Cis-anti CAGGAG-N17-CTAATA N/A No 486.1326461 HBBG
BB121_1 1277701 1278072 372 F Cis-anti CTGGAT-N14-GAATAA N/A No 1511.296872 Pl30
BB121_2 1278196 1278377 182 F BbsR13 Cis-anti Cannot Decipher N/A No 18412.30814 Pl30
RF00169 1281192 1281290 99 R SRP sRNA Yes SRP sRNA Cannot Decipher N/A No 2006.872267 pH08
BB122 1302253 1302426 174 R No IGR CATTGAC-N20-CTATGT N/A No 1770.798921 HUVE
BB123 1350043 1350441 399 R Cis-anti Cannot Decipher N/A No 719.0327519 HUVE
BB124 1360532 1360645 114 R No BbsR14 IGR CTAGTC-N14-GTATAA AGGCTGCATTATAATTTGTTTATGCAGCCTTTTTTTCTT Yes; 2 (TTCCTCCTAA) 1635.901098 Pl25 #pH08 vs pH06
BB125_1 1384358 1384612 255 R Cis-anti GATCAC-N12-GTTTAA N/A No 963.5677666 Pl30
BB125_2 1384921 1385123 203 R No IGR GAAGTA-N14-CAATAA N/A Yes; 1 (CCTCCT) 1108.332252 PlBG
BB126 1385968 1386222 255 R Cis-anti Cannot Decipher N/A No 642.7871349 Pl30
BB127 1410250 1410486 237 R Cis-anti GAGATA-N17-CTTTTT N/A No 351.9288207 Pl25
BB128 1422463 1422762 300 R Cis-anti GTGTCA-N20-CATTTT N/A No 420.8572183 HUVE
BB129 1429268 1429522 255 R Cis-anti CAAGTC-N12-CTTTAT N/A No 329.4885998 Pl25
BB130_1 1438680 1438878 199 R No Leader* GTTTTG-N15-GAAATCTAT N/A No 727.2795699 PlBG
BB130_2 1438979 1439214 236 R No IGR GTTTCC-N17-CTATAA N/A No 2770.117379 HBBG
BB025 duplicated in adjacent genomic areas several times with no transcription
BB026-2/BB026-3 are duplicated at BB027-1/BB027-2 with slight changes.
BB049 is duplicated at three other locations in the genome with no transcription
BB071 is duplicated in many locations (13) in the genome with varying homology. Among these duplications is a portion of BB098
BB084 is duplicated in many locations (11) in the genome with varying homology. None of these are transcribed.
BB104-1 is duplicated within BB104-2
A portion of BB116 is duplicated 4000bp downstream
A portion of BB118 is duplicated 800bp downstream
A Cis-anti sRNA is characterized by all of or a portion of the sRNA sequence running antisense to an annotated gene sequence
An intergenic region (IGR) sRNA is characterized by the sRNA sequence being wholly contained within an intergenic region
A potential leader sRNA is characterized by being immediately upstream and sense to an annotated gene sequence while having an identifiable peak separate from the peaks generated by the mRNA
*Leader sRNAs need to be verified as such.
**Consensus aphaprotobacterial promoter sequence: CTTGAC-N17-CTATAT
***Verified by 5' RACE analysis
****Rho-independent terminators predicted by the ARNold web tool
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Table S4.4: Average TPMs of identified B. bacilliformis sRNAs. 
 
Name Pl25 Pl30 Pl37 pH06 pH07 pH08 PlBG HUVE HB37 HBBG AVG St Dev Cut-Off Specific
BB001 496.281673 355.0882 261.7784 214.4198 203.5735 136.2476 436.7377 326.6814 168.5673 179.7341 277.91 121.44 399.35
BB002 6780.15889 2252.933 5268.244 14597.06 17276.29 9683.019 3215.727 1281.349 293.2723 255.9822 6090.4 6012.1 12103 S
BB003 1336.93564 929.6449 607.1764 463.9976 279.8368 134.6836 1831.387 5292.666 2633.749 3345.881 1685.6 1647.1 3332.7 I
BB004 604.971755 551.7564 428.0488 221.896 175.7485 155.7173 540.7636 1058.119 532.0631 667.8628 493.69 271.18 764.88
BB005 416.244633 158.835 91.33097 237.0055 199.4454 191.0331 217.4196 173.8117 222.1369 238.4801 214.57 83.368 297.94
BB006 5226.38713 2724.366 1161.087 4826.729 5530.814 3564.889 6155.516 9939.711 3037.116 2912.592 4507.9 2446.4 6954.3
BB007 2221.09914 2922.444 1356.977 419.9187 938.3363 455.1365 53.03346 946.4493 783.363 1200.609 1129.7 867.3 1997
BB008 420.472325 381.7612 136.8421 127.0299 89.12428 153.627 302.3291 647.3359 226.5039 256.0073 274.1 171.56 445.67
BBffH 511.694974 152.5887 201.0233 218.9877 72.9172 135.0689 522.7546 850.8311 232.1132 277.8666 317.58 239.61 557.19
BB009 102.076297 50.95892 57.87471 48.0806 47.83368 70.01687 101.8461 1065.599 37.67142 52.89733 163.49 317.75 481.24
BB010 650.427422 506.7517 272.6527 169.8482 151.5391 169.0627 415.7373 210.6175 94.98924 78.73111 272.04 190.6 462.64
BB011 176.443376 92.18907 86.55054 33.82523 22.26634 40.55508 203.0318 707.1929 176.2003 283.013 182.13 203.09 385.21
BB012 383.073643 461.4989 328.183 117.7198 115.005 93.85092 394.7877 57.75204 42.35532 41.0943 203.53 167.25 370.78
BB013 604.125006 1333.822 924.0228 188.7438 377.0009 122.7182 190.8603 589.4512 496.7412 559.3282 538.68 370.04 908.72
BB014 167.432504 170.2782 111.0845 144.1497 91.69551 59.87598 281.2 425.4314 207.9048 239.3835 189.84 106.63 296.47
BB015 523.596022 320.5067 366.6048 93.15389 70.26132 111.1741 253.1459 692.8677 338.7034 385.9669 315.6 196.94 512.54
BB016 71.7684769 55.80893 57.06662 26.55306 19.25249 15.26721 110.8978 345.6361 218.7939 301.1687 122.22 121.92 244.14 I
BB017 163.262924 320.9189 102.982 68.5975 87.02759 42.2084 80.2017 49.33542 107.5717 124.6905 114.68 80.816 195.5
BB018 554.527535 405.3938 447.8946 245.9185 268.2929 713.568 515.1939 481.5326 151.9881 176.8074 396.11 181.57 577.68
BB019 632.180909 711.1818 481.6992 156.1502 231.8251 132.4912 236.2538 87.8217 129.5953 159.0255 295.82 226.97 522.8
BB020 298.008697 172.179 98.92058 101.7274 65.37053 56.65238 464.9246 229.1876 243.2976 347.2185 207.75 134.54 342.29 I
BB021 491.341899 966.3944 657.9737 170.6068 163.185 78.04279 1040.212 1795.005 765.9353 1082.971 721.17 530.5 1251.7
BB022 426.462993 995.9694 1017.476 203.1249 188.3647 94.10134 429.8425 1287.867 717.4385 1087.647 644.83 431.75 1076.6 I
BB6S 25043.3746 8439.385 11618.14 220820.8 335928.5 402121.6 36686.4 11180.84 27009.04 18460.69 109731 151393 261123 S
BB023 2172.24517 436.5188 632.8404 414.7754 164.9013 511.5875 1505.105 1053.713 297.739 426.8075 761.62 633.89 1395.5
BB024 148.076796 236.9635 961.3708 104.5203 123.7008 47.12176 1954.901 2378.895 2030.043 2906.471 1089.2 1116.4 2205.6 I
BB025 818.264627 2134.598 2551.78 1032.291 907.2288 495.1546 8951.143 13148.52 3247.903 3704.811 3699.2 4140.8 7839.9 I
BB026_1 12820.6501 2448.968 2900.803 12724.51 6223.749 4174.382 5797.677 1616.631 7375.695 7737.729 6382.1 3944.7 10327 S
BB026_2 2419.19079 1724.189 1608.817 619.6049 474.9493 283.0937 620.3166 1172.613 516.745 565.6484 1000.5 702.35 1702.9
BB026_3 4916.71227 5971.758 5097.68 2209.464 1991.992 537.6892 759.3877 6879.352 4333.144 4949.106 3764.6 2221.3 5986
BB026_4 1061.48397 298.3998 322.9151 1719.788 1543.905 1228.067 830.6596 13303.02 274.8566 304.8648 2088.8 3977.3 6066.1
BB026_5 1012.29667 511.6615 305.6435 1071.646 737.442 536.3487 424.5746 1991.765 95.29877 78.1965 676.49 572.14 1248.6
BB026_6 510.588768 1058.003 658.4091 191.0989 263.423 95.61526 204.7118 636.6194 159.519 141.2912 391.93 313.61 705.54
BB027_1 1854.05251 1018.427 1146.852 1379.768 1241.823 718.0987 826.3864 11853.58 983.9935 1202.708 2222.6 3398.7 5621.2
BB027_2 3046.59559 948.8716 1180.915 4320.998 3147.575 3232.133 2828.439 11219.11 717.0406 958.5495 3160 3092 6252
BB028 307.232924 302.4516 192.9082 53.1616 88.00946 81.2821 63.48193 91.12551 45.91663 45.72519 127.13 102.83 229.96
BB029 367.994486 299.5016 191.0167 93.41232 103.1092 47.2494 432.7158 407.2171 374.8025 487.6771 280.47 159.14 439.61
BB030 350.135266 698.5395 349.6149 159.8816 197.9999 138.6489 554.5447 561.7907 283.3865 278.3033 357.28 188.9 546.18
BB031 325.17987 417.5108 193.5004 240.3349 229.219 258.1843 236.0756 307.8706 328.2474 357.3796 289.35 69.288 358.64
BB032 274.683035 340.8093 115.0336 90.12971 122.1232 67.41984 37.38817 128.6255 56.76688 68.02435 130.1 99.414 229.51
BB033 296.702866 454.4661 240.2845 94.89685 94.57767 31.34044 175.4968 144.5604 90.13126 94.26719 171.67 127.03 298.7
BB034 319.673295 342.3876 196.3561 117.6612 131.1013 48.45703 233.7548 88.64983 104.6191 117.0662 169.97 99.777 269.75
BB035 516.799307 605.5225 344.4244 94.60037 173.1977 60.82428 549.8415 851.0611 911.3474 1171.631 527.92 370.87 898.79 I
BB036_1 660.541698 710.178 334.8262 202.4536 235.1499 104.7914 306.203 315.5596 266.5505 437.9428 357.42 194 551.42
BB036_2 590.525059 616.6129 291.697 179.9272 203.364 95.07 270.6425 339.3522 266.7184 436.4141 329.03 171.32 500.36
BB036_3 960.878633 474.0072 133.5273 157.8306 137.8946 210.9479 47.9791 610.1676 258.0122 228.6069 321.99 281.05 603.04
BB036_4 642.650509 214.9473 104.6245 184.3745 179.5666 149.6257 241.683 771.0831 260.8984 339.856 308.93 221.34 530.28
BB037 288.188925 175.2369 189.1463 124.1646 109.7646 151.6657 313.0461 282.5354 320.3999 351.9824 230.61 89.785 320.4 I
BB038 598.51536 735.9568 310.019 252.0444 270.1891 81.96199 191.1948 75.06511 63.64589 67.17829 264.58 233.32 497.9
BB039 740.919339 528.6875 396.6356 810.5112 472.2024 1128.306 2645.049 2548.956 3522.978 3708.411 1650.3 1315 2965.2 I
BB040 224.107301 433.1188 346.3147 72.28228 184.9189 136.6577 163.2562 401.5428 258.1302 403.9554 262.43 126.87 389.3
BB041 510.944396 538.6592 394.3467 206.2553 133.939 90.72333 249.6925 324.1868 115.2657 174.6566 273.87 162.15 436.02
BB042 344.554468 774.3039 429.0012 41.75375 124.027 34.98344 147.0514 215.7558 43.85225 49.66122 220.49 237.36 457.85
BB043 223.142756 526.7062 249.5801 74.7058 154.064 59.60163 106.7515 99.47767 25.55547 30.14216 154.97 150.94 305.92
BB044 186.708545 434.8789 269.5569 99.42693 266.9863 72.75748 145.1509 132.9191 99.82227 117.9773 182.62 111.67 294.29
BB045 718.71061 690.5309 379.5445 168.9944 198.0634 108.8854 214.7779 735.948 351.9168 452.5732 401.99 239.79 641.79
BB046 329.54722 365.7986 209.84 86.0165 104.7747 93.65417 28.53721 166.3197 27.31351 33.67072 144.55 122.48 267.03
BB047 480.974279 485.7051 176.2431 54.15996 127.6259 37.61825 110.4182 41.9719 20.132 22.72946 155.76 179.88 335.64
BB048 157.734861 250.5587 176.2653 70.9104 108.2427 75.31724 117.8684 444.2793 397.9973 503.7205 230.29 161.32 391.61 I
BB049 357.655523 357.8118 294.852 142.4805 108.6153 113.7462 514.4467 943.3427 409.7021 389.3256 363.2 245.58 608.78
BB050 261.814354 560.6879 329.8038 88.66957 183.8473 73.81209 138.5793 119.2558 73.21432 47.164 187.68 159.01 346.69
BB051 303.810337 240.2345 173.5363 118.0903 147.9681 116.7088 360.3237 205.6907 106.0328 117.4115 188.98 87.953 276.93
BB052 102.76717 133.9297 101.0641 48.24658 60.19751 30.46652 43.50422 372.0047 272.2816 309.8956 147.44 124.13 271.56 I
BB053 355.971449 225.915 156.1479 176.8417 139.892 113.7646 280.7633 26.82198 51.71602 50.89614 157.87 106.19 264.07
BB054 368.829075 350.2621 269.9674 133.913 251.83 125.2511 324.0297 311.7748 50.54563 96.16062 228.26 116.25 344.51
BB055 189.612668 197.1108 162.0038 80.39799 66.94351 31.93417 379.6426 114.2548 40.54335 58.07848 132.05 105.85 237.9
BB056 656.905509 869.9735 855.7954 408.5809 296.2914 230.1841 1135.258 1801.853 925.9694 1179.522 836.03 474.12 1310.2
BB057 716.387965 492.6844 420.6755 429.868 344.2598 353.9569 382.8162 349.5526 257.2441 303.031 405.05 128.07 533.11
BB058 901.029707 979.7848 403.5959 249.6212 260.5086 124.7752 607.806 664.0311 365.2419 426.619 498.3 283.47 781.77
BB059 237.061931 399.325 183.6403 77.56931 72.38496 48.3676 181.0029 119.7821 45.33751 58.02973 142.25 112.13 254.38
BB060 489.911111 494.0511 355.1127 232.7186 147.4718 59.38701 1475.846 2214.144 1891.576 2353.471 971.37 909.91 1881.3 I
BB061 231.830413 379.1072 400.9741 147.3797 156.6597 62.10264 232.3166 277.3936 192.7724 234.4331 231.5 103.01 334.51
BB062 433.256896 574.1522 185.4082 69.11379 178.9611 74.28101 129.2165 197.9015 104.7574 109.6332 205.67 166.64 372.31
BB063 354.946475 432.1115 365.282 124.0033 131.3285 230.7329 706.3074 1664.856 282.746 460.0475 475.24 451.63 926.86
BB064 290.537767 375.4599 197.7904 60.06465 108.4338 67.61872 97.8107 185.0351 46.72835 54.68406 148.42 112.12 260.54
BB065 366.417099 330.3586 254.2579 156.575 175.416 163.2833 347.8948 292.6381 141.1781 187.1022 241.51 87.126 328.64
BB066 352.476646 210.6201 155.9131 63.21188 64.10958 63.57965 283.8488 714.1883 243.2809 342.099 249.33 197.27 446.6
BB067 381.041656 304.2419 282.9994 137.0866 101.3921 80.3013 63.23738 318.677 41.58271 84.78748 179.53 127.15 306.69
BB068_1 598.461769 824.7071 429.242 170.4434 191.7078 111.5518 521.3269 322.4612 128.6248 186.8065 348.53 238.8 587.34
BB068_2 532.531228 443.0651 268.7777 162.4738 151.8778 125.825 408.1832 220.797 204.3874 208.0139 272.59 139.35 411.95
BB069 327.144906 477.6685 312.0723 55.16504 108.2412 71.08251 225.0267 230.5119 69.47676 110.7217 198.71 140.79 339.5
BB070 678.759974 326.4783 230.0698 83.50372 105.3729 279.6675 628.2335 436.1977 121.1444 135.4579 302.49 215.9 518.39
BB071 1627.28054 793.3775 665.3765 732.7659 715.7462 845.0456 1382.095 1444.228 1013.123 1050.844 1027 343.7 1370.7
BB072 213.597306 316.0681 156.3719 61.78344 56.86545 46.30738 91.29691 86.16907 33.83925 38.70862 110.1 92.106 202.21
BB073 313.477678 294.7395 113.3382 79.78813 152.9438 136.4413 106.1369 519.9038 231.9374 221.6717 217.04 133.25 350.29
BB074 690.565003 1098.905 666.3118 110.0169 320.0579 130.9471 190.5273 149.7323 110.9173 114.6807 358.27 343.31 701.58
BB075 231.511706 127.348 119.3441 115.7535 108.9518 236.0343 420.7544 377.4143 97.87516 126.7315 196.17 118 314.17 I
BB076 262.584561 234.9488 350.5645 93.63779 185.514 135.5438 28.10665 35.70313 80.65548 94.45938 150.17 105.71 255.89
BB077 800.03833 713.2503 369.8534 283.3159 233.8144 228.3348 668.6046 293.7326 97.69315 109.3272 379.8 254.95 634.75
BB078_1 106.401429 384.5918 199.1735 35.19846 67.99452 38.28889 64.48811 158.0028 74.28925 107.9322 123.64 105.23 228.87
BB078_2 318.4134 339.7 133.7285 132.4709 164.7989 85.04491 256.1764 57.05093 28.61479 34.11559 155.01 114.11 269.12
BB079 341.284745 413.5967 214.7857 170.9629 190.54 127.3889 363.9222 136.2971 88.21985 109.8781 215.69 115.99 331.68
BB080 585.832779 769.923 346.3523 195.4594 272.788 91.03496 145.0927 17.45049 51.96482 92.61719 256.85 247.15 504
BB081 378.85474 781.0749 559.4355 152.8784 228.8427 86.99601 244.7029 245.4552 189.5073 228.6644 309.64 210.67 520.31
BB082 747.130919 1183.094 524.0637 179.8843 297.0433 88.77553 387.3977 222.0479 165.4853 171.5766 396.65 340.58 737.23
BB083 243.620532 353.3191 164.0545 330.9215 452.4502 611.6682 168.1633 179.0767 257.5662 155.0259 291.59 149.05 440.64 S
BB084 650.880506 532.7412 162.3119 342.9731 261.7926 166.1786 244.013 296.2548 96.07459 119.6164 287.28 180.47 467.75
BB085_1 261.35661 224.4993 143.3102 157.8852 183.6809 135.2653 219.35 361.1507 124.5502 129.8162 194.09 74.849 268.94
BB085_2 529.190118 633.2456 193.7919 189.4115 184.223 89.22076 296.6596 203.1408 138.8989 149.0771 260.69 178.76 439.44
BB086 279.416263 239.0659 176.3913 34.20663 42.66434 41.99699 17.13943 637.0525 62.09834 101.4947 163.15 190.09 353.24
BB087 453.347933 499.0692 415.7385 246.0219 141.9824 74.13605 201.7042 53.87698 36.53076 44.66469 216.71 179.79 396.49
BBtmRNA 19442.4032 17322.65 12334.52 49432.05 50553.26 110030.4 39388.58 128807.8 314430.1 294803.5 103655 112749 216404 I
BBRNAseP 240813.909 428996.7 457521.8 308500.5 336893.2 185428.4 188274.5 109688.5 224791.5 188524.3 266943 113222 380165
BB088_1 273.198869 335.1273 190.9538 33.37076 53.57955 21.70031 59.0506 81.69049 54.01417 61.2507 116.39 110.16 226.56
BB089 189.143969 162.6434 91.97164 67.46679 67.94362 92.30516 316.3932 225.4663 138.8458 178.6638 153.08 78.998 232.08
BB090 442.027783 416.8685 187.1979 147.7688 140.0678 247.8772 229.3037 118.1707 68.42478 84.99072 208.27 129.87 338.14
BB091 122.043331 87.45106 83.21218 55.09316 44.48606 44.19333 173.0611 404.3914 418.7804 463.1307 189.58 170.09 359.67 I
BB092 379.443361 158.6806 112.4885 9123.282 7221.958 13936.21 181.4977 167.9381 75.54182 39.03012 3139.6 5069.4 8209 S
BB093 495.083703 266.1492 196.1989 222.1314 136.1442 94.43841 1061.172 987.3418 1281.689 1911.895 665.22 615.09 1280.3 I
BB094 390.332928 213.9006 158.4259 112.2414 83.44362 200.7864 142.8467 121.2921 113.1242 108.9979 164.54 89.537 254.08
BB095 267.271777 327.7481 434.2029 104.0519 156.1351 84.53462 405.9492 276.4481 98.77019 121.6737 227.68 132.14 359.81
BB096 385.701359 390.6854 183.6712 297.8884 229.8164 211.9839 847.5209 353.9396 545.1214 475.4792 392.18 197.31 589.49
BB097 426.323702 437.3399 371.4102 95.54965 137.3572 123.0601 433.6923 472.2337 260.4838 357.7289 311.52 145.52 457.04
BB098 514.018604 948.8995 530.1956 85.33739 215.824 50.86943 85.8162 243.106 81.67664 83.52095 283.93 293.67 577.59
BB099 312.144434 228.3959 123.7823 215.0763 136.1833 118.6554 204.4773 243.458 298.0347 376.0464 225.63 85.67 311.3
BBspeF 371.647908 178.4116 371.404 167.675 114.5098 575.6127 3120.286 979.8654 394.0825 413.1213 668.66 896.39 1565.1
BBar45 555.441642 195.0332 327.4399 587.9792 649.9371 1453.576 3236.169 947.8318 347.7166 361.9515 866.31 910.01 1776.3
BB100 597.579464 1207.95 596.6917 321.1579 354.6874 175.2911 465.6404 496.2974 183.0318 194.9301 459.33 308.54 767.87
BB101_1 131.932162 176.779 178.7252 69.28139 71.66459 46.00189 256.3726 384.3275 231.5393 290.7084 183.73 108.85 292.58
BB101_2 324.124905 201.442 98.3094 90.7163 148.0383 95.86954 78.18405 79.58947 35.00911 35.95488 118.72 87.336 206.06
BB102 477.082624 596.2911 579.7693 190.9088 177.2367 99.1084 457.4175 592.2828 254.6559 313.7954 373.85 189.34 563.2
BB103_1 24534.225 2150.582 1351.537 3681.434 3372.439 4771.812 4876.949 6963.81 43933.98 42319.41 13796 16820 30616 I
BB103_2 16854.3283 1550.926 1179.037 11196.35 2982.026 4067.151 3508.035 407.0011 2431.215 2253.889 4643 5233.9 9876.9 S
BB103_3 13789.2893 1318.755 1001.653 9408.019 2354.007 3997.431 1547.845 478.9296 1725.089 1658.47 3727.9 4375.4 8103.3 S
BB103_4 482.761923 226.4913 262.2218 157.7326 90.18855 85.24615 518.4092 3763.102 2178.283 2359.409 1012.4 1286.1 2298.4 I
BB104_1 2157.92981 122.0493 105.6033 1334.557 702.142 951.6676 408.4418 686.1369 1793.063 2329.96 1059.2 811.43 1870.6
BB104_2 532.204368 72.3747 57.81754 188.3075 54.27911 129.972 226.0384 556.4679 2272.04 3223.724 731.32 1101.2 1832.5 I
BB105_1 3383.89401 648.5271 461.4739 745.745 416.5371 795.3154 447.2481 2877.825 9354.669 8704.32 2783.6 3459.6 6243.2 I
BB105_2 423.00542 569.6361 544.7256 185.1116 161.5011 100.1391 436.3821 1127.41 807.6754 1169.877 552.55 380.04 932.59 I
BB106 199.842177 299.0306 233.9579 92.6139 86.15237 42.76914 108.9409 363.8788 95.22931 120.2618 164.27 105.35 269.62
BB107_1 2724.5208 1991.73 1957.317 735.6687 591.4861 819.6458 405.3686 1622.051 449.5969 575.7949 1187.3 817.57 2004.9
BB107_2 3357.10237 2699.52 2443.829 1231.982 1359.229 2417.168 281.7174 1614.161 511.5469 635.8276 1655.2 1037.7 2692.9
BB107_3 2442.60441 1685.996 1369.376 885.6213 829.3546 1153.534 122.8438 3482.17 1240.386 1873.785 1508.6 938.05 2446.6
BB108 612.931082 511.3048 366.5154 978.8257 376.9907 983.7782 475.2998 364.2498 639.2356 671.1033 598.02 231.12 829.15 S
BB109 2977.43093 6402.064 3043.709 1453.525 2355.855 1984.529 2440.322 1395.491 1041.63 1238.558 2433.3 1564.5 3997.8
BB110 1445.06128 3573.185 1898.523 283.9721 806.8761 101.7905 175.0421 305.3503 310.6251 305.489 920.59 1107.6 2028.2
BB111 312.432795 585.739 346.6421 87.40798 180.0605 90.42414 111.5499 141.5414 37.041 52.38694 194.52 172.34 366.86
BB112 76.1275193 94.02042 58.14484 30.7334 27.76421 15.00712 64.51041 516.0034 168.4895 227.2601 127.81 151.68 279.49
BB113 88.7740386 50.48516 34.7599 47.65324 81.69832 347.5907 75.53579 100.3604 85.48432 77.64176 98.998 89.759 188.76
BB114 749.777825 467.3767 145.7038 405.2286 350.9563 446.856 302.4716 176.7304 65.2524 53.7115 316.41 215.42 531.82
BB115 283.23527 255.1752 127.6819 72.88804 60.17154 40.41213 114.1625 603.5838 182.9434 226.9835 196.72 165.84 362.57
BB116 386.860684 463.5127 243.8813 79.4913 93.09005 181.7094 197.565 330.4772 65.23436 65.89707 210.77 143.21 353.98
BB117 354.25929 476.544 298.6725 167.834 145.4245 77.8761 241.56 107.1798 65.40299 70.69686 200.55 139.09 339.63
BB118 537.653253 687.8962 379.7209 144.1069 145.3259 102.9878 1 1008.299 308.6478 275.0549 359.07 308.62 667.69
BB119 1805.89812 1109.787 638.1871 648.5879 419.8632 437.4673 2207.422 439.663 283.7755 315.136 830.58 669.64 1500.2
BB120 246.505926 194.2599 135.0042 74.92066 48.83287 51.80266 179.4514 245.3647 355.49 486.1326 201.78 139.59 341.37 I
BB121_1 920.792856 1511.297 636.4139 210.2122 341.356 142.6457 279.7619 203.7383 195.2214 181.4373 462.29 443.68 905.97
BB121_2 11669.8659 18412.31 4809.886 1185.018 3377.111 733.89 316.4279 255.3965 833.0573 858.2561 4245.1 6083.4 10328
BBSRP 300.271822 234.3135 225.6228 860.9071 768.3485 2006.872 92.8433 91.03039 212.8621 166.312 495.94 594.92 1090.9
BB122 816.675959 439.3797 660.8004 322.2178 287.6851 407.6271 1617.527 1770.799 761.6592 890.7983 797.52 517.99 1315.5 I
BB123 303.839729 519.6717 407.9949 130.9959 209.8089 125.5209 197.5667 719.0328 495.4105 610.5364 372.04 209.73 581.77 I
BB124 1635.9011 112.0891 99.01927 395.3434 219.4397 1270.394 126.5486 16.23152 24.17041 55.54666 395.47 574.74 970.2 S
BB125_1 738.31857 963.5678 735.2077 236.6555 240.5886 283.0279 556.2148 220.8494 137.5356 151.8695 426.38 296.31 722.69
BB125_2 410.697517 230.9142 220.4415 113.7877 67.18871 66.46507 1108.332 474.5114 191.0529 249.5645 313.3 309.71 623
BB126 466.407064 642.7871 520.5039 183.3066 273.1611 122.6094 593.7753 287.2139 113.0735 139.5737 334.24 204.14 538.38
BB127 351.928821 250.3317 261.0218 162.0284 176.9269 224.7689 306.5443 232.7855 82.16717 107.4522 215.6 84.572 300.17
BB128 151.470901 80.84457 62.41229 52.83837 36.23647 40.46633 153.1045 420.8572 100.7948 142.9293 124.2 113.54 237.74
BB129 329.4886 327.1539 187.9458 134.3244 148.619 92.32172 249.8832 139.7903 34.81202 46.25113 169.06 104.93 273.99
BB130_1 657.554405 523.09 492.2728 268.1249 141.0131 128.048 727.2796 414.2803 274.2309 349.6073 397.55 203.86 601.41
BB130_2 951.774683 743.4078 545.7157 319.3034 398.5611 566.6704 1522.55 1874.871 2341.665 2770.117 1203.5 872.11 2075.6 I
rpoD 348.921354 245.5633 298.6134 260.3189 255.3644 254.9965 312.7889 371.0605 269.5809 258.6272 287.58 43.792 331.38
I: Upregulated in ONLY two of 4 of PlBG, HUVE, HB37, and HBBG (1 STDEV higher than mean)
S: Upregulated in ONLY two of four of Pl25, pH06, pH07, pH08 (1STDEV higher than mean)
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Table S4.5: Predicted IntaRNA targets of B. bacilliformis infection-specific sRNAs. 
An “X” indicates transcripts of the indicated gene to which the sRNA is predicted to bind 
(p < 0.01). Targets with a FDR < 0.05 are indicated with a red “X”. 
 
Gene Name Product BB003 BB016 BB020 BB022 BB024 BB025 BB035 BB039 BB048 BB060 BB075 BB093 BB103-1 BB103-4 BB104-2 BB105-1 BB105-2 BB122 BB130-2
BARBAKC583_RS05120 DUF1561 X X X
BARBAKC583_RS05100 glutathione S-transferase X X X X
BARBAKC583_RS06570 cysteine biosynthesis protein X X X X X
BARBAKC583_RS04740 Potassium transporter X
BARBAKC583_RS05285 MFS transporter X X
BARBAKC583_RS00785 ABC transporter X
BARBAKC583_RS05700 bifunctional riboflavin kinase/FAD synthetase X
BARBAKC583_RS02940 NAD kinase X
BARBAKC583_RS04335 DUF1561 X
BARBAKC583_RS00225 1-acyl-sn-glycerol-3-phosphate acyltransferase X
BARBAKC583_RS00920 DUF1376 X X
BARBAKC583_RS00500 YdcF family protein X X
BARBAKC583_RS04305 protein translocase subunit SecDF X X X
BARBAKC583_RS05805 DUF1561 X X
BARBAKC583_RS02365 replicative DNA helicase X X
BARBAKC583_RS04885 metallophosphatase X X
BARBAKC583_RS00875 dUTP diphosphatase X X
BARBAKC583_RS06040 tRNA threonylcarbamoyltransferase TsaB X X
BARBAKC583_RS01605 lytic murein transglycosylase X
BARBAKC583_RS00560 ATP synthase subunit alpha X
BARBAKC583_RS04685 Na/Pi cotransporter family protein X
BARBAKC583_RS00520 YggS family pyridoxal phosphate-dependent enzyme X X
BARBAKC583_RS06070 apolipoprotein N-acyltransferase X
BARBAKC583_RS03885 ABC transporter ATP-binding protein X
BARBAKC583_RS02890 glutamate--tRNA ligase X X X
BARBAKC583_RS03690 DUF1561 X
BARBAKC583_RS03935 tyrosine--tRNA ligase X
BARBAKC583_RS00740 Holliday junction branch migration DNA helicase RuvB X X X
BARBAKC583_RS06260 heme exporter protein CcmC X
BARBAKC583_RS02000 DUF721 X
BARBAKC583_RS00090 septation protein A X X
BARBAKC583_RS05960 cell wall hydrolase X
BARBAKC583_RS02725 transcription termination/antitermination protein NusG X X
BARBAKC583_RS03670 bifunctional N-acetylglucosamine…. X
BARBAKC583_RS01850 S49 family peptidase X X
BARBAKC583_RS04485 MFS transporter X X
BARBAKC583_RS06645 PTS IIA-like nitrogen-regulatory protein X
BARBAKC583_RS00985 5-formyltetrahydrofolate cyclo-ligase X
BARBAKC583_RS04990 ABC transporter permease X X
BARBAKC583_RS04665 DUF541 X X
BARBAKC583_RS06305 FxsA cytoplasmic membrane protein X
BARBAKC583_RS01780 Na+/H+ antiporter NhaA X
BARBAKC583_RS02820 phosphatidate cytidylyltransferase X
BARBAKC583_RS00285 diaminopimelate decarboxylase X
BARBAKC583_RS06155 type I pantothenate kinase X
BARBAKC583_RS01055 DNA gyrase inhibitor YacG X
BARBAKC583_RS05860 DUF2093 X X X
BARBAKC583_RS05965 phosphate transport system regulatory protein PhoU X
BARBAKC583_RS06225 DNA replication and repair protein RecF X
BARBAKC583_RS04370 membrane protein X
BARBAKC583_RS06580 bifunctional folylpolyglutamate synthase/dihydrofolate synthase X X
BARBAKC583_RS06045 ribosomal-protein-alanine N-acetyltransferase X
BARBAKC583_RS01225 sensor histidine kinase X
BARBAKC583_RS05905 nucleoside deaminase X
BARBAKC583_RS02115 aminopeptidase N X X
BARBAKC583_RS00630 metalloprotease X
BARBAKC583_RS06285 ornithine carbamoyltransferase X X
BARBAKC583_RS04845 photosystem reaction center subunit H X
BARBAKC583_RS01815 ATP sythase subunit b 2 X
BARBAKC583_RS00600 monofunctional biosynthetic PG transglycosylase X
BARBAKC583_RS02025 S9 family peptidase X
BARBAKC583_RS02980 NADPH:quinone oxidoreductase X X
BARBAKC583_RS05130 type II toxin-antitoxin system HicB family antitoxin X
BARBAKC583_RS05275 transcriptional repressor X X
BARBAKC583_RS00200 shikimate kinase X
BARBAKC583_RS06280 acetylornithine transaminase X
BARBAKC583_RS05870 3-deoxy-D-manno-octulosonic acid transferase X
BARBAKC583_RS02490 CDP-diacylglycerol--glycerol-3-phosphate X X
BARBAKC583_RS00375 bifunctional….. X
BARBAKC583_RS06430 tRNA pseydouridine synthase TruA X
BARBAKC583_RS02210 hemin ABC transporter substrate-binding protein X
BARBAKC583_RS03255 30S ribosomal protein S3 X
BARBAKC583_RS05845 alpha-hydroxy-acid oxidizing enzyme IldD X
BARBAKC583_RS02435 molecular chaperone SurA X
BARBAKC583_RS05900 rRNA pseudouridine synthase X
BARBAKC583_RS01230 two-component system response regulator X
BARBAKC583_RS01520 ribosomal RNA large subunit methyltransferase E X
BARBAKC583_RS02605 PAS domain-containing sensor histidine kinase X
BARBAKC583_RS04760 SH3 domain-containing protein X
BARBAKC583_RS04340 DUF1561 X
BARBAKC583_RS06030 YbaB/EbfC family nucleoid-associated protein X
BARBAKC583_RS01425 glutamine synthetase X
BARBAKC583_RS02335 CDP-diacylglycerol--serine O phosphatidyltransferase X
BARBAKC583_RS04110 glycerol-3-phosphate acyltransferase X
BARBAKC583_RS05445 flagellar hook protein FlgL X
BARBAKC583_RS02635 ATP-dependent Clp protease ATP-binding subunit X
BARBAKC583_RS02540 triose-phosphate isomerase X
BARBAKC583_RS02245 DNA polymerase X
BARBAKC583_RS04505 ATP-dependent DNA helicase X
BARBAKC583_RS06685 RNA methyltransferase X
BARBAKC583_RS06585 complex I NDUFA9 subunit family protein X
BARBAKC583_RS05420 flagellar biosynthesis protein FliQ X
BARBAKC583_RS04725 pyridoxal phosphate-dependent aminotransferase X X
BARBAKC583_RS04530 DNA ligase LigA X
BARBAKC583_RS02340 oxidoreductase X
BARBAKC583_RS01690 ABC transporter ATP-binding protein X
BARBAKC583_RS03490 preprotein translocase subunit SecY X
BARBAKC583_RS03925 peptide chain release factor 2 X
BARBAKC583_RS04840 redox-regulated ATPase YchF X
BARBAKC583_RS04090 Holliday junction resolvase RuvX X
BARBAKC583_RS06680 class I SAM-dependent rRNA methyltransferase X X
BARBAKC583_RS04310 lysylphosphatidylglycerol synthetase X X X
BARBAKC583_RS04695 chorismate lyase X
BARBAKC583_RS01715 peptide chain release factor N(5)-glutamine methyltransferase X
BARBAKC583_RS00395 cobaltochelatase subunit CobT X X X X
BARBAKC583_RS04765 excinuclease ABC subunit UvrB X
BARBAKC583_RS01990 site-specific DNA methyltransferase X
BARBAKC583_RS03875 proline--tRNA ligase X
BARBAKC583_RS04200 adenylosuccinate lyase X
BARBAKC583_RS03650 deoxyguanosinetriphosphate triphosphohydrolase X
BARBAKC583_RS00855 bipolymer transporter ExbB X
BARBAKC583_RS00665 cell division protein ZapA X
BARBAKC583_RS00415 tyrosine recombinase XerC X
BARBAKC583_RS02425 ribosomal RNA small subunit methyltransferase A X
BARBAKC583_RS06465 molecular chaperone DnaK X
BARBAKC583_RS03270 30S ribosomal protein S17 X
BARBAKC583_RS02125 hydroxymethylpyrimidine/phosphomethylpyrimidine kinase X
BARBAKC583_RS03080 phosphate acyltransferase X
BARBAKC583_RS04260 ribonuclease D X
BARBAKC583_RS05995 molybdopterin-synthase adenylyltransferase X
BARBAKC583_RS03480 50S ribosomal protein L30 X
BARBAKC583_RS05335 ATP-dependent protease X
BARBAKC583_RS02560 enolase X
BARBAKC583_RS01730 protein translocase subunit SecA X
BARBAKC583_RS04940 histidine phosphotransferase X
BARBAKC583_RS06220 3-dehydroquinate dehydratase X
BARBAKC583_RS06140 HslU--HslV peptidase ATPase subunit X
BARBAKC583_RS06125 polyribonucleotide nucleotidyltransferase X
BARBAKC583_RS00255 DNA polymerase III subunit delta X
BARBAKC583_RS06600 double-strand break repair protein AddB X
BARBAKC583_RS03570 excinuclease ABC subunit UvrA X
BARBAKC583_RS04815 polyphenol oxidase X
BARBAKC583_RS00615 ferredoxin family protein X
BARBAKC583_RS03870 MBL fold metallo-hydrolase X
BARBAKC583_RS00735 tol-pal system-associated acyl-CoA thioesterase X
BARBAKC583_RS02380 30S ribosomal protein S18 X
BARBAKC583_RS00095 signal recognition particle-docking protein FtsY X
BARBAKC583_RS02870 amino acid ABC transporter permease X
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Table S4.6: Predicted IntaRNA targets of B. bacilliformis sand fly-specific sRNAs. 
An “X” indicates transcripts of the indicated gene to which the sRNA is predicted to bind 
(p < 0.01). Targets with a FDR < 0.05 are indicated with a red “X”. 
 
 
 
 
 
 
 
Gene Name Product BB026-1 BB083 BB092 BB103-2 BB103-3 BB124
BARBAKC583_RS04075 cold shock protein X
BARBAKC583_RS01990 site-specific DNA-methyltransferase X
BARBAKC583_RS00630 metalloprotease X
BARBAKC583_RS05275 transcriptional repressor X
BARBAKC583_RS06065 HlyC/CorC family transporter X
BARBAKC583_RS02255 bifunctional (p)ppGpp synthetase/guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase X
BARBAKC583_RS05190 exonuclease X
BARBAKC583_RS05865 tetraacyldisaccharide 4'-kinase X
BARBAKC583_RS02830 outer membrane protein assembly factor BamA X
BARBAKC583_RS00345 signal recognition particle protein X
BARBAKC583_RS04685 Na/Pi cotransporter family protein X
BARBAKC583_RS02620 Trk system potassium transporter TrkA X
BARBAKC583_RS01875 FAD-binding oxidoreductase X
BARBAKC583_RS00690 phosphoglycerate kinase X
BARBAKC583_RS00660 DUF1036 domain-containing protein X
BARBAKC583_RS04320 BolA family transcriptional regulator X
BARBAKC583_RS00065 tRNA uridine-5-carboxymethylaminomethyl(34) MnmG X
BARBAKC583_RS06555 2-polyprenylphenol 6-hydroxylase X
BARBAKC583_RS02125 hydroxymethylpyrimidine/phosphomethylpyrimidine kinase X
BARBAKC583_RS06655 LPS export ABC transporter ATP-binding protein X
BARBAKC583_RS00200 shikimate kinase X
BARBAKC583_RS05325 glycine cleavage system aminomethyltransferase GcvT X
BARBAKC583_RS00430 tRNA methyltransferase TrmD X
BARBAKC583_RS02100 DNA-binding response regulator X
BARBAKC583_RS02225 energy transducer TonB X
BARBAKC583_RS03820 NADH-quinone oxidoreductase subunit NuoF X
BARBAKC583_RS00835 ATP-dependent zinc metalloprotease FtsH X
BARBAKC583_RS04900 tRNA 2-thiouridine(34) synthase MnmA X
BARBAKC583_RS02220 TonB-dependent hemoglobin.transferrin/lactoferrin receptor protein X
BARBAKC583_RS00455 succinate dehydrogenase hydrophobic membrane anchor protein X
BARBAKC583_RS04560 cell division protein FtsA X
BARBAKC583_RS01535 glutamate-5-semialdehyde dehydrogenase X
BARBAKC583_RS05065 16S rRNA (cytidine(1402)-2'-O)-methyltransferase X
BARBAKC583_RS03490 preprotein translocase subunit SecY X
BARBAKC583_RS01680 metal ABC transporter substrate-binding protein X
BARBAKC583_RS05755 peroxiredoxin X
BARBAKC583_RS00070 ribosomal RNA small subunit methyltransferase G X
BARBAKC583_RS01630 phospholipase X
BARBAKC583_RS06440 2345-tetrahydropyridine-26-dicarboxylate N-succinyltransferase X
BARBAKC583_RS02150 phosphomethylpyrimidine synthase X
BARBAKC583_RS00380 SURF1 family protein X
BARBAKC583_RS04465 protease modulator HflC X
BARBAKC583_RS05815 amino acid permease X
BARBAKC583_RS04535 DNA repair protein RecN X
BARBAKC583_RS04720 cold shock protein X
BARBAKC583_RS03380 30S ribosomal protein S10 X
BARBAKC583_RS03220 30S ribosomal protein S10 X
BARBAKC583_RS06280 acetylornithine transaminase X
BARBAKC583_RS02910 DUF2059 domain-containing protein X
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Chapter 5: Conclusions and Future Directions 
 
QMITEs as a source for sRNAs and highly basic proteins 
We have shown that QMITE1 and QMITE2 copies can serve as sources for novel 
sRNAs. Specifically, the sRNAs CbsR3 and CbsR13 were derived from QMITE1 loci, 
whereas CbsR16 was derived from a QMITE2 locus. Although QMITE1 and QMITE2 
exist in multiple copies throughout C. burnetii genomes, RNA-Seq analysis has shown 
that certain loci have unambiguous reads mapping to them, indicating that these loci are 
transcriptionally active. Indeed, we have shown that predicted promoter elements exist 
within the confines of QMITE copies (see Figure S2.11). When transcribed, CbsR13 and 
CbsR16 produce large, stable stem-loop structures (see Figures 2.1B, 2.4B) that may 
serve as substrates for RNase III degradation. The roles for these sRNAs remain unclear, 
although their high ambiguous expression (see Figure S2.3) suggests that they may serve 
some adaptive role. 
          In addition to being the source for sRNAs, some QMITE1 copies contain a short 
ORF coding for highly basic proteins (average pI ~12.4). These uncharacterized proteins 
may confer some adaptive advantage for C. burnetii within the host, where it must 
survive low pH conditions within acidified phagolysosomes. Indeed, while the 
extracellular pH in this niche is ~ 4.5-5, C. burnetii maintains an intracellular pH of 5.1 to 
6.95 [228]. Determining the roles of these proteins within the intracellular niche could 
provide further insights into how C. burnetii survives such an extreme environment. 
enhC and QMITEs as a timeline for C. burnetii strain divergence 
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We determined that QMITE copies show inter-strain sequence and linkage conservation 
(see Table 2.1). While this is useful for establishing a timeline for IS1111 insertion and 
determining recent horizontal gene acquisition, it also allows for tracing individual 
QMITE insertions in order to gauge their effect on strain phenotype. For example, it is 
very interesting to note a QMITE2 insertion in the 3' end of the C. burnetii Dugway 
strain’s enhC gene. This insertion effectively provides a C-terminal extension for the 
resulting EnhC protein, but it is very possible that the strong secondary structure of the 
QMITE2 insertion may cause ribosome stalling, leading to degradation of the transcript 
via tmRNA [229, 14]. Since EnhC has been implicated in the virulence of L. 
pneumophila, a close pathogenic relative of C. burnetii, it is conceivable that this 
QMITE2 insertion in the Dugway strain enhC gene renders it avirulent [161, 162, 139]. 
The avirulent nature of the Dugway strain remains a mystery, so this could provide 
valuable information on the factors necessary for successful host infection. 
CbsR12 is a trans-acting sRNA that also binds CsrA 
In this study, we carried out a comprehensive characterization of a highly expressed, 
infection-specific sRNA of C. burnetii, named CbsR12. This sRNA was found to be 
necessary for CCV expansion during early infection of a human monocyte-derived 
alveolar macrophage cell line (THP-1s) (see Figure 3.4). Growth rate also correlated to 
CbsR12 expression, both in vitro and during THP-1 infection (see Figures 3.2, 3.3). We 
also determined that the regulation of CbsR12 was dependent on the genomic context, as 
a transposon-based genetic complement of a cbsR12 mutant targeted towards a different 
genomic locus resulted in the dysregulation of CbsR12 expression (see Figures 3.2, 3.3). 
As a result, we conclude that there may be an unknown transcriptional regulator of 
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CbsR12 expression. Indeed, there is a predicted PmrA binding site within the cbsR12 
promoter, although this element was also present in the cbsR12 complementation 
cassette. As a result, it does not fully explain the noted dysregulation of CbsR12 
expression. Determining the mechanisms for CbsR12 regulation would help in 
understanding its expression pattern during infection. 
          We determined that CbsR12 is a trans-acting sRNA that engages in the post-
transcriptional regulation of carA and metK. We also determined that CbsR12 binds to 
transcripts of cvpD and ahcY in vivo. Additionally, CbsR12 binds to CsrA-2, but not 
CsrA-1, in vitro. These data, in addition to the E. coli biofilm induction data, indicate that 
in addition to its in-trans activities, CbsR12 also serves as an RsmY/Z sRNA of C. 
burnetii. These sRNAs act by binding CsrA, sequestering it away from its regulatory 
activities [29]. We have also determined that CbsR1, another highly expressed infection-
specific sRNA, also harbors multiple CsrA-binding sites. Furthermore, CbsR1 seems to 
contain a classical GacA/LetA-binding site that is common amongst RsmY/Z sRNAs 
[27]. Since the CsrA regulon of C. burnetii is wholly unknown, we hope that these 
conclusions will lead to more research into this important regulatory network. For 
example, determining the regulatory mechanisms of CbsR1 and CbsR12 expression 
would be important, as would determining the repertoire of mRNAs to which CsrA-1 and 
CsrA-2 bind. The regulation of CsrA-1 and CsrA-2 production would also be a fruitful 
area of research. Despite all that is unknown, we have developed a model of what we 
know about the C. burnetii CsrA regulon, to date (Figure 5.1). 
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Figure 5.1: What is known of the CsrA regulatory cascade/regulon in C. burnetii. An 
uncharacterized host signal triggers a putative sensor kinase(s), leading to regulation of 
CbsR1/CbsR12 by an unknown response regulator. In turn, CbsR12 may promote CCV 
expansion via regulation of the CvpD T4BSS effector. CbsR12 also promotes replication 
through in-trans regulation of CarA and MetK production. CbsR1/CbsR12 may also bind 
CsrA-1/CsrA-2, leading to sequestration and indirect regulation of the CsrA-1/CsrA-2 
targetome. 
 
Determining the role of the methionine cycle in C. burnetii 
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Our research into CbsR12 has lead to many additional questions regarding the methionine 
cycle in C. burnetii. Since C. burnetii is a semi-auxotroph for methionine, it is presumed 
that the bacterium can scavenge it from the host [182]. Indeed, an ABC transporter for 
methionine has been predicted in C. burnetii [182]. We determined that CbsR12 
negatively regulates MetK production. MetK is responsible for converting methionine to 
SAM, which is an essential methyl group donor in bacterial cells [166]. Although the 
regulation of MetK production in the context of retaining scavenged methionine is 
intuitive, C. burnetii would seemingly also require a mechanism for producing or 
scavenging SAM. Indeed, SAM scavenging has been reported in another obligate 
intracellular pathogen, Rickettsia prowazekii [185]. Furthermore, we have determined, 
through position-specific iterated BLAST (PSI-BLAST) homology and in silico protein 
folding analysis [230], that CBU_0636 may be a SAM transporter homolog (Figure 5.2). 
If so, it may provide a compensatory mechanism for the down-regulation of MetK 
production by CbsR12. Also, determining the nature of ahcY regulation by CbsR12 may 
also provide insights into the role of the methionine cycle during infection. 
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Figure 5.2: CBU_0636 may be a SAM transporter homolog. I-TASSER protein 
structure comparisons of the R. prowazekii Madrid E SAM transporter (sam gene) (A) 
and the C. burnetii RSA493 CBU_0636 gene product (B). 
 
BbsRs as a means of rapid regulation in rapidly changing environments 
We performed total RNA-Seq analysis on B. bacilliformis grown in vitro then shifted to 
one of ten conditions designed to mimick the various environments encountered by the 
pathogen during its life cycle. In doing so, we discovered 160 novel sRNAs, some of 
which were found to be differentially expressed under certain conditions (see Table 
S4.3). We hope that the discovery of these sRNAs leads to many future characterization 
studies. Additionally, since we performed total RNA-Seq, global gene expression 
analyses can be carried out. Alternatively, the results may be used as reference datasets in 
future studies. 
          Determining the B. bacilliformis Hfq targetome would be useful in further 
characterizing the identified sRNAs. For example, by performing an in vivo crosslinking 
analysis such as CLASH [48], one could simultaneously determine the repertoire of Hfq-
binding sRNAs along with the mRNAs they target. It is worth noting, though, that the 
majority (149 out of 160) of the sRNAs we identified do not have a predicted Rho-
independent terminator, which is thought to be essential for binding Hfq (see Table S4.3) 
[20]. However, this doesn’t rule out the possibility of some unknown sRNA chaperone 
being involved. 
          Among the B. bacilliformis sRNAs we identified, the BB103 grouping (BB103-1, 
BB103-2, BB103-3, and BB103-4; see Table S4.3) is ideal for future characterization. 
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While each sRNA shows high expression under certain conditions (see Table S4.4), we 
determined that BB103-1 and BB103-4 are infection-specific, while BB103-2 and 
BB103-3 are sand fly-specific. Furthermore, BB103-1 and BB103-4 are both predicted to 
target transcripts of the RS04310 gene, coding for lysylphosphatidylglycerol synthetase, 
which is involved in the defense against host antimicrobial peptides by other pathogens 
(see Table S4.5) [219]. Determining the targetomes of these sRNAs and how they are 
regulated may help in understanding how B. bacilliformis adapts to the mammalian host 
and sand fly vector. 
BbsR9 is a Bartonella-specific sRNA uniquely expressed in the arthropod vector 
We determined that BbsR9 is a highly expressed, sand fly-specific sRNA that targets 
transcripts of the ftsH, nuoF, and gcvT genes, in vitro (see Figures 4.6, 4.7). We 
hypothesize that the regulation of these transcripts aids B. bacilliformis in persistence in 
the sandfly vector. Additionally, BbsR9 has a predicted Rho-independent terminator and 
is also conserved in some other Bartonella spp. Since pathogenic Bartonella spp. are 
vector-borne, we predict that BbsR9 is involved in persistence in a wide array of 
arthropod vectors. Experimental infections of L. verrucarum with a bbsR9 mutant strain 
could be done to help determine its role in persistence. Additionally, since BbsR9 may be 
bound by Hfq, CLASH [48] could be useful in determining its repertoire of mRNA 
targets. Finally, since BbsR9 is appreciably expressed under very limited conditions 
(pH06, pH07, and pH08; see Tables 4.1, S4.4), it would be prudent to identify the 
specific regulators involved, as they may also be generically involved in the transition of 
B. bacilliformis from vector to host and back again. 
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